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Abstract
W. JOHN MACMULLEN: Contextual Analysis of Variation and Quality in
Human-curated Gene Ontology Annotations
(Under the direction of Gary Marchionini)
Two prospective randomized controlled studies of scientific curators of model
organism databases (MODs) were conducted using common document collections to
investigate the origins, nature, and extent of variation in curators’ Gene Ontology (GO)
annotations. Additional contextual data about curators’ backgrounds, experience,
personal annotation behaviors, and work practices were also collected to provide
additional means of explaining variation. A corpus of nearly 4,000 new GO annotations
covering 5 organisms was generated by 31 curators and analyzed at the paper, instance,
and GO element levels. Variation was observed by organism expertise, by group
assignment, and between individual and consensus annotations. Years of GO curation
experience was found to not be a predictor of annotation instance quantities. Five facets
of GO annotation quality (Consistency, Specificity, Completeness, Validity, and
Reliability) were evaluated for utility, and showed promise for use in training novice
curators. Pairwise matching and comparison of instances was found to be difficult and
atypical, limiting the usefulness of the quality measures. Content analysis was performed
on more than 600 pages of curators’ hand-annotated paper journal articles used in GO
annotation, yielding six types of common notations.
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ABBREVIATIONS AND TERMS
EC Evidence Code
Evidence source An entity from which claims are drawn in order to create
GO annotations; these are most often individual scientific
journal articles.
GO Gene Ontology
GO annotation A set of one or more individual GO annotation instances
created in relation to a particular evidence source.
GO annotation element One of the 15 components of a formal GO annotation
instance, currently defined by the GO Consortium
documentation as containing 11 required and 4 optional
elements; a database-independent subset of 9 of these
elements was used for the two studies in this project.
GO annotation instance The set of GO annotation elements created in relation to
a particular gene product from an evidence source.
MMS Multi-MOD study
MOD Model organism database
SMS Single-MOD study
1. Introduction
1.1. Problem statement
The wide variety of information in databases for biological model organisms has
great potential utility for biomedical researchers, but only if it is of high quality. Human-
curated annotations made in model organism databases are viewed as important links
between an organism’s underlying genomic data and the experimental literature. Gene
Ontology (GO) annotations in particular are expected to provide significant value in
reducing disciplinary fragmentation, and facilitating cross-organism information
integration. As an organism-independent set of controlled vocabularies, scientists could
use GO to cut across disciplinary boundaries to discover information relevant to their
specialty. However, a common question associated with manually-curated
knowledgebases (such as GO, model organism databases (MODs), and even
PubMed/MEDLINE) is to what degree variation in human curators’ annotations affects
the overall quality of information in the resource. Information quality is a complex
concept, with many facets that have interdependencies. While annotation quality is of
great importance to the genomics community, very little is known about the types and
amounts of GO annotation variation in MODs. Dolan, et al. (2005) state that:
Since differences in application of annotation standards would dilute the
effectiveness of comparative analysis, methods for assessing annotation consistency
are essential. The development of methodologies that are broadly applicable for the
assessment of GO annotation consistency is an important issue for the comparative
genomics community (i136).
21.2. Research questions
A broad question the opening problem statement implies is, “How and why do
human curators differ in their GO annotation processes and outcomes?” This project
investigated this through three more specific questions:
1. How significantly do curators differ in annotation outcomes? This question was
investigated by conducting individual and consensus annotation experiments and
comparing differences in curators’ formal GO annotations against a parameterized
model of annotation quality, and through the use of statistical analysis.
2. Do differences in curators’ educational-, training-, and research backgrounds
influence their GO annotation performance? This question was investigated by
comparing the formal GO annotation data from the individual and consensus
annotation experiments with demographic data collected from questionnaires, and in
individual semi-structured interviews.
3. Do differences in curators’ personal annotation behaviors influence their GO
annotation performance? This question was investigated by comparing formal GO
annotation data from individual and consensus annotation experiments with data on
personal annotation behaviors collected in individual interviews, observations, and
artifact analyses.
While this work focuses on individual differences in human curation, many other
related questions are not addressed by this project. Lack of variation should not
3necessarily be viewed as equating with high-quality annotations (or vice-versa); for
example, curators could be in perfect agreement but be incorrect. We may be interested in
comparing not only individual curators’ annotations against human-created reference
annotations, but also comparing them to the performance of automated and semi-
automated approaches to curation.
1.3. Project context
Biomedical database curation is a quickly-evolving role within the biomedical
research community. ‘Curation’ is the process of collecting, organizing, synthesizing, and
presenting biomedical data and information in online environments in order to increase
their utility for end users. The underlying data and information are generally a
combination of biological and biochemical data, such as gene- and genome sequences or
protein structures, and information extracted from the scientific literature. Through the
use of controlled vocabularies such as the Gene Ontology (GO), curators integrate these
forms of information to bring together what is known about particular organisms or
diseases. Curators are typically Ph.D-trained scientists who use their subject-matter
expertise in conjunction with additional training in controlled vocabularies and
information systems to make large quantities of data and information more accessible by,
and useful for, researchers. Sections 3.6 and 3.7 describe in more detail the characteristics
of the curators involved in this study.
1.4. Prior work
This section reviews the existing literature on annotation-related work relevant to this
study. Since no studies of the process and context of GO annotation had been performed
4prior to this work, other work is reviewed from different domains that used methods
similar to those employed here.
1.4.1. Introduction
Social and historical studies of biological science and scientists often focus on the
culture and practice of science as socially-constructed epistemic activities (e.g., Knorr-
Cetina, 1999; Latour, 1987; Latour and Woolgar, 1986), on the history of specific
scientists and trends in science (e.g., Angier, 1999; Judson, 1996; Kay, 1996 & 2000;
Lindee, 2005), and, increasingly, on particular organisms and the specific tools and
materials of experimentation used to understand them (e.g., Ankeny, 1997; Bowker,
1995; Burian, 1993; de Chadarevian, 1998; Clause, 1993; Creager, 2002; Fujimura, 1987;
Hilgartner, 1995; Hine, 2006; Kellog & Shaffer, 1993; Kohler, 1994; Leonelli,
forthcoming; Rader, 2004). In biomedical informatics and information and library
science, the scope is often much narrower, frequently focused on end-user information
seeking and use behaviors (e.g., Bartlett & Toms, 2005; Brown, 2003; Detlefsen, 1998;
Wildemuth, 2004), including interdisciplinary collaboration (e.g., Palmer, 1999), as well
as such technical facets as interface design and usability (e.g., Rose et al., 2005),
vocabulary and ontological issues (e.g., Whetzel, et al., 2006), retrieval performance
(e.g., Camon et al., 2005; Cohen & Hersh, 2006), data- and text mining, and knowledge
discovery approaches (e.g., Shatkay & Feldman, 2003; Srinivasan, 2004), and
visualization of large data sets (e.g., Wong & Cartwright, 2005). Bibliometrics and
scientometrics have been a longstanding but often separate approach to the measurement
of the growth, productivity, and impact of the knowledge produced by science in the form
of publications, and the relationships among them. (e.g., Price, 1986; White & McCain,
51989). Those approaches can be useful in understanding the structures of, and
relationships between, multiple biomedical databases that are linked both physically and
conceptually (e.g., MacMullen 2005b).
This project takes a different approach, and focuses on people as actors in an
information management context, in an attempt to understand how human information
interactions affect the development and use of information systems for biomedical
research, particularly the phenomenon of annotation in model organism databases, and
the unique features and challenges human scientific curators face when creating Gene
Ontology (GO) annotations.
1.4.2. Structured data annotation in biomedicine
While personal or informal annotations similar to those in other domains are made in
many contexts in biomedical research, formal annotation in the specific context of
biomedical research databases is manifested in very different forms, as illustrated below.
The phenomenon, however, is conceptually the same: assertions are extracted from some
evidence source (e.g., a scientific article) and linked to an underlying object. To use an
example relevant to the work proposed below, scientific curators making Gene Ontology
annotations to a particular organism examine evidence sources (e.g., scientific articles) to
identify entities (e.g., genes) and assertions (e.g., ‘gene x was found to be of type t’) for
use in creating formal annotations (e.g., ‘gene x has molecular function f, participates in
biological process p, and is found in cellular component c’). As with the earlier concepts,
this process creates both intellectual linkages and linkages between physical artifacts.
The ‘annotation’ that results from this process is quite different, however, from the
colloquial instance of textual marginalia. While scientific curators may in fact make those
6types of personal annotations on an evidence source when extracting assertions, the
ultimate annotation entity that is created is a highly structured, distilled, formalized,
unambiguous artifact that is intended not only for public consumption, but is expected to
be computationally manipulatable as well. Use of the term ‘annotation’ varies
significantly even within biological sub-domains, such as molecular biology, and
research that on its face appears to be about the types of annotation quality this project is
interested in evaluating are often quite different. Ouzounis and Karp (2002), for example,
define annotation as “the process by which structural or functional information is inferred
for genes or proteins”. Ussery and Hallin (2004) implicitly define annotation quality as
gene-finding accuracy, in which factors such as the methods used to infer homology
(such as sequence similarity algorithms) can affect the quality of the annotation.
An additional difference is that, in many cases, controlled vocabularies of various
types are employed by annotators rather than free text. In the case of GO annotations, the
large, complex three-aspect system necessitates software tools to search and browse the
vocabularies to locate appropriate terms to use when creating annotations.
The term ‘annotation’ frequently occurs in reference to nucleic or amino acid
sequence data, as any information that is overlaid to provide context, disambiguation, and
linkage of entities. In MEDLINE there were 834 papers with the term ‘annotation’ in the
title, and 3,389 with the term in the title or abstract, as of 2007-03-09.
While paper-based exist in biomedical contexts (especially in the clinical
environment; see, e.g., Chapman & Dowling, 2005), this project is focused primarily on
annotations that occur in structured online information resources, particularly model
organism databases (MODs) such as those for the mouse, yeast, fruit fly and roundworm.
7Although a substantial body of research exists on annotation in the humanities and
everyday life contexts (see, e.g., Marshall 1997, 1998), very little research has
characterized annotation in biomedical contexts. Apart from some basic statistics and
annual reports from the databases themselves, almost no work has independently
explored annotations in any of the three facets of biomedical annotation in which we are
interested: as a process, as an artifact, and as a unit of knowledge. As noted in
MacMullen (2005a), “[t]he majority of annotation-oriented research in the biomedical
domain is focused on the problem of automatically deriving and assigning high-quality
annotations to large databases of gene and protein sequences in order to understand single
genes or organisms, and to aid in the recognition of cross-organism similarities of
multiple molecules.”
The concept of annotation quality in biomedical databases, and particularly MODs,
has been studied very little. The research on which this project builds includes Stein’s
(2001) review that described the concept of biomedical annotation and its goals, and
proposed four generalized examples of annotation workflow models. As part of the
BioCreAtIve project (Hirschman, et al., 2005), Camon, et al. (2005) and Colosimo, et al.
(2005) investigated the feasibility of automated classification for the functional
annotation of proteins in the UniProt database using GO terms, and performed the first
inter-annotator agreement study of manual GO curation. Camon, et al. provided a general
description of the manual GO curation process, but not from the perspective of individual
model organism databases, or how that process relates to other curation activities.
Colosimo, et al. (2005) performed a very small inter-annotator reliability test (3
annotators, 89 documents), and seemed to equate agreement with how ‘hard’ (difficult)
8particular organisms are to annotate. Their task involved the extraction of genes from
articles, not GO annotation consistency specifically. Dolan, et al. (2005) developed a
method for assessing the consistency of GO annotations made to orthologous genes
across manually-curated joint mouse-human GO annotations. However, this work
focused on the ultimate inconsistencies, not on the processes that led to them, or on the
human components of annotation. The results were limited by the small set of annotations
available for comparative purposes, the use of ‘Slim’ versions of the GO ontologies
(discussed in section 4, below), and minimal comparisons at very granular levels of
detail. They did not discuss how inconsistencies in gene identification or Evidence Code
assignment by different curators may impact their measures, nor how to rationalize cases
where the numbers of annotation instances differ across curators, a major issue in
evaluating consistency, as discussed in the Results section below. Apart from resource-
level overviews (such as Chen et al., 2005, or Christie et al, 2004), no other detailed
characterizations of annotation in biomedical databases have been found. Rother et al.
(2005) compared annotations in fifteen protein databases to assess coverage, linkages,
and overlap, using the unique approach of a phylogenetic tree model to assess similarity
of content, but while that method could possibly be useful to assess GO annotation
quality at a high level, it is not granular enough to be useful to this project. Other research
on annotation quality has focused on the ontological consistency of the underlying GO
infrastructure (e.g., Yeh, et al., 2003), or on the general concern about the quality of
automatically-assigned annotations in biomedical databases (see, e.g., Karp, 1998; Devos
& Valencia, 2001; Green & Karp, 2005), rather than on the content or the creation of the
annotations themselves. While documentation and reports of individual resources are
9valuable, such as those published in the annual database issue of Nucleic Acids Research,
they do not provide cross-resource comparisons of facets such as overlap or level of
coverage, or linkages within and between resources.
1.4.3. Gene Ontology annotations
Gene Ontology annotations are standardized formal knowledge structures derived
from claims extracted by human scientific curators from evidence sources (typically in
the form of experimental journal articles). Each evidence source can contain zero to many
claims relevant to the underlying organism, or to GO, or to both. Figure 1 provides a
high-level illustration of a generic GO annotation process. The process and actual
workflows may vary by model organism, and by individual curator.
Scientific
evidence
sources
Scientific
evidence
sources
Scientific
evidence
sources
Curators
Claims
Evidence
Entities
Education
Knowledge
Experience
are used by to extract
from
to make
GO
terms
and
apply
GO
termsGO
terms
Annotations
Figure 1. Generic, high-level schematic of the GO annotation process
Formal GO annotations follow a common structure across organisms, in the form of:
object | qualifier | ontology | GOID | GO term | evidence code | reference | with/from
where:
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- object is the gene or gene product;
- qualifier a is modifier that affects the interpretation of an annotation depending upon
which of its values are used: 'NOT', 'contributes_to', and 'colocalizes_with’;
- ontology is which of the three GO ontologies (or ‘aspects’) a particular claim in an
evidence source is associated with (molecular function, biological process, cellular
component);
- GO term and GOID are the most specific applicable term from one of the three GO
ontologies, and its unique identifier;
- evidence code is the type of evidence supporting the claim (e.g., a direct assay or
genetic interaction);
- reference is the specific source of the claim (article, database entry, etc.); and
- with/from is a contextual field that relates the object to other objects.
The object, ontology, GO ID/term, evidence code and reference elements are
mandatory for a valid GO annotation (GO, 2007). As noted above, one evidence source
(and one gene) may have multiple annotatable claims, and a single claim may have
multiple instances of annotations for the function and process aspects (e.g., one gene may
participate in multiple biological processes). When this project uses the term ‘GO
annotation’ (or simply ‘annotation’) in reference to the data and measures described
below, it refers to the collection of instances associated with a particular evidence source,
while an ‘annotation instance’ or simply ‘instance’ refers to one stand-alone component
of an annotation, namely one set of values for the mandatory GO elements. That is, if an
evidence source yields a claim about a gene that a curator annotates as having a particular
11
molecular function, as participating in a particular biological process, and localized in a
particular cellular component, this project views that annotation as being comprised of
three individual instances. Table 1 provides an example annotation. From this paper, four
genes are each annotated once to both the Process and Component aspects, for a total of 8
annotation instances. While this is a straightforward example, section 3.2.1 describes the
complexity encountered while attempting to quantify the annotation instances generated
during the studies from this project.
Table 1. GO annotations from Takayama Y, et al. (2003) [PMID: 12730134]
Object Ontology GO ID GO Term Evidence With/From
PSF1 Process GO:0006261 DNA-dependent DNA
replication
IMP
PSF1 Component GO:0000811 GINS complex IPI PSF2, PSF3, SLD5
PSF2 Process GO:0006261 DNA-dependent DNA
replication
IGI SLD5
PSF2 Component GO:0000811 GINS complex IPI PSF1, PSF3, SLD5
PSF3 Process GO:0006261 DNA-dependent DNA
replication
IGI PSF1
PSF3 Component GO:0000811 GINS complex IPI PSF1, PSF2, SLD5
SLD5 Process GO:0006261 DNA-dependent DNA
replication
IMP
SLD5 Component GO:0000811 GINS complex IPI PSF1, PSF2, PSF3
Source: GO sample yeast annotations (GO Consortium, 2006).
The human curatorial staffs of MODs have created large collections of literature
annotated to GO. For example, Table 2 shows descriptive statistics for the quantities of
GO annotations in the Saccharomyces Genome Database (SGD) as of 2006-01-29.
Table 2. Descriptive statistics for SGD GO annotations
Qty. %
Total annotations in orf_geneontology.tab 5,806 -
Total unique GO annotations 1,907 100.00
- Unique GO Molecular Function annotations 986 51.70
- Unique GO Biological Process annotations 672 35.24
- Unique GO Cellular Component annotations 249 13.06
Source: MacMullen (2006a)
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1.4.4. Indexer consistency
In information and library science, indexing consistency has been a topic of interest
for many decades, particularly the question of whether consistency influences
information retrieval performance. Rolling (1981), following Cooper (1969),
differentiates indexing quality (“whether the information content of an indexed document
is accurately represented”), and effectiveness (“whether an indexed document is correctly
retrieved every time it is relevant to a query”), from consistency, asserting that the third is
used as an imperfect surrogate for the first two, because they are both difficult and costly
to measure (69). (Optimal consistency here would seem to need to be between the
indexer and the searcher, not between indexers, but this does not seem promising;
Iivonen (1995), for example, found significant inconsistency between searchers’ queries
for the same topics, and Murphy, et al. (2003) found inconsistency between authors,
indexers, and searchers.) Funk and Reid (1983) note that although some challenges have
historically been raised to the idea that consistency is an informative measure, more
recent work has demonstrated a positive correlation between high inter-indexer
consistency and high information retrieval effectiveness.
Funk and Reid’s study assessed indexing consistency in MEDLINE. They computed
the inter-indexer consistency of 760 articles that had been indexed twice, and found that
headings “were applied more consistently to central concepts than to peripheral points”,
and that “[w]hen subheadings were added to a main heading, consistency was lowered”
(176). They also found that terms from certain MeSH categories appeared more
frequently in high-consistency articles than terms from other categories. Hurwitz (1969)
found in part that very granular indexing vocabularies contributed to inter-indexer
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inconsistency because different but near-synonymous terms were often chosen by
different indexers of the same text. Sievert and Andrews (1991) found that in a database
of document abstracts indexed by a very small vocabulary, “indexing matched
completely almost half of the time, and did not match at all almost half of the time”, with
consistency decreasing as the number of terms assigned per article increased. However,
Schultz, Schultz, and Orr (1965) compared indicia supplied by authors for their own
papers with those assigned to the same papers by a group of readers and found substantial
agreement compared to the control group of terms extracted from document titles. In a
small study, Boles (1989) found that the presence or lack of domain expertise on the part
of indexers did not necessarily lead to better or worse indexing performance.
Both Funk and Reid (1983) and Olson and Wolfram (2006) note that consistency
studies have shown that indexers often have higher agreement about what the main or
“core” topics of a text are than those that are more peripheral. Olson and Wolfram argue
that this suggests that the choices might adhere to a power law that can predict the
distribution of topics. If the distribution of topics indexed is predictable it might be
possible to minimize the variation or to develop interfaces for searching databases that
would take that distribution into account. It could also be that the variation is a positive
factor [1-2].
Cooper (1969) was a critic of the idea that indexer consistency resulted in positive
effects on retrieval performance, arguing that in fact the opposite could occur: as indexers
became more consistent with each other, retrieval performance could be diminished if
indexer-requester consistency was low (this was prior to IR systems with thesauri or full-
text searching). While commonalities clearly exist between document indexing and GO
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annotation, it is useful here to distinguish their differences. As an example, consider the
document from which Table 1 is drawn in section 1.4.3 above. The MeSH terms assigned
to the article are shown below in Table 3. Consider the levels of conceptual granularity
between index terms such as ‘Amino Acid Sequence’, or ‘Fungal Proteins/*metabolism’
and GO terms such as ‘DNA-dependent DNA replication’ and ‘GINS complex’. While
natural language has significant variation and redundancy, information systems have
features such as thesauri that are used to compensate for mismatches between indexers’
term selections and searchers’ query terms in order to return sets of relevant results. But,
with the exception of some adjacent terms, the process and vocabulary of GO annotations
is less tolerant of both vagueness and error. If a GO term is too vague, it is not useful, and
if it is incorrect, it could actually be harmful, or a least wasteful, in terms of resources
such as time, money, and material, that are mis-allocated due to an incorrect annotation.
In other words, while most believe that there is not one ‘true’ set of index terms for a
document, we are much closer to that in the case of GO annotations.
Table 3. MeSH terms assigned to Takayama et al. (2003) [PMID: 12730134]
- Amino Acid Sequence
- Cell Cycle Proteins/*metabolism
- DNA Replication/*physiology
- DNA, Fungal/genetics
- DNA-Binding
Proteins/*genetics/metabolism
- Fungal Proteins/*metabolism
- Molecular Sequence Data
- Saccharomyces cerevisiae/
*genetics/metabolism
- Saccharomyces cerevisiae
Proteins/*genetics/metabolism
- Sequence Alignment
* = MeSH Major Topic
The process of creating GO annotations is quite different from topical indexing, both
in concept and in practice. The goals of GO annotation include the extraction and
formalization of specific claims from the literature, and the ability to link annotations of
biological data back to the primary literature, while indexing is focused instead on
providing topical access points into the literature – a focus on ‘aboutness’ rather than
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specific claims. Thus, while this project was informed by prior work on indexer
consistency, different approaches were needed, as described in the next section, to
address quality evaluation in the unique environment of GO annotation.
2. Research Design and Methods
This project used multiple research methods and data collection points in an attempt
to ‘triangulate’ (‘surround’ is perhaps a more accurate term in this case) the issues of
curation and annotation behavior described above. The study designs described below
included both experimental approaches (empirical individual and consensus annotation
experiments), and contextual approaches (individual interviews, focus groups,
observations, and task- and artifact analyses). The experimental approaches were
prospective, in that they generated new GO annotations from evidence sources that had
not been curated until that time. Prior to the studies, a set of five GO annotation quality
facets were identified, and corresponding metrics were created (as described in detail in
section 2.9). The newly-generated GO annotations were used to assess the utility of these
metrics.
Two separate but related studies were conducted: the first in June 2006 with 10
curators from a single model organism database (MOD). The second study occurred in
July 2006 with 23 curators from 11 databases prior to and during the Gene Ontology
Consortium meeting and Annotation Camp (GO Camp, 2006). These studies are hereafter
referred to as the ‘single-MOD study’, or ‘SMS’, and the ‘multi-MOD study’, or ‘MMS’,
respectively.
To generate the core GO annotation data for the quality measurement studies, two
types of annotation activities were performed by scientific curators: individual
experiments, and co-curator (or consensus) experiments. Individual experiments to
17
generate GO annotations for evaluation consisted of expert database curators individually
annotating previously uncurated scientific articles, in natural work environments, with a
predefined level of redundancy for each article to enable multiple pairwise comparisons
and the subsequent creation of consensus annotations by curator pairs who annotated the
same articles. The variations of this model for the two studies are described below.
For the individual experiments, curators were instructed to perform their normal
annotation work processes, but to not seek assistance from other curators, if doing so is a
normal action, since that could potentially influence the final annotation and obscure
differences in annotations of papers shared by curators, especially if curators annotating
shared papers discussed their annotations prior to completing them. The consensus-
formulation process that followed the individual annotation step enabled curators to
discuss their annotations with fellow curators and make adjustments that are reflected in
the resulting sets of reference annotations.
2.1. Individual annotation experiments
2.1.1. Single-MOD study
A corpus of 48 scientific articles related to the organism on which the MOD is
focused was identified, with at least 16 that were predetermined to contain one or more
assertions amenable to GO annotation (see section 2.4.2 for corpus construction details).
The articles are papers that would normally be annotated by the curators, but were
uncurated prior to this study. Eight curators from the MOD were randomly assigned to
two equal groups of four, and then assigned 16 articles from the corpus. Each curator was
assigned four articles per week for four weeks. The curators were instructed to fully
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curate each paper as they normally would. ‘Full’ curation in this MOD’s context includes
other kinds of annotations in addition to GO, such as phenotypic characterization, and the
selection of broad index terms selected from a small controlled vocabulary and applied to
each paper (see MacMullen 2006a). Since each paper was annotated in full, follow-on
studies should be able to use this additional data to examine variation in annotations of
types other than GO.
Figure 2 provides a graphical view of the design for this part of the study, with the
articles listed as PubMed unique identifiers (PMIDs). As described in more detail in
section 2.4.2, sixteen of the articles were annotated by four curators each, and the
remaining 32 articles were annotated by 2 curators each. Section 3.1.1 describes in detail
the observations obtained from this design.
The two-group schema facilitated pairing for the production of consensus
annotations, as described in the following section. The double-blind assignment process
for the SMS study (see section 2.3.2) should have minimized experimenter bias.
Progressive effects or carryover effects were not expected for multiple reasons. First, the
participants performed normal work tasks, not tasks that were new to them. These are the
same tasks they have performed tens, hundreds, and even thousands of times, so learning
effects are unlikely. Second, the duration of the experiment (about four weeks) should
have been long enough (and a low enough workload per week) to avoid performance
degradation due to fatigue, yet brief enough to not have learning effects that might be
expected to arise if the study occurred over a period of months.
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Figure 2. Experimental design schema for SMS study with paper assignments
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Reliability pilot study
During the single-MOD study, two curators who did not participate in the main study
were observed re-annotating two papers each had curated 6- and 12 months earlier in
order to pilot-test an approach to evaluating the Reliability facet of annotation quality as
defined in section 2.9. Reliability is essentially a measure of ‘intra-annotator’
consistency. That is, rather than comparing two or more curators’ annotations of the same
paper, we were interested in whether a single curator makes different annotations to the
same paper when he or she annotates it a second time (i.e., a repeated-measures approach
with time as the independent variable). The concurrent verbal report (or “think-aloud”)
protocol was used to elicit tacit knowledge and unobserved facets of the annotation
process by having a curator verbalize decisions and actions while he or she performed an
actual annotation task. Each participating curator selected two papers that the other had
previously curated. This approach was intended to minimize bias that could be introduced
by having curators select which of their prior papers to annotate, especially the risk of
seeing the specific prior annotations. For the same reason, the curators were also
instructed to not use the SMS database while creating their annotations. Appendix A6
provides the complete citations for the four papers re-annotated in the Reliability studies.
Additional data were collected during the individual interviews with these curators about
any personal or workflow changes or experiences in the time between original annotation
and re-annotation that may have influenced the outcome (e.g., training received, different
work process or tools used). The curators’ original and repeated GO annotations for the
papers are compared in section 3.3.4 as a part of the annotation quality facet analysis.
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2.1.2. Multi-MOD study
A corpus of 10 scientific articles was selected by expert curators, as described in
section 2.4.3. Two papers related to each of five different MODs were chosen by
representatives from each MOD. All 10 articles were curated for GO annotations by two
curators from each represented MOD (a total of 10 people), and by 13 additional curators
from other databases who agreed to participate in the study.
While this study had a similar overall design as the single-MOD study, here both the
curator pool and article corpus are heterogeneous in terms of model organism
representation. The main research question in this case was: Does a curator’s knowledge
of an organism significantly influence the quality of the annotations s/he produces?
2.2. Consensus annotation experiments
Subsequent to the individual annotation task in both the SMS and MMS, curators
were paired and asked to arrive at a single consensus annotation, based on their two
individual annotations. In the SMS, the pairings were determined by the groups to which
the curators had been assigned, while in the MMS, the two representatives from each of
the participating MODs were paired. For the consensus annotation process, curators were
not given any guidance or training as to how the rationalization process should be carried
out, other than the restriction that each of their individual annotations must have been
completed prior to the occurrence of any consensus discussions. Since in practice,
particularly in the larger curation community, a formal GO annotation training
component may not be available, the decision was made to keep this task as natural as
possible. However, the study PI observed a number of the consensus discussions during
both studies, and collected data on how the curators may have differed in their
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approaches to consensus formation. (See section 2.7 for details of the observation
protocol.)
The consensus annotations function as reference standards, and could possibly be
used for evaluating the performance of automated annotation tools. The consensus
process employed was similar to Figure 1 in Hripcsak & Wilcox (2001), as modified
below in Figure 3. Rather than treating either the individual or consensus annotation
processes as black boxes, the data collection and analysis methods described in the
following sections were used to acquire additional contextual information to assist in
understanding how annotations are made, and why variation exists.
Scientific
evidence
sources
Scientific
evidence
sources
Individual
annotations
rationalization
Annotation
task
generates
Consensus
annotation
compare
performance
Figure 3. Construction of a reference annotation from individual annotations
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2.2.1. Single-MOD study
For the consensus annotation component of this study, the 16 papers with four-fold
coverage were used to generate two consensus annotations per paper, with the pairings
determined by group assignment. For example, in Figure 2 above, paper P1 was
annotated by curators C2 and C4 from Group 1, and C6 and C8 from Group 2, yielding
curator pairs {C2,C4} and {C6,C8}. This is one reason two groups were defined in the
design. The consensus annotations provide additional data points for comparison with the
individual annotations, and served as the ‘gold standards’ to evaluate individual
performance on the Consistency quality facet. The single-MOD leadership plans for the
two curator pairs for each paper to eventually create a joint consensus annotation from
the two pairwise consensus annotations, which will be made available to the larger GO
community as ‘reference annotations’. As of the date of this work, those rationalizations
had not been finalized.
2.2.2. Multi-MOD study
The consensus pairs for the MMS study consisted of the two representatives from
each participating MOD, for a total of 9 consensus annotations per paper. (While there
were 23 participants, in one case a MOD’s senior curator and three intermediate-level
curators participated, and rationalized all four of their individual annotations into a single
consensus annotation. There was also one instance where one participant was the only
representative of a MOD, and so no consensus annotations were made for that database.)
The consensus annotations generated by the MOD representatives served as the ‘expert’
reference annotations against which the other individual and consensus annotations were
compared.
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2.3. Participant selection and group assignment
2.3.1. General
Model organism database curators are typically current or former scientists with
Ph.D-level training in molecular biology, biochemistry, or in a related area. The majority
of their work time is spent curating literature and the different resources contained in
their respective MODs. While this is an accepted and growing role in biomedicine, the
total cross-MOD population of scientific curators numbers perhaps fewer than 100. Not
all curators do GO annotation as a part of their job role. Some MODs have curators who
specialize in certain types of annotation, while in other MODs, each curator may perform
a greater variety of tasks. Taking a random sample of GO curators, particularly from one
MOD, is not feasible, so essentially ‘convenience samples’ were used for the studies
described here, although in both cases, the sample represented much, if not most, of the
overall population from each MOD. Demographic data on education, training, and
experience were collected from curators, as described in later sections, to check for
attributes that may influence annotation behavior and outcomes. However, the creations
of a uniform pool of curators was not the goal; the project is interested in investigating
individual differences, not removing them.
2.3.2. Single-MOD study
The total population of the MOD’s curators is 14; the sample that participated in this
study consisted of the 10 who were able to participate in the MOD's bi-annual group
meeting in June 2006. This group included 4 off-site curators and 4 local curators. Of the
four off-site curators, three are located on the east coast and one is in California. All work
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from home full-time. Two additional local curators participated in a separate arm of the
study to gather data to test the Reliability quality facet (described in section 2.1.1).
The study was designed as two groups of four curators each. Curators were assigned
randomly to groups, and papers were assigned randomly to curators. The two curators
who participated in the Reliability facet study were involved in discussions of the
research design for the main arm of the study, in selection of papers for annotation, and in
assignment of curators and papers. While the characteristics of the four non-participating
curators is not known, there is no reason to expect that the outcomes from the
experiments would be significantly different had they participated.
When the list of participating curators was finalized by the MOD leadership, each
curator was randomly assigned a curator ID by MOD staff so that the study PI would not
know the curators’ identities prior to the completion of the data collection and analysis.
The study PI randomly assigned the papers to the curator IDs before sending them to the
MOD staff, to avoid any influence by the staff on which curators received which papers.
The linkage of curator IDs with names, and the subsequent joint analysis of the
annotation data with the contextual data, did not occur until the individual analyses of
each of those data were complete. This ensured that the study PI had no knowledge of
which curator produced which data.
Participants were instructed to avoid discussing their assigned papers or their
annotations with other curators prior to completing the individual and consensus
annotations to avoid influencing the results or converging on the same annotations.
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2.3.3. Multi-MOD study
The core pool of 10 curators for the MMS was composed of the expert curators who
participated in the Gene Ontology Consortium meeting, and the GO Annotation Camp.
The meeting organizers invited their participation based upon the availability of two
curators from each participating MOD (to enable the creation of consensus annotations),
and the ability to attend the meetings. The five organisms represented in the corpus of
papers for the experiment were Arabidopsis thaliana (a flowering plant) Caenorhabditis
elegans (a nematode worm), Mus musculus (common mouse), Saccharomyces cerevisiae
(yeast), and human. An additional 13 curators participated from databases other than the
5 that contributed papers for curation, and represented organisms such as Dictyostelium
discoideum (mold), Drosophila melanogaster (fruit fly), and Rattus norvegicus (rat). Two
curators who participated in the single-MOD study also participated in the multi-MOD
study as the experts representing their MOD.
2.4. Document corpus construction and article assignment
2.4.1. General
Since the two studies were intended to be naturalistic, it was important that the
scientific articles annotated by the curators were systematically selected, in order to be
representative of the range of papers they typically encounter in their normal work. In
selecting the articles for the two studies as described below, some considerations
included document type (e.g., experimental article, review article, book chapter), the
domain of the paper (e.g., genetics, biochemistry), and the existence of content amenable
to GO annotation.
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2.4.2. Single-MOD study
For the main portion of the SMS, 48 journal articles were selected. The inclusion /
exclusion criteria were:
- Experimental papers only, no review articles, book chapters, or other non-
experimental papers (‘experimental’ here refers to articles which describe one or
more experiments carried out by the authors);
- Each article in the four-fold subset (defined below) must contain 1 or more assertions
that are annotatable to GO;
- Papers must not have been previously curated by a MOD curator.
Two expert curators who did not participate in the individual or consensus
annotation arm of the study selected the 48 papers from a pool of several hundred recent
uncurated papers, using the criteria above.
Sixteen articles deemed to have one or more annotatable assertions were annotated
by four different curators (‘four-fold coverage’), two from each group. The remaining 32
articles were each annotated by two curators (‘two-fold coverage’), one from each group.
Of the four papers each curator annotated each week, two were from the four-fold
coverage set, and two from the two-fold coverage set. The two-fold coverage set
provided additional data for pairwise comparisons, while improving the productivity of
the curators. (Normally there is a 1:1 relationship between papers and curators, so any
redundancy in curation results in a significant reduction in productivity.)
Paper assignment was completed as follows, using random numbers generated by
random.org (2006). First, each paper in the 4-fold set was randomly assigned a number
from 1-16, and each 2-fold paper was randomly assigned a number from 1-32. The papers
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were assigned by group using a partially counterbalanced design. The goals were that (a)
each four-fold paper be annotated by four curators per week, and 2 curators per group; (b)
that curators be paired for maximum variation (i.e., maximizing the number of unique
pairings, and minimizing the frequency with which pairings occur). Groups one and two
had the same pattern of assignment. Paper assignments were provided to the curators
weekly, rather than at once, but curators chose the order in which they annotated the
papers each week. Annotation was performed by curators in their normal work settings.
The SMS curators do not all work in a centralized facility; some are based at universities,
and several work at home or in other locations. Figure 4 shows the final paper
assignments as consensus pairings used in the study.
This approach was designed to minimize assignment and order effects, and to create
one pair of curators per paper in each group who would create consensus annotations, as
described in the following section. Assignment effects should have been minimized
because (a) the papers were assigned by the PI to Curator IDs, thus blinding him to which
curator received which papers; (b) the Curator IDs were assigned to curators by the non-
participating senior curators, so they did not assign papers directly to curators; (c) the
curators did not know which of the papers each week had four-fold or two-fold coverage,
and did not know for which papers they were to create consensus annotations until after
they had completed their individual annotations.
Appendix A6 provides the complete citations for each of the papers in the corpus.
2.4.3. Multi-MOD study
Because the main purpose of the GO Camp meeting was to train novice GO curators
in GO annotation, representatives from each participating MOD were instructed to select
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Figure 4. Paper assignments and consensus pairing for SMS study
(derived from Fig 2.)
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two recent articles of average length and complexity that were related to their organism.
These articles were to be used for the study, as well as the training camp portion of the
meeting, during which novice curators would read and annotate them prior to the
meeting, and then discuss them during the meeting in small group settings with the expert
curators. Since all 23 participating curators annotated each paper, there was a resulting
increase in coverage from 4-fold, as in the SMS study, to 23-fold. Annotations made by
novice curators who participated in the GO Camp were not collected for this study.
Since the single-MOD curators who participated in the MMS had previously
participated in the single study, they selected two articles they had already annotated in
that study. As a result, for PMIDs 16642040 and 16598690 (SMS papers P11 and P12,
and MMS papers P1 and P2), a total of 25 individual annotations exist.
Appendix A7 provides the complete citations for each of the papers.
2.5. Individual curator interviews
Curators who participated in the individual and consensus annotation tasks were
interviewed using a semi-structured protocol to gather multiple types of data, including
details about their personal education, training, and lab- and curatorial experience; their
work roles; and their descriptions of their personal annotation processes and tasks. Of
particular interest are curators’ individual differences in their performance of the
‘standard’ GO process: what workflows they follow, which information tools they use,
their approaches to claim extraction from journal articles, their personal annotation (note-
taking) behavior, and other facets. The approach to the work- and task-related questions
can be viewed as a variant of contextual inquiry, and as similar to the critical incident
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technique, since curators were asked for a retrospective self-report of how a task was
performed in relation to one or more specific evidence sources.
Appendix A1 lists the semi-structured interview questions, and related prompts and
probes.
2.5.1. Single-MOD study
Each of the ten participating curators was interviewed on-site during the SMS.
Curators were asked first about their backgrounds and experiences, and then about their
personal approaches to GO annotation.
2.5.2. Multi-MOD study
The interview protocol used for the MMS differed slightly from that which was used
for the SMS. In the MMS, participants were provided with a spreadsheet template in
which to record their annotations. The spreadsheet also included a brief questionnaire
sheet (attached as Appendix A2) that collected data about their experience with biology,
curation, and GO annotation. In the SMS, this information was collected during the
interviews.
2.6. Curator focus groups
2.6.1. Single-MOD study
During the SMS an hour-long focus group discussion was conducted with all
participating curators in an attempt to elicit additional information about their GO
annotation experiences, and to enable comparisons of these statements with those made
in the individual interviews, and with the observation data. This meeting was also used to
gather feedback about the study itself and how similar studies might be conducted more
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effectively in the future. This meeting was audio recorded and transcribed. Appendix A3
lists the focus group question guide.
2.6.2. Multi-MOD study
A formal focus group was not held during the MMS due to the presence of a large
number of unconsented participants. However, during the GO Consortium meeting prior
to the camp, a large group discussion of the MMS occurred with the study participants,
which included discussion of differences in annotation outcomes on specific papers. This
meeting was not audio recorded, but the study PI took field notes of the discussions
involving variation in curators’ annotations and approaches to curation.
2.7. Curator observations
2.7.1. Single-MOD study
The two senior curators involved in the Reliability facet assessment were observed
performing individual annotations. The general approach was a combination of
observation, during which the researcher recorded curator behavior for later task
decomposition, and what Beyer & Holtzblatt (1998) call “contextual inquiry”, where
participants were asked about the tasks and their interactions with the artifacts used while
performing them. The concurrent verbal report (or “think-aloud”) protocol was used to
elicit tacit knowledge and unobserved facets of the annotation process by having a
curator verbalize decisions and actions while he or she was performing an actual
annotation process.
Thirteen of the consensus pairs were observed to gather contextual data. One area of
interest is effects of strong or weak personalities, and different levels of knowledge and
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experience, that may artificially pressure one curator to change his/her annotation to
conform to the other. The consensus observation protocol is detailed in Appendix A4.
2.7.2. Multi-MOD study
Formal observations were not conducted during the MMS, but notes were made in
four of the expert/novice discussions about attributes such as areas of agreement and
disagreement, and curators’ descriptions of their individual workflows.
2.8. Artifact collection
2.8.1. Single-MOD study
One surprising early finding of this study is that the vast majority of SMS curators
read and curate articles on their computers rather than printing paper copies and making
hand-written notes. All of the local curators, and some of the off-site curators, have high-
resolution 23-inch LCD flat panel screens that they are very comfortable using to read
text. They frequently have the articles and curator web interface side-by-side on the
screen to allow curation directly from the papers into the database with no intermediate
steps, such as manual annotation. In addition, many commented that they need the papers
for such a short period of time (and will very rarely ever refer back to them) that it seems
pointless to print and/or save copies of the papers. Only one curator had made printed
copies of the articles, which were given to the study PI for content analysis.
2.8.2. Multi-MOD study
For this study, most participants printed paper copies of the articles, because they
anticipated referring to them during the discussion portions of the GO Camp. Six
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complete sets of hand-annotated articles were collected from participating curators, and
the personal annotations were analyzed as described in section 3.4.
Appendix A5 lists the details of the artifact protocol.
2.9. GO annotation quality metrics
2.9.1. Purpose and goals
The preceding sections described the processes by which structured annotation data
was generated and collected, but only implicitly described the end uses of the data. The
two primary purposes for this project are to quantitatively compare the degree of
variation in GO annotations, and explore the contextual reasons variation exists. This
section describes the quantitative measures used to analyze the annotation data. The data,
in turn, provide a way to assess the utility of the draft metrics defined below, to enable
their future refinement.
Camon, et al. (2005:6) assert that “[v]ariation is acceptable between curators but
inaccuracy is not”. It is unclear what the authors meant by this statement, and neither that
article or the small number of others that have investigated variation in GO annotations
have characterized the kinds and degrees of variation. As noted in the Introduction,
variation should not necessarily be equated with quality, as quality is a multifaceted
concept. The six quality facets defined below attempt to deconstruct that concept into
mutually exclusive elements, but even those do not permit assessments of absolute
accuracy or truth about which annotations are correct, only in relation to reference
standards created in the consensus process.
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Two or more curators annotating a set of the same papers are likely to differ at
certain times and in certain ways, which is often referred to as measurement error (see,
e.g., Friedman & Wyatt, 2006:120). A frequent goal of measurement studies is the
identification and minimization of measurement error through some means prior to
conducting an evaluation study. In this study, we were interested in understanding why
curators have different annotation outcomes. Only then can we decide whether it is
feasible to discuss error reduction. In other words, the purpose of this project was not to
eliminate curator measurement error, because that variation is in fact the object of study.
In this section, the concept ‘annotation quality’ is operationalized as five facets:
Consistency, Reliability, Specificity, Completeness and Validity (revised from
MacMullen 2006b). Each of these facets can be further decomposed into multiple
attributes, which are parameterized below. Cumulative values for facets (and certain
combinations of facets) are described synonymously here as ‘measures’ or ‘metrics’,
which are derived from the values or ‘scores’ of their underlying attributes.
One goal of this approach was to have the ability to view and compare the annotation
quality of two or more arbitrary GO annotations at varying levels of granularity,
including:
- An overall quality score (all facets and underlying elements);
- individual facet-level scores (all elements of a single facet); and,
- individual element-level scores (each element of each facet).
Secondly, it was desirable that the measures be unambiguously parameterized so that
the process could be automated (i.e., no human judgment required to determine scores).
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A broader goal was that the facets, elements, and parameters be organism-
independent to permit the use of the same measures for studies of annotation quality
within and across all organisms that use GO annotation.
2.9.2. Definitions
Let Pi denote a scientific paper used as an evidence source, and let Ai be an
annotation instance extracted from that paper. A particular paper may have 0-n
annotation instances, and each may be made to any one (but only one) of the three GO
aspects. For each Ai, two or more curators, denoted as Cij, may have created annotation
instances. If we take the Takayama annotation shown above in Table 1 as paper P1,
annotated by curator C1, we can represent the annotation instance in the third row as
‘P1A3C1’.
For each annotation PiAiCij, the following measures are defined below: PiAiCij
CONSISTENCY, PiAiCij RELIABILITY, PiAiCij SPECIFICITY, PiAiCij COMPLETENESS, and PiAiCi VALIDITY. While
the Consistency facet applies to multi-annotator cases, and the Reliability facet applies a
similar measure to single-annotator cases, the Specificity, Completeness, and Validity
facets are applicable to both cases.
2.9.3. Consistency
The Consistency facet measures simple pairwise and cumulative agreement among
the elements of individual GO annotation instances, for two or more annotators. This is a
dichotomous measure of the agreement between the element values (i.e., whether they are
the same or different). The attributes of which Consistency is composed are the
mandatory GO annotation elements ‘Gene product’, ‘GO ID’, ‘GO term’, and ‘Evidence
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code’, and the optional elements ‘Qualifier’, ‘and With/from’. For each evidence source
or each annotation instance, Consistency may be measured at the element level or the
facet level (i.e., as an overall consistency score). The Consistency facet is defined as:
PiAiCij CONSISTENCY =
Attributes Values
Gene {0,1}
GO aspect {0,1}
GO ID {0,1}
GO term {0,1}
Evidence {0,1}
With/from {0,1,-} 
Qualifier {0,1,-} 
Overall {0,1}
where ‘0’ is a mismatch, ‘1’ is a match, and ‘-’ means ‘not used’. ‘Overall’, both here and
in the facets below, is a binary metric that summarizes the other attributes for each
calculation: if the values for all attributes agree, ‘Overall’ will equal ‘1’; if not, it will
equal ‘0’.
2.9.4. Reliability
The Reliability facet measures simple pairwise and cumulative agreement among the
elements of the original and one or more repeated annotation instances, as made by the
same annotator at different time points. Reliability is thus essentially an ‘intra-annotator’
version of Consistency. Both Reliability and Consistency require reference to GO to
determine whether any changes made in the GO vocabularies over the time intervals
between compared annotations had material effects on term selection. The Reliability
facet is defined as:
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PiAjCij RELIABITY =
Attributes Values
Gene {0,1}
GO aspect {0,1}
GO ID {0,1}
GO term {0,1}
Evidence {0,1}
With/from {0,1,-} 
Qualifier {0,1,-} 
Overall {0,1}
2.9.5. Specificity
The Specificity facet measures the degree of agreement between the GO IDs in two
or more annotation instances, by GO aspect. Degree of agreement is measured using
three types of granularity: first, categorically, following Camon, et al. (2005), as being 1)
an exact match; 2) different terms, but with the same lineage; or 3) different terms, not in
the same lineage; second, as a binary distinction of one term being broader or narrower
than the other; and third, as the nodal distance(s) between the compared GO IDs in
relation to the depth of the branch(es) on which they reside. Since GO is a
polyhierarchical vocabulary, the shortest path between the compared terms is used when
calculating distance. The nearest common ancestor of the two terms is also identified.
PiAiCij SPECIFICITY =
Attributes Values
Exact match {0,1}
Mismatch, same lineage {0,1,-} 
Mismatch, different lineage {0,1,-} 
Broader {0,1,-} 
Narrower {0,1,-} 
Difference, in nodes {0,n}
Nearest common ancestor {GO_ID, -} 
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where ‘same lineage’ means the terms are descended from the same ancestor closest to
the root, while ‘different lineage’ means the terms have different ancestors. Nodal
difference is calculated by counting the nodes in between the two terms, but not the terms
themselves, and counting their nearest common ancestor only once. A zero node
difference means the terms are adjacent on the tree. ‘Broader’ or ‘narrower’ is calculated
only when the terms are located on the same branch.
2.9.6. Completeness
The Completeness facet measures simple presence or absence of instances in
annotations in relation to a consensus or reference annotation. Measurement of this facet
requires a paper to have been curated by at least two curators, who then rationalize their
individual annotations to create a reference standard against which their (and other
curators’) individual annotations can be compared. The semantic content of the
annotation instances is not evaluated by this facet. Completeness is defined as:
PiAiCij COMPLETENESS =
Attributes Values
False positives {0, +1}
False negatives {0, -1}
Overall {0,1}
where ‘Overall’ means the annotation being compared to the reference annotation is
complete or not complete; ‘false positives’ means the compared annotation has instances
the reference annotation lacks; and ‘false negatives’ means the compared annotation
lacks instances the reference annotation has. In practice, Completeness is evaluated by
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examining elements of the annotation instances to determine which instances match and
which do not, starting with the Gene Name element and considering Aspect.
2.9.7. Validity
The Validity facet is a basic error-checking test that evaluates whether the values
supplied for each element of an annotation instance fall within the range of allowed
values. This is a dichotomous measure that evaluates an annotation against the GO
annotation definition, not against other individual or consensus annotations. Some MODs
perform this check as an internal function of their databases, but this measure is MOD-
and database-independent.
PiAiCi VALIDITY =
Attributes Values
Gene {0,1}
GO aspect {0,1}
GO ID {0,1}
GO term {0,1}
Evidence {0,1}
Qualifier {0,1,-} 
With/from {0,1,-} 
Overall {0,1}
3. Results
3.1. Summary of data obtained
3.1.1. GO annotations
In both the single-MOD and multi-MOD studies, the formal GO annotations were
collected using a spreadsheet template distributed to all participants. The forms had a
separate sheet for each article with predefined columns for each of the GO annotation
elements. Each of the participants sent the completed forms to a non-participating
curator, who then compiled them, ensured they were de-identified, and sent them to the
study PI. In the single-MOD study, this person was a supervisory member of the MOD
staff; in the multi-MOD study, this was a curator who was coordinating the meeting at
which the study was based. The participants in both studies also used the same template
to record their consensus annotations, which were collected in the same manner. The
observations resulting from the studies are shown in Table 4. A total of 480 annotations
composed of 3,915 instances were generated by the curators during the two studies. On
average, there were about 2 instances per annotation in the SMS, and 8 per annotation in
the MMS.
Section 3.3.4 below assesses incomplete instances during the evaluation of the
Validity quality aspect. In cases where curators made no annotations, these observations
were counted as having zero instances rather than as missing data, because it is a valid
annotation outcome to conclude that an evidence source contains no annotatable
information. In the SMS there were 60 cases of zero annotations across the individual and
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Table 4. Aggregate GO annotation data points by study
Single-MOD Multi-MOD Total
Individual annotations per paper *2/4 23 -
Total individual annotations **128 230 358
Total consensus annotations 32 90 122
Overall annotations (individual + consensus) 160 320 480
Total individual annotation instances 265 2,289 2,554
Total consensus annotation instances 103 1,258 1,361
Overall instances (individual + consensus) 368 3,547 3,915
*4 each from the 16-paper 4x coverage set, and 2 each from the 32-paper 2x coverage set
**64 from the 4x coverage set, and 64 from the 2x set
consensus annotations, and 11 in the MMS. In the latter, most (n=8) of the cases were
related to one curator, C23, while in the SMS the cases were distributed across all 8
curators; every curator had at least four papers where zero annotation instances were
made, and 6 of the 12 consensus pairs had at least one case of zero instances. Thirty-four
of the cases were from the 2-fold coverage set of 32 papers, which was not assessed in
detail by the MOD leadership for the presence of putative annotations, while the 4-fold
set was.
Within the spreadsheet templates, some curators made notes that describe why they
made certain annotations, and the decisions underlying them. In some cases these notes
provide additional contextual detail, but many of them relate to current database policy or
other issues that do not directly affect the GO annotations, and so they were not
considered in the quality evaluation. In some cases, curators chose existing GO terms for
their annotations, but also noted that in a real-life situation they might request a new term
instead of using the existing terms.
Because curator IDs were assigned randomly to participants, and the contextual data
were not linked to the annotation data, the study PI had no knowledge of the identities of
the curators until after the quantitative analysis had been performed. Likewise, the data
from the personal experience questionnaire pages of the MMS template was not compiled
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until after the analysis of the GO annotations, since it could have been possible to identify
curators based on their attributes.
3.1.2. Individual interviews (both studies)
Fifteen interviews with individual curators were conducted over the course of the two
studies, ten with participants in the single-MOD study, and five with those in the multi-
MOD study. Digital audio recordings were made of all interviews, which were then
transcribed, corrected, and verified. Table 5 lists each interview’s acquisition date,
duration in minutes, and transcribed length in pages and words.
Table 5. Audio recordings of individual curator interviews
ID* Date Duration Transcribed pages / words
SI01 2006-06-05 00:40:12 21 / 6,300
SI02 2006-06-05 00:37:34 21 / 7,200
SI03 2006-06-05 00:30:05 19 / 5,300
SI04 2006-06-06 00:30:35 15 / 4,700
SI05 2006-06-06 00:22:33 13 / 3,800
SI06 2006-06-07 00:32:21 18 / 4,300
SI07 2006-06-09 00:34:00 21 / 5,900
SI08 2006-06-09 00:44:48 29 / 8,900
SI09 2006-06-09 00:29:56 26 / 5,500
SI10 2006-06-09 00:23:20 16 / 4,000
MI01 2006-07-14 00:19:18 18 / 3,500
MI02 2006-07-14 00:25:00 18 / 4,200
MI03 2006-07-11 00:21:22 20 / 4,100
MI04 2006-07-12 00:27:26 14 / 4,500
MI05 2006-08-03 00:41:08 20 / 5,800
Total 07:39:38 289 / 78,000
*‘S’ prefix = single-MOD study, ‘M’ prefix = multi-MOD study
The interviews contained data on curators’ workflows and individual work
processes. These data were coded as described in section 3.2.2 and used for the workflow
analysis in section 3.5
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3.1.3. Curator background and experience data (both studies)
In the multi-MOD study, the template file in which curators recorded their
annotations also contained a four-item self-administered questionnaire which was used to
gather information about each curator’s backgrounds and experience. All 23 curators
completed the questionnaire, and the data are described in section 3.6 below. The
questionnaire is attached as Appendix A2. Subsequent to the completion of the study,
curators were asked a follow-up question by email about the number of years or months
experience each had with GO annotation at the time of the study.
In the single-MOD study, similar questions were asked of the 10 participating
curators during the individual interviews that were conducted. This information was
extracted from the transcribed interviews, recorded, and analyzed as described in section
3.7 below.
3.1.4. Evidence sources and other artifacts (both studies)
Several types of additional artifacts were collected during the two studies. Six
participants in the multi-MOD study provided complete sets of their paper copies of the
10 articles used in the study, for analysis of their intermediate manual notes and
annotations. These total approximately 630 pages, which included about 15 separate
pages of associated notes in addition to the marked-up primary articles. Other documents
and data included one curator’s manual notes and article annotations from the single-
MOD study, and a chain of emails from one of the consensus pairs from the single-MOD
study to document their process of consensus formation. Also available were the PI’s
notes from both studies of observations and interviews, and screenshots of a MOD’s
curator web interface, collected during a portion of the single-MOD study.
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3.2. Data coding
3.2.1. GO annotation coding and analysis
Annotations and annotation instances
For this project, an ‘annotation’ is defined as the set of individual instances of GO
annotations that is made at the level of individual associations between gene products and
GO terms, in the context of a single experimental journal article. An annotation can be
composed of one or more annotation instances, which in turn are composed of the set of
required and optional elements defined by the GO Consortium, as described above in
section 1.4.3.
Instance-counting rubrics
The ways in which individual curators entered their annotation elements into the
spreadsheet template used for data collection created some challenges in counting
annotation instances. Significant space is devoted here to these issues because they are
relevant to future work on GO annotation analysis, both in studies of this type as well as
others that do not require a common article corpus or multiple curators annotating the
same documents. These challenges range in complexity from minor formatting issues to
greater ambiguity about the nature of what an instance is.
In some cases, curators used the spreadsheet application’s ‘merge’ function to
combine cells that would otherwise have had their contents duplicated exactly across
multiple instances. For example, if creating three instances using the same gene product,
a curator might merge the three cells so that the gene product name appears only once,
but spans the three rows. In this type of case, the count is straightforward: three instances
were counted. A similar situation results when curators made several annotation instances
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to the same gene product, and omitted the gene, gene ID, and species information in
subsequent instances, presumably for readability. These and other formatting
irregularities were normalized for consistency in an intermediate spreadsheet that
combined all curators’ and consensus pairs’ annotations. Incomplete or non-canonical
instances were not counted or analyzed. There were very few of these, which involved
cases where required GO elements were not populated with values, or in one case where
the Gene Product element had the value ‘various’. Missing values are discussed above in
section 3.1.1.
A different situation occurs when an instance has two (or more) GO Evidence Codes
recorded in the Evidence Code element. Should this be coded as one instance, or more?
The rubric used in this project is that a case with two evidence codes in one instance is
coded as two instances, since presumably each could stand alone as an instance in the
absence of the other, given that evidence codes are mutually exclusive. For example, an
instance provided by Curator 15 on Paper 4 in the multi-MOD study is (in part):
Gene 
product GO aspect GOID GO term 
Evidence 
Code 
ced-10 P GO:0043652 engulfment of apoptotic cell IMP, IGI 
Since apparently an experiment using mutant phenotypes (IMP) was conducted, as
well as an experiment using genetic interactions (IGI), this is counted as two instances:
Gene 
product GO aspect GOID GO term 
Evidence 
Code 
ced-10 P GO:0043652 engulfment of apoptotic cell IMP 
ced-10 P GO:0043652 engulfment of apoptotic cell IGI 
It is important to this study that this distinction be made, in order to partially address
the problem of matching instances across curators, discussed further below. When
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calculating the similarity of the above instances with other curators’ annotation instances,
for example, each of those instances may be present separately (or both, or neither).
There were 56 cases of multiple evidence codes in the SMS, and 43 cases in the
MMS (SMS: P3: 2; P7: 12; P11: 14; P12: 1; P13: 1; P14: 9; P15: 8; P32: 1; P33: 1; P35:
1; P39: 2; P40: 3; P43: 3; P45: 3; MMS: P1: 10; P2: 2; P3: 1; P4: 6; P5: 1; P6: 12; P7: 3;
P8: 5; P9: 3). Additionally, 6 papers in the SMS had a total of 16 cases of instances with
multiple gene names with the same GO annotations (P3: 2; P11: 3; P14: 6; P40: 1; P43:
3; P45: 1); these were counted in the same manner as the cases with multiple evidence
codes.
Instance counts below also include instances with proposed GO terms (if complete –
some lack gene referents), NOT annotations, and those with evidence codes such as TAS
or ISS that are sometimes deprecated by individual MODs or the GO Consortium as a
whole. Local database policy decisions were ignored in calculations (e.g., if a curator
made an annotation, but then stated in the Notes column that s/he would not have made it
in real life due to database policy, it was still counted).
Issues with matching instances across curators
As seen below in section 3.3.1, there were large variances in the numbers of
instances created by different curators for the same paper. As a result, it is often difficult
to match instances for the purposes of pairwise comparison of variation of annotation
element values. For example, for Paper 4 in the multi-MOD study, the instance shown
above for Curator 15 is the only one that curator made, while Curator 2 had the
following:
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Gene
product GO aspect GOID GO term
Evidence
Code
ced-10 P GO:0043652 engulfment of apoptotic cell IMP
ced-10 P GO:0035262 gonad morphogenesis IGI
and Curator 10 had:
Gene
product GO aspect GOID GO term
Evidence
Code
ced-10 P GO:0043277 apoptotic cell clearance IGI
ced-10 P GO:0035262 gonad morphogenesis IGI
ced-10 P GO:0040039 inductive cell migration IGI
and Curator 21 had:
Gene
product GO aspect GOID GO term
Evidence
Code
ced-10 P GO:0012501 programmed cell death IMP
ced-10 P GO:0008354 germ cell migration IMP
ced-10 P GO:0035262 gonad morphogenesis IMP
ced-10 F GO:0005515 protein binding IPI
Since the numbers of instances vary, as well as the terms and evidence codes, it is
difficult to perform pairwise comparisons of the annotations at the instance level. In this
case, the curators are at least annotating to the same gene product. This is not always true,
and in situations where there are multiple gene products with varying numbers of
instances, or mutually exclusive gene products for each curator’s instances, it becomes
even more difficult to make comparisons at the instance level.
There are multiple approaches to addressing this problem, but each requires some
level of manual evaluation. At a very high level, exact match comparisons can be
performed at the annotation level, as shown below in section 3.3.2. At a finer grain, the
numbers of individual instances per paper by curator can be compared (also shown
below).
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At the element level, one approach is to focus on the gene product as the unit of
analysis. For each gene product that is shared across curators, we can manually review
the instances to attempt to determine whether they are capturing the same claim from the
paper. For instance, in the examples above, Curator 2 and Curator 15 both annotate the
term ‘engulfment of apoptotic cell’ to ced-10. Similarly, Curators 2, 10, and 21 annotated
‘gonad morphogenesis’ to ced-10. Matching those instances enables pairwise evaluation
of similarity. For other cases, in which term-based matching is not possible, an approach
is to match instances first by gene, GO aspect, and evidence code, and then use the
Specificity quality facet to assess term distance. In cases with large numbers of instances
across annotations, doing this in a semi-automated fashion with matrices is more feasible.
Another approach is to calculate the intersection of the corresponding GO term sets,
including the number of total terms, and the number of shared terms. In the example
above, the four term sets are:
C2 C10 C15 C21
- engulfment of
apoptotic cell
- gonad
morphogenesis
- apoptotic cell
clearance
- gonad
morphogenesis
- inductive cell
migration
- engulfment of
apoptotic cell
- engulfment of
apoptotic cell
- programmed cell
death
- germ cell migration
- gonad
morphogenesis
- protein binding
There is a total of 8 distinct terms, but there are no terms in common across all four
sets; the closest is ‘gonad morphogenesis’, which was selected by three curators: C2,
C10, and C21. Curators C2 and C15 share ‘engulfment of apoptotic cell’, but that is the
only other term shared by two or more curators. For large-scale analysis, this step could
be performed by loading the term sets in a database and performing intersections or inner
joins.
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Issues with counting genes
In multi-organism papers where gene names are identical or similar (e.g., in MMS
P1, ‘Tyw1’ in mouse, ‘Tyw1’ in yeast, and ‘TYW1’ in human), counting distinct genes is
unclear. Does the above example count as one gene, or more? For the analysis below,
genes in different species are counted as distinct genes.
3.2.2. Interviews
For this project, the interview transcripts were coded primarily for two types of
information: 1) curators’ backgrounds and experiences, and 2) individual annotation
behavior and personal workflows. The former was primarily extracted from the single-
MOD study interviews, as the multi-MOD study participants self-reported that
information in the curator questionnaire portion of the annotation worksheet (see
Appendix A2 for the questionnaire instrument). Curators provided varying levels of detail
about their workflows and annotation behavior, so they were not comparable at granular
levels. Questions where specific answers were available included whether the curator
normally reads and curates paper or electronic versions of the articles; which GO
ontology searching and browsing tools are most often used, and which additional
resources curators use to supplement their knowledge. The results are reported in section
3.5 below as a combination of quantified findings and more traditional narrative text
extracts from the curators’ actual words. The Future Work section (5.2) addresses
additional analysis that could be performed on these data.
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3.2.3. Curators’ personal annotations
The 636 pages of manually-annotated paper articles were digitized, coded and
analyzed. A content-analytic approach was employed using emergent coding (Marshall
1997, 1998), with an emphasis on characterizing:
- The numbers of annotations made per curator by physical type (underline, circle,
highlight, text, etc.). 
- The physical location of annotations in documents at different levels of granularity
(e.g., page, paragraph, sentence).
- The conceptual or intellectual location of annotations in documents (e.g., section,
table, figure).
- A comparison of the above features across documents by curator, and curators by
document.
Coding was performed at the sentence level. ‘Paragraphs’ were counted by including
partial paragraphs at the top and bottom of each page, so a partial paragraph at the top of
Page 2 would be coded as ‘P2G1’, a partial paragraph at the bottom of Page 2 as ‘P2Gn’,
and then the continuation of Gn on the following page is counted as ‘P3G1’. This coding
scheme was employed because it was observed that curators often marked up the
fractional paragraph on a following page without marking up the text on the preceding
page. Section titles are coded as ‘Gn section’, except for claims in sentence form, which
are counted as S1. A multi-paragraph section with a section title in sentence form was
counted as the section title being S1 of the first paragraph, and subsequent paragraphs in
that section counted normally.
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Annotations were coded as distinct instances when significant white space occurred
between them. For example, a case where two phrases in a long sentence were
underlined, but they were distinct claims separated by other phrases would be coded as
two annotations, but a case where an entire sentence was underlined with the exception of
article citations enclosed in parentheses would be coded as one annotation. Text that was
both highlighted and underlined was counted as separate instances. Marks were
quantified by both type and location in order to assess not only similarity of notation
form, but also the placement of marks within the documents. Marks were localized at the
section level (Abstract, Introduction, Methods, Results, Discussion, References), at the
page level, and at the sentence level. Sentence-level coding enabled granular comparisons
of precisely which claims, phrases, and words the curators thought were important. This
analysis was performed to enable relationships between manual annotations and GO
annotations to be assessed.
3.3. GO annotation data
3.3.1. Annotation counts
The claims in this section examine the differences observed in the quantities of
annotation instances created by curators and consensus pairs. The content of the instances
is explored in the two sections that follow.
1. Ranges of individual annotation instances per paper vary widely.
In the single-MOD study, the 64 annotations made on the 16 4-fold coverage papers
were composed of a total of 185 instances, or nearly 3 instances per annotation, with an
aggregate range of zero to 13 annotation instances per paper. Two papers (P8 and P9) had
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zero instances from all curators, and 10 of the remaining 14 papers had ranges between 1-
6 instances. Eight of the papers had at least one curator who supplied zero annotations.
The instances have a per-paper mean of 2.8 and standard deviation of 3.3. Figure 5 shows
a boxplot of the individual instance counts for the 16 4-fold coverage papers. While we
might expect that the numbers of annotation instances would vary across papers due to
differences in content, we can see also that several papers have large ranges of instance
counts. The origins of these are explored below.
Figure 5. Boxplot of individual SMS instances by paper (4x set)
The 64 annotations made on the 32 2-fold coverage papers totaled 80 instances, and
had a range of zero to 6 annotation instances, with 11 papers having zero instances from
all curators, and 13 having 1-2 instances. The 65 instances have a per-paper mean of 1.3
and standard deviation of 1.9.
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The preceding addressed aggregate instance variation across all papers in the study.
At the individual paper level, the papers with the smallest variation in instance counts
(excluding those with zero annotations by all curators) were P1, P4, and P5 (1 instance
difference). The largest ranges were observed in papers P3 (11, 0-11 instances), P3 (12,
0-12 instances), P15 (9, 0-9 instances) and P10 (6, 0-6 instances). Figure 6 shows the
distributions of the instances for the 16 4-fold papers. In only two cases were all four
curators consistent: P8 and P9, which had zero instances from all curators.
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Figure 6. Frequency distributions of instances from 16 4-fold papers (SMS)
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In the multi-MOD study, the quantities and ranges of instances were larger. The 23
curators made a total of 230 annotations to the set of 10 papers. These were composed of
2,289 annotation instances, which have a per-paper mean of 9.9 and standard deviation of
8.1. The number of instances ranges from zero to 46. Figure 7 shows a boxplot of the
MMS instances, which illustrates the wide ranges per paper.
Figure 7. Boxplot of individual MMS instances by paper
At the individual paper level, the papers with the smallest variation in instance counts
were P2 (13, 0-13 instances), P7 (14, 0-14 instances), and P10 (16, 0-16 instances). The
largest variation was observed in papers P3 (46, 0-46 instances), P9 (37, 0-37 instances),
P4 and P5, (both 36, 0-36 instances), and P1 (35, 0-35 instances). Curator 23 made no
annotations for 8 of the 10 papers, and those zero values tend to skew the ranges of some
of the papers, such as P3 and P4, where the lowest non-zero instance counts are 5.
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However, because of the large means (18, 13) and medians (21, 13) for those papers, the
variation is still significant. Interestingly, the two papers from the SMS study that were
included in the MMS study have significantly higher instance ranges, as shown in Table
6. 
Table 6. Differences in instance count ranges, means, and standard deviations for papers included in
both SMS and MMS
n Range (min-max) Mean SD
SMS P11 4 4 (4-8) 5.8 1.7
MMS P1 23 35 (0-35) 12.6 8.9
SMS P12 4 2 (1-3) 1.8 1.0
MMS P2 23 13 (0-13) 4.5 3.2
The SMS distributions are much lower and within tighter ranges, while the MMS
distributions are more spread out, as shown in Figure 8a-b. 
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Figure 8a-b. Frequency distributions of instances in the overlapping papers from the SMS & MMS
Figure 9 shows the frequency distributions of the instances for the 10 MMS papers.
With 10 data points per paper rather than the four of the SMS, we might expect that the
shapes of the distributions would become more coherent, but extreme values make the
ranges so wide that there are often large gaps between data points.
2. Consensus instance counts varied from individual annotations by study.
The 32 consensus annotations made on the 16 4-fold coverage papers in the single-
MOD study were composed of 103 instances, and had a range of zero instances (papers
P8 and P9) to 13 (P7). Seven cases had zero variance (i.e., matching instance counts),
while the paper with the largest mismatch was P15, with a range of 0-9 instances. The
mean and standard deviation of the consensus instances are 3.2 and 3.6, which are higher
than those measures for either the 4-fold or 2-fold individual annotations. Figure 10
shows a boxplot of the consensus instance counts by paper, which illustrates that several
papers have very small absolute ranges (e.g., P1, P12-P14, P16), while others’ are large.
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Figure 9. Frequency distributions of MMS instances by paper
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An interesting difference observed here compared with the individual instances is that
the wide range of P3 has been collapsed from 0-12 to 9-12; the ranges of other papers
diminished as well.
Figure 10. Boxplot of SMS consensus instances by paper
As Figure 11 shows, in only two of the 16 cases were the consensus ranges higher
than those of the individual annotations: P5 and P6. All others had fewer instances (n=8),
or the same number (n=6).
P8 and P9 remained unannotated, but 4 papers had matching non-zero instance counts
(P1, P12, P13, and P16). P15 and P10 remained the papers with the largest variances.
The 90 consensus annotations made on the MMS papers yielded 1,258 instances, and
had a range of 0-45, with the smallest non-zero value being 3. The mean and standard
deviation of the consensus instances are 13.9 and 9.6, which are higher than those
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Figure 11. Comparison of instance ranges (individual and consensus, SMS)
measures for the individual annotations. For those papers with the smallest variation in
instance counts (discussed above), two (P2 and P7) had slight increases in instances,
while the third (P10) decreased slightly. Of the papers with the largest variation, P1 and
P5 had slight increases in instance counts, while P3, P4, and P9 decreased slightly. Figure
12 shows a boxplot of the instances by paper. While the compression of ranges is not as
large here as in the SMS, we can see that the number of cases with zero annotation
instances has gone from nine in the individual instances (Figure 7) to one in the
consensus annotations (P10).
Figure 13 shows that the nine consensus annotations per paper in the MMS had larger
instance means in every case than did the counts for individual curators.
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Figure 12. Boxplot of consensus instances by paper (MMS)
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Figure 13. Mean and Median Values for Individual and Consensus Instances (MMS)
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3. Variation in annotation instances was observed by group assignment (SMS).
As described in section 2.3, the single-MOD study participants were randomly
assigned to one of two groups, and were then assigned papers. These assignments
enabled analysis of differences in annotation instance quantities by group. We would
expect that with random assignment, attributes such as years of experience would be
distributed equally across groups. To verify this, Table 7 was constructed, which shows
the differences in instance counts across groups, for the two- and four-fold coverage
paper sets, combined values for both sets, and the consensus values.
Table 7. Instance count summary measures by group and coverage
Total instances Range (min-max) Mean SD
G1 individual 4x 107 13 (0-13) 3.3 3.4
G2 individual 4x 78 13 (0-13) 2.4 3.2
G1 individual 2x 45 7 (0-7) 1.4 1.7
G2 individual 2x 35 8 (0-8) 1.1 2.1
G1 individual combined 152 13 (0-13) 2.4 2.9
G2 individual combined 113 9 (0-9) 1.8 2.7
G1 consensus 59 11 (0-11) 3.7 3.6
G2 consensus 44 9 (0-9) 2.7 3.6
All 4x 185 11 (0-11) 2.9 3.3
All 2x 80 9 (0-9) 1.3 1.9
All consensus 103 11 (0-11) 3.2 3.6
All individual & consensus 368 9 (0-9) 2.3 3.0
The differences between groups appears large, particularly in the instance counts. To
investigate whether one group had curators with more experience than the other, Table 8
was computed from the data extracted from individual curator interviews on years of GO
experience, as described in section 3.7. The curators in Group 1 had more cumulative
years of experience than those in Group 2, which could explain part of the observed inter-
group variation. However, claim 4 below would seem to contradict this.
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Table 8. Distribution of curators’ years of GO annotation experience by group (SMS)
Yrs exp Group 1 Group 2
0.5 0 1
1 0 0
2 0 1
3 1 0
4 2 1
5 1 1
Total yrs 16 11.5
4. Years of GO curation experience is not a predictor of instance counts.
Curators’ instance counts were plotted against their years of GO annotation
experience to determine whether more experience led to the creation of more or fewer
instances. The plot of the eight SMS curators and their instance counts is shown in Figure
14. An R2 value of 0.008 means that less than 1% of the variation in instances is
explained by years of GO experience (p=0.31).
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Figure 14. SMS individual instances by years of GO experience
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A plot of 20 MMS curators and their instance counts against years of GO experience
is shown in Figure 15 (the experience data is from Section 3.6). Data on experience was
not available for two curators, and curator C23 was excluded from this analysis since he
or she made annotations on only two of the ten papers. An R2 value of 0.036 means that
less than 4% of the variation in instances is explained by years of GO experience
(p=0.007). As with the SMS findings, something other than experience is influencing
instance variation.
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Figure 15. MMS individual instances by years of GO experience
5. Variation in annotation instances was observed by organism expertise (MMS).
In analysis of the MMS data, those curators representing the MODs whose organism
was the subject of the paper were characterized as ‘organism experts’, while those who
are not affiliated with that organism were characterized as ‘organism novices’. These
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labels vary for each paper as the subject organism of the paper changes. Table 9 is a
crosstabulation of annotation instances by organism and curator expertise. Each row
contains the cumulative instances for the two papers associated with each organism, the
numbers of experts and novices providing annotations, and the mean number of instances
per curator. The largest expert/novice differences are with human (more than twice as
many instances made by experts), and mouse (60% more by experts).
Table 9. MMS individual instances by subject organism and curator expertise
Experts Novices
Organism Instances # Experts
Instances /
# Experts Instances # Novices
Instances /
# Novices
Arabidopsis 75 4 18.8 405 19 21.3
human 141 5 28.2 210 18 11.7
mouse 141 7 20.1 208 16 13.0
worm 132 3 44.0 584 17 34.4
yeast 86 5 17.2 307 17 18.1
The individual and consensus annotation instance counts of the organism experts
were plotted with the minimum, maximum, and mean instances per paper, as shown in
Figure 16. In 5 of the 10 cases, the experts’ consensus counts are greater than the mean.
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Figure 16. Organism experts' consensus annotation instances vs. mean instances (MMS)
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6. Curators exhibit high variability in the number of annotation instances they make,
across papers.
The preceding claims clearly show that the numbers of instances per paper vary by
curator. As we try to apprehend the origin of this variation, we are also interested in
whether individual curators tend to have a consistent range of total annotation
instances that they make, regardless of organism or paper. Figures 17 and 18 show
plots of the SMS and MMS instances by curator to illustrate the intra-curator ranges
across papers.
Figure 17. Boxplot of instances by curator (SMS)
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Figure 18. Boxplot of instances by curator (MMS)
3.3.2. Paper-level comparisons
7. Paper-level exact-match comparisons exhibit very low consistency.
At the highest level of pairwise comparison – the comparison of annotations at the
paper level – very few exact matches across individual curators or consensus pairs were
observed, in either study. ‘Exact match’ in this case means that 1) the numbers of
annotation instances for all curators and consensus pairs were the same, and 2) all values
for all elements of the GO annotation were the same.
In the single-MOD study, 3 out of the 16 4-fold coverage papers had exact matches
at the consensus level, but in two of those cases, consistency came from no annotations
being made. The 32 2-fold coverage papers had 11 exact matches, all of which came
from no annotations being made.
In the multi-MOD study, 5 of the 10 papers had at least one pair of exact matches
from the pool of 32 annotations (23 individual and 9 consensus). In the P1 and P5 sets,
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one individual annotation matched the subsequent consensus annotation to which the
curator contributed. For P2, two curators’ individual annotations matched that of their
consensus pair, as did a third curator’s. For P10, two curators did not make annotations,
and one of their consensus pairs also declined to make an annotation, based on a technical
aspect of the paper. (The other curator in the pair had originally created a single
annotation instance, but that did not carry over to the consensus.)
8. Consensus annotations exhibit low consistency with each other.
In the single-MOD study, only two of the 16 pairs of consensus annotations matched
across groups at the paper level; papers P1 and P13 had exact matches across all
elements. Papers P8 and P9 each had zero instances from both consensus pairs. The pairs
for P12, P14, and P16 each had the same number of instances, but differences in term
selection, differing genes identified, and different evidence codes.
In the MMS, none of the consensus annotations had exact matches at the instance
level.
3.3.3. Element-level comparisons
The claims in this section examine differences between the annotations from both
studies at the GO element level.
9. Variation is greatest in the GO Term element. 
 
Since the Ontology (aspect), Evidence Code, and Object (gene) elements of the
formal GO annotation have relatively small possible values, and the numbers of terms in
the three GO vocabularies are so large, it is not surprising that the GO Term element had
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the most observed variation. Figure 19 shows distributions by paper of the frequency of
distinct terms assigned by the 23 curators in the MMS.
The variation in the numbers of total and distinct GO terms assigned per annotation
reflect the variation seen above at the higher levels of comparison. Figure 20 shows mean
values for the total and distinct term counts per paper, by individual, consensus, and
combined groups. The consensus term counts are higher than the individuals for both
total and distinct terms for all papers, suggesting that curators may be adding their non-
overlapping terms rather than rationalizing them.
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Figure 19. Mean total and distinct terms by paper (MMS)
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Figure 20. Frequency distributions of distinct terms (MMS papers)
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Variation is present in curators’ per-annotation GO term selections.
Where Figure 20 showed term variation from the paper perspective, Figure 21 shows
the cumulative variation in individual curators’ quantities of total and distinct terms
across the full paper corpus. The 1,947 terms have a mean of 6.1, median of 5, standard
deviation of 4, and a range of 26.
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Figure 21. Curators' total and distinct GO terms (MMS)
3.3.4. Facet analysis
This section evaluates a sample of the annotation instances from both the single-
MOD and multi-MOD studies against the five GO annotation quality facets defined in
section 2.9. As discussed in section 2.1.1, a pilot study of the Reliability facet was
conducted with two SMS curators who did not participate in the main study. Their
original and repeated annotations are compared below. Their annotations are also
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compared using the Specificity facet. Two consensus annotations from the SMS and one
from the MMS were selected in order to test the viability of the other four facets. The two
SMS annotations were chosen by selecting one annotation that had matching instance
counts (P12), and one that did not (P3). P12 had 4 total instances, while P3 had 21. The
MMS annotation (P2) was chosen because it had a manageable number of total instances
(54) for an example, while also having a similar range of instances (13) as half of the
papers, and was close to the mean number of instances of the entire corpus (14).
Reliability
For paper RP1, curator R1 originally had four instances, but created only two upon
reannotation, as shown in Table 10 (denoted On and Rn, respectively). After performing
the reannotation task, the curator stated that the evidence for the IMP instances was not as
strong as thought during the original reading, and so decided not to make them for the
reannnotation.
Table 10. Original and repeated annotation instances for paper RP1 (curator R1)
i Gene Aspect GOID GO Term EC With/from Qualifier
O1 JHD1 F 46975 histone-lysine
demethylase activity
(H3-K36 specific)
IDA
O2 JHD1 F 46975 histone-lysine
demethylase activity
(H3-K36 specific)
IMP
O3 JHD1 P 16577 histone demethylation IDA
O4 JHD1 P 16577 histone demethylation IMP
R1 JHD1 F 46975 histone-lysine
demethylase activity
(H3-K36 specific)
IDA
R2 JHD1 P 16577 histone demethylation IDA
In this case, the only instance pairs with matching evidence codes are {O1, R1} and
{O3, R2}, so Reliability for RP1 is calculated as:
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P1AO,RCR1 RELIABILITY = 0
from:
O1R1 O3R2 O2 O4 Paper level
Gene 1 1 0 0 0
GO aspect 1 1 0 0 0
GO ID 1 1 0 0 0
GO term 1 1 0 0 0
EC 1 1 0 0 0 
With/from - - - - -
Qualifier - - - - -
Overall 1 1 0 0 0
where ‘0’ = mismatch, and ‘1’ = exact match, and ‘-’ = ‘not applicable’.
In this case, we can see that all of the elements in the matched instance pairs were
consistent, but the presence of IMP annotations to the same terms in the original but not
the reannotation led to inconsistencies. This yielded an overall mismatch at the paper
level.
Table 11 shows the initial and subsequent annotations for paper RP2. Similar to RP1,
the curator stated that upon a second reading of the paper, the evidence for the SSE1
Function annotation to ‘unfolded protein binding’ was not strong enough to warrant
making that annotation. We can also see that while both sets of annotations have three
Function instances, O4 is a Component annotation while R4 is a Process annotation. An
additional difference is that all four original instances are annotated to the SSE1 gene,
while only two of the reannotated instances are; the other two are to the YDJ1 gene. As a
result, the only comparable instance pairs are {O1, R1} and {O2, R2}.
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Table 11. Original and repeated annotation instances for paper RP2 (curator R1)
i Gene Aspect GOID GO Term EC With/from Qualifier
O1 SSE1 F 5524 ATP binding IDA
O2 SSE1 F 5524 ATP binding IMP
O3 SSE1 F 51082 unfolded protein
binding
IMP
O4 SSE1 C 5737 cytoplasm IC from
51082
R1 SSE1 F 5524 ATP binding IDA
R2 SSE1 F 5524 ATP binding IMP
R3 YDJ1 F 30188 chaperone regulator
activity
IGI YDJ1
R4 YDJ1 P 6457 protein folding IC from
30188
Reliability for RP2 is calculated as:
P2AO,RCR1 RELIABILITY = 0
from:
O1R1 O2R2 O3 O4 Paper level
Gene 1 1 0 0 0
GO aspect 1 1 1 0 0
GO ID 1 1 0 0 0
GO term 1 1 0 0 0
EC 1 1 0 1 0 
With/from - - 0 0 0
Qualifier - - - - -
Overall 1 1 0 0 0
Table 12 shows the initial and subsequent annotations for paper RP3, annotated by
curator R2. In this case, there were six original annotation instances, and seven
subsequent. The reannotation set has two instances made to a fourth gene, DRS2, and one
fewer made to CDC50 than the original. The comparable instance pairs are {O1, R1},
{O2, R2}, {O4, R5}, and {O5, R6}.
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Table 12. Original and repeated annotation instances for paper RP3 (curator R2)
i Gene Aspect GOID GO Term EC With/from Qualifier
O1 CDC50 P 45332 phospholipid
translocation
IGI LEM3
O2 CDC50 C 5802 Glogi trans face IDA
O3 CDC50 F 4012 phospholipid-
translocating ATPase
activity
IPI DRS2 contributes
to
O4 DRS2 P 45332 phospholipid
translocation
IGI LEM3
O5 DRS2 C 5802 Glogi trans face IDA
O6 LEM3 F 4012 phospholipid-
translocating ATPase
activity
IPI DNF1 contributes
to
R1 CDC50 P 30866 actin patch
organization
IMP
R2 CDC50 C 5802 trans-Golgi network IDA DRS2 colocalizes
with
R3 DNF1 C 5933 bud IDA
R4 DNF1 C 5935 bud neck IDA
R5 DRS2 P 30866 actin patch
organization
IMP
R6 DRS2 C 5802 trans-Golgi network IDA CDC50 colocalizes
with
R7 LEM3 C 5933 bud IDA
Reliability for RP3 is calculated as:
P3AO,RCR2 RELIABILITY = 0
from:
O1R1 O2R2 O4R5 O5R6 O3 R3 R4 Paper level
Gene 1 1 1 1 0 0 0 0
GO aspect 1 1 1 1 0 0 0 0
GO ID 0 1 0 1 0 0 0 0
GO term 0 0 0 0 0 0 0 0
EC 0 1 0 1 0 0 0 0 
With/from 0 0 0 0 0 - - 0
Qualifier - 0 - 0 0 - - 0
Overall 0 0 0 0 0 0 0 0
For instance pairs {O2, R2} and {O5, R6}, the GO IDs matched, but in the six months
between annotations, the term name had changed within the GO Component ontology,
leading to a mismatch.
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The initial and subsequent annotations for paper RP3 are shown in Table 13. The
reannotation set has four instances compared with three in the original, with a new
Function annotation made to the VTI1 gene.
Table 13. Original and repeated annotation instances for paper RP4 (curator R2)
i Gene Aspect GO ID GO Term EC With/from Qualifier
O1 PEP12 F 5486 t-SNARE activity IDA
O2 SNC2 F 5485 v-SNARE activity IDA
O3 TLG1 F 5486 t-SNARE activity IDA
R1 PEP12 F 5486 t-SNARE activity IDA
R2 SNC2 F 5485 v-SNARE activity IDA
R3 TLG1 F 5486 t-SNARE activity IDA
R4 VTI1 F 5486 t-SNARE activity IDA
Reliability for RP4 is calculated as:
P4AO,RCR2 RELIABILITY = 0
from:
O1R1 O2R2 O3R3 R4 Paper level
Gene 1 1 1 0 0
GO aspect 1 1 1 0 0
GO ID 1 1 1 0 0
GO term 1 1 1 0 0
EC 1 1 1 0 0 
With/from - - - - 0
Qualifier - - - - -
Overall 1 1 1 0 0
While the three comparable instance pairs were perfectly consistent, the fourth
reannotation instance led to a Reliability score of 0.
Consistency
For SMS paper P12, both curator pairs created two annotation instances, as shown in
Table 14.
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Table 14. SMS SP12 consensus annotation instances; curators SC2C4 and SC6C8
i Pair Gene Aspect GOID GO Term EC With/from Qualifier
C2C4 GRE2 P 6950 response to stress IMP - -1 C6C8 GRE2 P 6950 resp to stress IMP - -
C2C4 GRE2 P 6696 ergosterol biosynthesis IMP - -2 C6C8 GRE2 P 8204 ergosterol metabolism IMP - -
Consistency for SMS SP12 is thus calculated as:
P12A1,2CC2C4,C6C8 CONSISTENCY = 0
from:
i1 i2 Paper level
Gene 1 1 1
GO aspect 1 1 1
GO ID 1 0 0
GO term 1 0 0
EC 1 1 1 
With/from - - -
Qualifier - - -
Overall 1 0 0
In this case, we can see that all of the elements in the first pair of instances were
exact matches, but the second pair had mismatches for the values of the GO ID and GO
term elements. This yields an overall mismatch at the paper level.
For SMS SP3, in which the curator pairs had differing numbers of instances, 
significant manual manipulation of the annotation data was required prior to evaluation.
Since GO annotations are focused on gene products, the instances were ordered by the
Gene Name element, and cross-pair matches were searched for. Curator pair SC2C3
identified 6 distinct genes, while SC6C7 identified 4, as shown in Tables 15 and 16.
SC2C3 made a total of 12 annotation instances, while SC6C7 made 9.
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Table 15. SMS SP3 annotation instances for consensus pair SC2C3
Gene Aspect GOID GO Term EC With/from Qualifier
ARF1 P 6893
Golgi to plasma
membrane transport IPI FMP50|CHS6
ARF1 P 6893
Golgi to plasma
membrane transport IGI
BCH1 P 6893
Golgi to plasma
membrane transport IGI
BUD7 C 30140
trans-Golgi network
transport vesicle IDA colocalizes_with
BUD7 P 6893
Golgi to plasma
membrane transport IGI
CHS5 P 282 bud site selection IMP
CHS5 P 6893
Golgi to plasma
membrane transport IMP
CHS5 P 6893
Golgi to plasma
membrane transport IGI
CHS6 C 30140
trans-Golgi network
transport vesicle IDA colocalizes_with
CHS6 P 6893
Golgi to plasma
membrane transport IGI
FMP50 C 30140
trans-Golgi network
transport vesicle IDA colocalizes_with
FMP50 P 6893
Golgi to plasma
membrane transport IGI
Table 16. SMS SP3 annotation instances for consensus pair SC6C7
Gene Aspect GOID GO Term EC With/from Qualifier
BCH1 C 5798
Golgi-associated
vesicle IDA
BCH1 P 6038
cell wall chitin
biosynthesis IGI
BCH1 P 6038
cell wall chitin
biosynthesis IPI CHS3
BUD7 C 5798
Golgi-associated
vesicle IDA
BUD7 P 6038
cell wall chitin
biosynthesis IGI
BUD7 P 6038
cell wall chitin
biosynthesis IPI CHS3
CHS6 C 5798
Golgi-associated
vesicle IDA
FMP50 C 5798
Golgi-associated
vesicle IDA
FMP50 P 6038
cell wall chitin
biosynthesis IPI CHS3
The intersection of the two Gene sets is {BCH1, BUD7, CHS6, FMP50}, which
leaves SC2C3 with two genes (ARF1 and CHS5) that are not shared. Only FMP50 has
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the same number of instances across consensus annotations; the other three genes have
mismatches. Of the mismatched cases, SC2C3 has only one instance for BCH1, which is
made to the GO Biological Process aspect, while SC6C7 has three: two to Process and
one to Cellular Component. SC2C3 has 2 instances for BUD7, one Process and one
Component, while SC6C7 has two Process and one Component. For the purposes of
calculating the Consistency score, instances that were the closest matches were used, and
the others were discarded. For example, for BCH1, SC2C3’s instance was matched with
the second SC6C7 instance, because it was to the same aspect (Process), and had the
same Evidence Code (IGI). The full set of instance pairs that the Consistency score was
calculated from is shown in Table 17. Instance pairs are labeled ‘in’ for reference
purposes.
Table 17. Instance pairs from SMS SP3 for Consistency facet calculation
i Pair Gene Aspect GOID GO Term EC With/from Qualifier
C2C3 BCH1 P 6893
Golgi to plasma
membrane transport IGI1
C6C7 BCH1 P 6038
cell wall chitin
biosynthesis IGI
C2C3 BUD7 C 30140
trans-Golgi network
transport vesicle IDA
colocalizes
_with2
C6C7 BUD7 C 5798
Golgi-associated
vesicle IDA
C2C3 BUD7 P 6893
Golgi to plasma
membrane transport IGI3
C6C7 BUD7 P 6038
cell wall chitin
biosynthesis IGI
C2C3 CHS6 C 30140
trans-Golgi network
transport vesicle IDA
colocalizes
_with4
C6C7 CHS6 C 5798
Golgi-associated
vesicle IDA
C2C3 FMP50 C 30140
trans-Golgi network
transport vesicle IDA
colocalizes
_with5
C6C7 FMP50 C 5798
Golgi-associated
vesicle IDA
C2C3 FMP50 P 6893
Golgi to plasma
membrane transport IGI6
C6C7 FMP50 P 6038
cell wall chitin
biosynthesis IPI CHS3
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From these instance matches, Consistency is calculated as:
P3A1-6CC2C3,C6C7 CONSISTENCY = 0
from:
i1 i2 i3 i4 i5 i6 Paper level
Gene 1 1 1 1 1 1 1
GO aspect 1 1 1 1 1 1 1
GO ID 0 0 0 0 0 0 0
GO term 0 0 0 0 0 0 0
EC 1 1 1 1 0 0 0 
With/from - - - - - 0 0
Qualifier - 0 - 0 0 - -
Overall 0 0 0 0 0 0 0
Only the Gene and aspect elements had exact matches across all six instances.
The nine consensus annotations for MMS MP2 are included as Appendix 10. The
expert consensus annotation from MC1C3 was used as the reference standard against
which to compare the other eight annotations. Applying the same strategy of matching
genes as was used for SMS SP3 yielded a set of 16 instance pairs, also attached in
Appendix 10. From those instances, Consistency is calculated as:
P2A1-16CO1-O9 CONSISTENCY = 0
from:
Ref: C1C3 i1 i2 i3 i4 i5 i6 i7 i8 i9 i10 i11 i12 i13 i14 i15 i16 P
Gene 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
GO aspect 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
GO ID 1 1 1 0 1 0 0 0 1 0 0 0 0 1 1 1 0
GO term 1 1 1 0 1 0 0 0 1 0 0 0 0 1 1 1 0
EC 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 
With/from 0 - - - - - - - - - - - - - - - -
Qualifier - - - - - - - - - - - - - - - - -
Overall 0 1 1 0 1 0 0 0 1 0 0 0 0 1 1 1 0
All of the consensus annotations had instances that matched the reference
annotation’s Gene and GO Aspect element values. Fourteen of the sixteen matched the
Evidence Code, while only half matched the GO ID / terms. While the subset of instances
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used for this calculation were relatively consistent, it is important to remember that of the
original 54 total instances from the nine consensus annotations, less than a third (16)
were used in the Consistency calculation.
Specificity
Using the matched instances from Tables 10 - 13, Specificity for papers RP1 - 4 is
calculated as:
P1AO,RCR1 SPECIFICITY = 1
from:
O1R1 O3R2
Exact match 1 1
Mismatch, same lineage - -
Mismatch, different lineage - -
Broader - -
Narrower - -
Difference, in nodes - -
Nearest common ancestor - -
P2AO,RCR1 SPECIFICITY = 1
from:
O1R1 O2R2
Exact match 1 1
Mismatch, same lineage - -
Mismatch, different lineage - -
Broader - -
Narrower - -
Difference, in nodes - -
Nearest common ancestor - -
P3AO,RCR2 SPECIFICITY = 0
from:
O1R1 O2R2 O4R5 O5R6
Exact match 0 1 0 1
Mismatch, same lineage - - - -
Mismatch, different lineage 1 - 1 -
Broader - - - -
Narrower 1 - 1 -
Difference, in nodes 6 - 6 -
Nearest common ancestor 9987 - 9987 -
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P4AO,RCR2 SPECIFICITY = 1
from:
O1R1 O2R2 O3R3
Exact match 1 1 1
Mismatch, same lineage - - -
Mismatch, different lineage - - -
Broader - - -
Narrower - - -
Difference, in nodes - - -
Nearest common ancestor - - -
In three of the four papers, the terms were exact matches. In RP3, the subsequent
annotation for the pairs {O1, R1} and {O4, R5} was to a narrower term on a different
branch from the original term.
Using the same instance pairs for SMS SP12 as above, we can calculate the
Specificity score as:
P12A1,2CC2C4,C6C8 SPECIFICITY = 0
from:
i1 i2
Exact match 1 0
Mismatch, same lineage - 1
Mismatch, different lineage - -
Broader - -
Narrower - 1
Difference, in nodes - 1
Nearest common ancestor - -
In the case of the first pair of instances, the GO terms were exact matches. The
second pair were mismatches, but were adjacent on the GO tree – ‘ergosterol
biosynthesis’ is a child term of ‘ergosterol metabolism’.
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For SMS SP3, Specificity is calculated as:
P3A1-6CC2C3,C6C7 SPECIFICITY = 0
from:
i1 i2 i3 i4 i5 i6
Exact match 0 0 0 0 0 0
Mismatch, same lineage - 1 - 1 1 -
Mismatch, different lineage 1 - 1 - - 1
Broader - 1 - 1 1 -
Narrower 1 - 1 - - 1
Difference, in nodes 11 3 11 3 3 11
Nearest common ancestor GO:
0016043
GO:
0016023
GO:
0016043
GO:
0016023
GO:
0016023
GO:
0016043
The terms for instance pairs i1, i3, and i6 were on different branches separated by 11
nodes, while those for i2, i4, and i5 were separated by 3 nodes.
For MMS MP2, Specificity is calculated as:
P2A1-16CO1-O9 SPECIFICITY = 0
from:
i1 i2 i3 i4 i5 i6 i7 i8 i9 i10 i11 i12 i13 i14 i15 i16
Exact match 1 1 1 0 1 0 0 0 1 0 0 0 0 1 1 1
Mismatch, same
lineage
- - - 1 - 1 1 1 - 1 1 1 1 - - -
Mismatch,
different lineage
- - - - - - - - - - - - - - - -
Broader - - - 1 - 1 1 1 - - - - - - - -
Narrower - - - - - - - - - 1 1 1 1 - - -
Difference, in
nodes
- - - 0 - 0 0 0 - 1 1 1 0 - - -
Nearest common
ancestor
- - - - - - - - - - - - - - - -
In the case of the first instance, ‘ergosterol biosynthesis’, 4 pairs matched the expert
consensus annotation, while the other four chose a broader adjacent term, ‘ergosterol
metabolism’. The second instance’s annotations were to three adjacent terms:
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GO:0006950 : response to stress
GO:0006970 : response to osmotic stress
GO:0009651 : response to salt stress
with the broadest term assigned by the MOD representatives and the narrower terms by
the other participating curators.
Completeness
Given the instances above, Completeness for SMS SP12 is calculated as:
P12A1,2CC2C4,C6C8 COMPLETENESS = 1
from:
Ref: C2C4 C6C8
False positives 0
False negatives 0
Overall 1
Note that the semantic differences (differences in element values) between instances,
such as the GO Term differences in i2, are evaluated by the Consistency measure;
Completeness is interested only in instance counts.
Completeness for SMS SP3 is calculated as:
P3A1-9CC2C3,C6C7 COMPLETENESS = 0
from:
Ref: C2C3 C6C7
False positives 3
False negatives -6 
Overall 0
where the three false positives are two annotations to BCH1 (one Process, one
Component) and one to BUD7 (Process), and the six false negatives are the two ARF1
annotations, the three to CHS5, and the one Process annotation to CHS6.
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For MMS MP2, Completeness is calculated as:
P2A1-16CO1-O9 COMPLETENESS = 0
from:
Ref: C1C3 O2 O3 O4 O5 O6 O7 O8 O9
False positives 1 2 1 13 1 7 10 1
False negatives 0 0 0 0 0 0 0 0
Overall 0 0 0 0 0 0 0 0
In this case, none of the compared annotations had false negative instances, only
false positives.
Validity
To assess Validity, the collections of all consensus annotations from both the SMS
and MMS were examined. There was one instance in the SMS and 51 in the MMS that
contained a variety of invalid element values, and thus were not used in the analysis of
instance counts. These amounted to <1% of the total number of consensus instances
obtained in the SMS, and 4% in the MMS. The most common sources of errors were
proposed GO terms that lacked direct Gene element referents, and ambiguous
relationships to the other instances provided.
3.4. Curators’ personal document annotations (MMS)
This section analyzes the personal manual annotations made by a sample of MMS
curators (n=6) on the paper copies of the articles used in that study. Figure 22 illustrates
an example of the quantity and variety of personal annotations that were made by
curators on the document set when curating for GO. (Other types of curation activities
could yield different annotations.) This example includes multiple writing media (pen and
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highlighter), and multiple annotation types, including underlining, highlighting, circling,
arrows, and textual notes.
Figure 22. Partial manually-annotated document (MMS P5, PMID: 166822356)
1. Curators’ annotations are of a limited number of types, and follow similar styles.
The six curators studied here used similar types of personal notes when manually
annotating the paper copies of the 10 common articles used in the study. The six note
types observed were: 1) highlight (semi-transparent color marker used to select text), 2)
underline (single or multiple lines drawn under text or other elements), 3) circle (line
drawn around text or other elements), 4) emphasis (vertical mark drawn next to block of
text), 5) textual note (words or phrase written in page margins or within text), and 6)
arrow (drawn to link extant text to notes, or as an indicator of importance). Most curators
used all six types at various times, though not always within the same article.
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Highlighting, underlining, and textual notes were the most common marks observed.
Highlighting and underlining are similar approaches to selecting text, and were often
used interchangeably. Some curators clearly preferred one over the other – one curator
never used highlights, but underlined extensively – but others used both within the same
paper.
2. Numbers of personal annotation instances varied widely by curator.
Despite the use of similar annotation types (and the common underlying work task),
the curators varied widely in the numbers of annotations instances made per paper. Figure
23 shows the total number of annotations made per paper by each curator to illustrate the
amount of variation. Overall, curators 7, 8, and 9 each made nearly twice as many (or
more) notes per paper than curators 3, 4, or 6.
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Figure 23. Total annotation instances per curator by paper
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Curators also used varying numbers of the six different types of annotations
described above. Figure 24 shows boxplots of the curators’ annotations by type. The note
type was the only kind of annotation that all curators employed for one or more papers;
each of the other types had at least one curator who did not use it for this set of papers.
While Curator 7, who made the most overall annotations, usually has the largest range,
Figure 24a shows that the ‘highlight’ type was the least frequently used by that curator.
Underlines were made most frequently by only two of the six curators, C7 and C8, as
were circles. Emphasis and arrows were made least frequently, while underlines and
highlights were the most often made.
3. Quantities of curators’ annotations varied by paper section.
Figure 25 shows the cumulative annotations made by all curators to the set of 10
papers, by paper section. For this analysis, the names of paper sections were normalized
to ‘Abstract’, ‘Introduction’, ‘Methods’, ‘Results’, ‘Discussion’, and ‘References’, which
the majority of the papers followed quite closely. The Results section is clearly where the
majority of annotations are made, with nearly 10 times more instances (1,528 total) than
the other leading sections, Discussion (169), Introduction (163), and Abstract (152).
Methods and References had very few by comparison (23 and 12, respectively). These
results partially confirm the curators’ self-reported annotation behavior (Section 3.5)
when they say they tend to focus on Results and Abstracts when curating papers.
The Acknowledgements section of each paper was examined (when present), but is
not shown here as no curator made annotations to it in any of the papers. Paper P10 was
the only paper whose title was annotated, by two curators.
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Figure 24a-f. Boxplots of curators’ annotations by type (all papers)
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Figure 25. Cumulative annotation instances by paper section (all curators)
4. Personal annotation behavior explains only 9% of instance variation.
To investigate whether personal annotation behavior is related to variation in GO
instance counts, the scatterplot in Figure 26 was constructed from the personal annotation
counts and GO instance counts of the six curators who participated in this portion of the
MMS. An R2 value of 0.096 means that less than 10% of the variation in GO instances is
explained by personal annotation instances (p=0.016).
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Figure 26. MMS individual GO instances by personal instances
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3.5. Workflow analysis
This section describes the analysis of the curator interviews, with regard to
differences among the individual work practices curators use when creating GO
annotations. A summary of three standardized questions is presented, followed by direct
quotes from curators contrasting their specific work practices and experiences.
Article format, ontology browsers, and related resources
Eleven of the fifteen curators interviewed always or almost always curate from
electronic versions of articles. Most have large, high-resolution monitors that remove
readability issues from the decision to read on the screen versus paper. The main benefits
they see to doing so include the ability to search for gene names and other terms in order
to find all of the instances within a paper, and the ability to access supplementary
information and other resources more easily. Most of the SMS interviewees used the GO
browser built into their MOD to access the GO vocabularies while curating, but other
frequent choices by both SMS and MMS curators were QuickGO (EBI, 2007), the MGI
browser from the Jackson Labs (Jackson Laboratories, 2007), which was used even by
non-mouse curators, and AmiGO (GO Browser, 2007). Other reference materials and
resources frequently used by curators when annotating included their own MODs, the
NCBI Bookshelf (NCBI, 2007) resources, PubMed, Google, Wikipedia, and standard
biology and biochemistry textbooks.
Quotes from curators in the following section are cited in the form of ‘[Study_prefix
Curator_ID: transcript_lines]’, where ‘Study_prefix’ is an ‘S’ for SMS, and an ‘M’ for
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MMS. Quotes are almost always verbatim, but in some cases, words in square brackets
are used to remove identifying information, such as the MOD for which a curator works.
Differences in common themes were observed in curator work practices.
Several common themes were present in the interviews, such as the relative utility of
abstracts and other information resources in the annotation process; whether organismal
or specialty differences are more difficult to overcome than differences in methods used
across papers; curation as another layer of peer review; perceptions of the meaning of
annotation- and curation quality; and observer effects as a potential source of variation.
1. If it is important, it will be in the abstract.
I always try to read the abstract first, just to try to get a basic idea of what
they feel is significant about what they’re reporting. [S09: 161-162]
I guess my mindset is, when I first look at a paper, the first thing I really
focus on is the abstract, because if they have some groundbreaking new process or
function that some protein is involved in, they usually talk about it in the abstract,
versus something more peripheral, that might be mentioned in the paper, but not
that important in terms of the biology of that gene product. So if I see something
in the abstract, that is usually the first key that if they’ve identified a new function
or process for that, that I want to capture that. [S04: 138-143]
I get most of my cues, again, off of the abstract, because I go back to that
main question of “What is this paper actually about?” That all should be in the
abstract. Some big, important point in the paper, some new function or some new
thing that somebody proved, and they didn’t even put it in the abstract? It can’t be
that important. [S06: 479-487]
Some curators said curation experience and organism familiarity are helpful in
understanding an abstract and placing the paper in context:
[I] definitely just read the abstract first. And I’m familiar enough with the
genome now that I can often tell if this is something really novel and, you know,
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high priority, or if it’s just one more fact to an existing mountain of facts. [S03:
94-98]
One curator takes a different approach, particularly with papers that are on
previously uncharacterized proteins:
Normally I start with the Introduction. I probably would read the abstract last,
actually, because the Introduction- especially if it’s the first paper on a protein, I
like to be led in a little bit slowly, more gently into the subject area - so I’d read
the Introduction and then go all the way through Results, Materials and Methods
for the species quite often is needed, all the way through the Discussion, mark up
the paper, and then I probably would turn to the abstract once I’ve got fair idea of
the GO terms just to double check, actually, that there isn’t anything in the
abstract [that I have overlooked]. [M07: 130-141]
Use of the abstract as a way to confirm that nothing important was overlooked was a
common theme among curators:
I sometimes look at the abstract first, but I find sometimes I get bogged down
in the abstract – it’s just too much information too fast. And I sometimes don’t
want to know the punchline, you know? But every time at the end, I go back to
the abstract, because I just want to make sure that I didn’t miss anything that the
authors [were claiming]. [S01: 180-185]
2. Context influences GO annotation
It seems that the broader work context in which GO annotation is performed heavily
influences the curators’ specific approaches to selecting, reading, and curating individual
papers, beyond the content of the papers themselves. Decisions about which portions of
papers to curate, or even to curate the papers at all, are dependent upon factors such as
prior annotations to a gene that are extant not only in the database in question, but other
resources (e.g., NCBI databases, UniProt) that also cover information about that gene.
Database policy questions, such as the strength of one evidence code over another;
whether the MOD accumulates evidence versus selectively acquiring and replacing
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annotations; or the presence and absence of annotations to orthologous genes in other
resources, all impact how prospective annotations are made.
Multiple curators said that they use GO annotations in other MODs to provide
guidance on creating annotations in their own resources. For example:
If I find out that some gene is homologous to another gene in mouse or fly, I
definitely go to their database and see how they have annotated it. [S02: 213-215]
Another curator said that extant annotations in other resources help drive whether to
make them in the curator’s own database:
So one of the things I do is that I go out there and I look first at Entrez Gene,
for what GO terms they’ve got, and also at Uniprot for the human, just so that I
can score whether it’s got manual annotations, electronic annotations, no
annotations at all, or protein incorporated annotations. So I will make a record of
that, just so that I know, and that might influence whether I then continue. You
know, if it had a lot of manual annotations, I might just go: “that’s been done,
OK, might not be done brilliantly, but it’s got something, and I’m going to put my
effort into other things.” But sometimes I get very frustrated – you know I might
read a paper, or I might see a gene that I know from my previous work, and I
know that it’s completely underrepresented, and I might just go, “you know, that
really isn’t helping.” So I’ll add some terms to it. [M18: 156-172]
One curator who had curated several different organisms was asked whether
differences in organisms were more significant that other aspects in affecting annotation
performance:
I actually don’t think it was that difficult to go from [my organism] to
curating human, mouse and rat. So, you know, this kind of speaks to your
question about whether or not you could have a general biology knowledge and
curate for any given organism. I guess I tend to think that yes, you probably
could. I think the big differences are organisms that use genetic techniques versus
those that more typically rely on biochemistry. [M08: 395-399] I think that it’s a
lot easier to curate different organisms that use similar experimental approaches
than it is to even curate the same organism with very different experimental
methods or techniques. [M08: 413-415]
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Another curator from a different MOD agrees:
Molecular biology and biochemistry methods are very general. Things like
where you’re assessing morphology and you’re making calls and well, this is
mutated and not... a lot of other people are telling me, “man, your [organism is]
just, you know, these pictures, they all look normal to me.” You know, and
they’re not – there are subtle differences that you look for. And I think that’s the
same probably if I were to look at a series of C. elegans mutants. You know,
they’re all the same to me. Yet, the person in that field would be able to point out
the subtle differences that make them different. [M09: 248-256]
Lack of knowledge of specialized techniques seems to cause some curators to rely
more on an author’s statements than on the curator’s own expertise:
I think that when you’re not that familiar with the technique, you’re much
more inclined – or at least I was – to just take the author’s word at whatever they
say. And you don’t really bring that much prejudice to making those kinds of
annotations. [M08: 345-348]
One curator in the MMS said that rather than differences in methods, it was
specialized terminology within a sub-domain that made the task of curating papers from
different organisms difficult:
Not so much the types of experiments, because – so, the only plant paper was
Arabidopsis, and that’s a genetic system just like [my organism] is a genetic
system, so I don’t think the types of experiments were different, but the
terminology was different, so when they talk about ‘pedial’ and ‘gynoecium’ and
‘stamen’ and ‘anther’.... I have done plant science. I have that in my background,
but probably not to that degree that they’re talking about in the paper, so the
terminology was kind of like, “Oh, I don’t know what this means,” you know; “I
have to look it up, or I’m just going to annotate to a very high level term and play
it safe.” [M06: 253-263]
3. Familiarity with certain organisms or areas may constrain a curator’s personal GO
vocabulary.
Multiple curators in the MMS noted that they realized in curating papers from
multiple organisms that their personal GO vocabularies seemed very small, since they
tend to focus on certain parts of the ontologies. For example:
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[N]ow that I’m using GO I tend to have a preference for certain nodes of the
ontology that I go down more frequently than others. [...] I visit certain GO terms
more than others, just simply because I know of their existence, and when I’m
reading the paper, if I’ve got a fair idea if the GO term’s right, and I look at the
term and it is, I then [would] probably be happy with that one rather than
searching all over again, so I think I have a – kind of like a sort of standard
vocabulary of GO terms that I visit more often, and those which I have to be a
little bit more imaginative where I don’t already have an idea of the terms to use.
This is where talking [with the other database representative, during the consensus
annotation process] was very interesting, because I think just from the type – the
randomness of the types of papers that she’s been going to in her curation process,
I think she’s got a different kind of standard vocabulary of her favorite GO terms.
And so the clash of those, actually, was really nice, because it just ended up
making me appreciate “Oh, I’ve got to remember to go down that node more
often.” And I think this is where it was really nice to actually remember that there
are 20,000 terms, and that I’ve really got to remember to go and see those. [M07:
269-288]
4. Curators are mixed about whether they do (or should) function as an additional layer
of peer review.
One gray area of GO annotation is whether curators should essentially be
gatekeepers, functioning as an additional layer of peer review. Some curators may say
“all of these papers are already peer reviewed – I’m not going to second-guess an article
that was published in Science.” Others, particularly those with significant lab experience,
may say, “you know, I’ve done this same experiment dozens of times, and never saw data
like this. I don’t buy it.” The following two quotes are representative of the ideas heard in
the interviews, and focus on examining and interpreting figures in articles:
I would say fifty percent of the time I would look at figures. Usually in two
cases. Either I can’t understand what the experiment was and I try to understand
better by looking at figures. You know, where really, they used this mutant or this
method, and so on and so on. And another reason is to verify. So, like it’s a final
check. Ok, I decided, based on the abstract, I decided that this GO term is needed
with this evidence code. And as a final kind of double check, I look at the figure
to make sure that they, for example, really studied the enzymatic activities. [S08:
198-205]
I don’t normally look at figures. Hardly at all, unless something is confusing
or whatever, but – I figure, in the Results, they’re going to describe what the
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figures say and, you know, I’m not going to reinterpret the figures, and we’re not
supposed so be judging the quality of the data. I’m not going to look at the figure
and say, you know, they- they’re making the wrong conclusion from it. I’m going
to just record their conclusions. [S03: 101-105]
5. Perceptions of annotation and curation quality.
Curators expressed similar themes about what terms such as ‘consistency’,
‘reliability’, ‘accuracy’, and ‘quality’ mean to them in relation to curation and GO
annotation:
I’m just very conscious of making sure that anything I’ve put up there is
defensible. You can say where you got it or why. We want people to be able to
look at what they have – what we have up there – and trust it. [S06: 527-530]
It is my belief that a user who comes into [our database] should find the
current information, and I should strive and make sure that that information, what
I put up there is accurate. That's my sense of trying to have good quality. [S02:
347-349]
I think to me, the most important thing is, am I bringing the information from
or taking information from that paper that I would expect a user to want to find?
And you want to try to represent everybody properly that spent a lot of time
working out there. So I try to make sure that I’m not biased based on my
background, wanting to curate more from one lab than another, but just properly,
trying to represent the information as accurately as I can, so that either if
somebody from a small group or somebody that’s doing large scale stuff is going
to go in and get that information and know that it’s correct. [S04: 303-310]
I guess I’m not too paranoid about it, though, because, you know, even if you
try to do the best job you can, you can’t get it right every time. Not even most of
the time, probably, and the whole thing is cumulative. You know, people are
going to be coming back to this gene many times. There are going to be new
papers, and it’s just – it all builds on this. I try, I guess, to compromise speed with
accuracy. You know, I’m not going to spend all day on a paper, because that’s
just not – you just can’t do that. [S03: 210-216]
Other curators discussed the idea that it can be frustrating knowing that the volume
of new papers that needs to be curated has an impact on factors such as accuracy or
quality, and those suffer when enough time is not taken to be certain about annotations,
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or when papers are complex and challenging and require additional work to understand
them. As one curator put it concisely:
I think that ‘quality’ in this job is the patience to be complete. [S01: 367-368]
6. Some variation may be due to observer effects.
The interviews indicate that some of the variation in instance counts may be due to
the fact that the curators knew that their work was being observed and analyzed, and,
especially in the MMS, that they would be using their annotations to train novice
curators. This theme was noted when curators were asked in interviews what attributes of
the study were different from their normal curation practices:
I think some of us probably over-curated papers, just knowing that we want it
to be complete and not miss things. So we maybe curated extra topics that we
wouldn’t have otherwise. [S04: 246-248]
I think I read the papers much more thoroughly than I would have otherwise.
Even the [papers from my organism], because in day-to-day work, I’m trying to
get through a lot of papers in a little amount of time. And for this, I was like,
“well, you know you’re trying to teach people so you really want to extract every
little last drop of information that you can out of the paper.” And so in some ways
I think, you know, we’re like overanalyzing our work in this whole workshop.
[M09: 162-172]
3.6. Curator background and experience (MMS)
The self-administered questionnaires in each curator’s annotation worksheet package
in the multi-MOD study were designed to enable comparisons to be made between
curators’ backgrounds and experiences and their formal GO annotations, as described in
section 2.5.2. The original survey instrument is attached as Appendix A2. The responses
from each of the four questions are characterized below.
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Question 1. Degrees
Question 1 asked participants to list the disciplines of each of their earned degrees.
Twenty of the 23 curators held Ph.D degrees at the time of the study. Of the three other
participants, two held master’s degrees, and one held a recently-earned bachelor’s degree.
Of the Ph.D holders, only 4 held one or more master’s degrees, and one of those was a
subsequent degree in bioinformatics. One respondent listed only a Ph.D, and no
undergraduate-level degree.
Table 18 shows the distribution of the Ph.D degrees by degree name and area. No
attempt was made to combine like degrees, and combinations of subject areas were exact
match only. While four curators held genetics degrees, six curators’ degrees had
‘molecular biology’ in their titles.
Table 18. Distribution of curators’ Ph.D degrees by degree name and subject area
Degrees # % Subject area # %
Genetics 4 20.0 Molecular biology 6 23.1
Biochemistry 3 15.0 Genetics 4 15.4
Biology 2 10.0 Biochemistry 3 11.5
Molecular biology 2 10.0 Biology 2 7.7
Molecular, Cellular, and
Development Biology 2 10.0 Cellular Biology 2 7.7
Veterinary Sciences 2 10.0 Developmental Biology 2 7.7
Botany and molecular
biology 1 5.0 Plant Biochemistry 2 7.7
Plant biochemistry 1 5.0 Veterinary Sciences 2 7.7
Plant biochemistry and
molecular biology 1 5.0 Botany 1 3.8
Plant genetics 1 5.0 Plant genetics 1 3.8
Virology 1 5.0 Virology 1 3.8
Total 20 100.0 Total 26 100.0
Question 2. Expertise
Question 2 asked respondents to list their main area or areas of scientific expertise.
Multiple responses were permitted. Of participants’ first responses, there were 17 distinct
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areas, as shown in Table 19, with one response of “none”, and one left blank. Only
‘development’ and ‘plant developmental biology’ received more than one response.
There were 48 total responses, of which 38 were distinct. Only five were given by more
than one curator: ‘development’ (5), ‘cell biology” (2), ‘cell cycle’ (2), ‘immunology’
(2), and ‘plant developmental biology’ (2).
Table 19. Distribution of curators’ areas of expertise (first responses)
Areas of expertise # %
development 4 17.4
plant developmental biology 2 8.7
cell biology 1 4.3
cell cycle 1 4.3
cell wall construction 1 4.3
DNA-protein interactions 1 4.3
DNA methylation 1 4.3
Embryonic development 1 4.3
enzymology 1 4.3
genome evolution 1 4.3
immunology 1 4.3
inflammation 1 4.3
Protein regulation and degradation 1 4.3
proteomics 1 4.3
transposition 1 4.3
regulation of gene expression 1 4.3
virology 1 4.3
"none" 1 4.3
blank 1 4.3
Total 23 100.0
Question 3. Laboratory Experience
Question 3 asked curators to list those biological organisms with which they have
had some amount of laboratory experience. Of participants’ first responses, there were 17
distinct organisms, as shown in Table 20, plus two curators who did not respond. There
were 59 total responses reflecting 38 distinct organisms. The number of organisms given
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by the curators ranged from 0 (2 cases) to 7 (1 case), with a mean of 2.6 and a mode of 2
(7 cases).
Table 20. Curators’ laboratory experience by organism (first responses)
Organism # %
Arabidopsis 3 13.0
mouse 3 13.0
[blank] 2 8.7
bovine 1 4.3
C. elegans 1 4.3
chicken 1 4.3
Dictyostelium discoideum 1 4.3
Drosophila 1 4.3
E. coli 1 4.3
Erlich ascites tumor cell lines in
mice 1 4.3
human tissue 1 4.3
Mammalian cells 1 4.3
Oil palm 1 4.3
sorghum 1 4.3
varied in vitro proteins 1 4.3
wild rodents 1 4.3
Xenopus laevis 1 4.3
yeast 1 4.3
Total 23 100.0
Question 4. GO Annotation Experience
Question 4 asked respondents to list those biological organisms with which they
have had some amount of Gene Ontology annotation experience. Of participants’ first
responses, there were 11 distinct organisms, as shown in Table 21, plus one curator who
responded “none”. There were 40 total responses reflecting 17 distinct organisms. The
number of organisms given by each curator ranged from 0 (1 case) to 5 (1 case), with a
mean of 1.7 and a mode of 1 (14 cases).
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Table 21. Curators’ GO annotation experience by organism (first responses)
Organism # %
Arabidopsis thaliana 3 13.0
chicken (Gallus gallus) 3 13.0
human 3 13.0
mouse 3 13.0
Caenorhabditis elegans 2 8.7
Dictyostelium discoideum 2 8.7
yeast (Saccharomyces cerevisiae) 2 8.7
E. coli 1 4.3
mammals 1 4.3
rat 1 4.3
rice 1 4.3
"none" 1 4.3
Total 23 100.0
Years of GO Curation Experience
A follow-up question asked of the participating curators via email was how many
months or years experience they had in performing GO annotation at the time of the
study. Responses were received from 21 of the 23 curators, and ranged from a low of 6
months to a high of 8 years, with a mean of 2.9 years and a standard deviation of 1.7
years. These data were used above in section 3.3 to test whether curators’ variation in
annotation was influenced by years of GO experience.
3.7. Curator background and experience (SMS)
The single-MOD study did not use a structured questionnaire for collection of
information on curators’ backgrounds and experience. These data were derived from
analysis of the individual semi-structured interviews conducted with the SMS curators,
following the five categories of questions in the MMS survey instrument described in
section 3.6 above: degrees, expertise, organism experience in the laboratory, organism
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experience with GO annotation, and duration of GO annotation experience. The protocol
used for the interviews is attached as Appendix A1.
Degrees
All 10 of the curators held Ph.D degrees at the time of the study; 6 had also
completed one or more post-doctoral research appointments. Three curators had genetics-
focused Ph.D degrees, and the other 7 were distributed over 6 other subject specialties, as
shown in Table 22.
Table 22. Distribution of curators’ Ph.D degrees
Degrees # %
Genetics 3 30
Genetics and molecular biology 2 20
Biophysics 1 10
Bacteriology 1 10
Genetics and biochemistry 1 10
Microbiology, molecular biology and genetics 1 10
Molecular biology 1 10
Total 10 100
Expertise
Given the small population, the name of the organism with which each of the
specialties below are associated was removed to afford the participants more privacy. As
Table 23 shows, there were no overlaps in expertise among the 10 curators’ verbatim
statements of expertise. No normalization of specialties was attempted.
Table 23. Distribution of curators’ areas of expertise
Areas of expertise # %
Chloroplast genes 1 10
Cell cycle 1 10
Evolutionary genetics 1 10
Gene therapy 1 10
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Areas of expertise # %
Metabolism 1 10
Miotic recombination 1 10
Protein folding 1 10
Splicing 1 10
Transcription 1 10
Transcriptional regulation 1 10
Total 10 100
Laboratory Experience
The curators predominantly had laboratory experience with the organism that is the
subject of their MOD, so those data are omitted here, again to protect their privacy. Given
that it is the same across almost all curators, it is unlikely to be a useful discriminant.
GO Annotation Experience
As with Laboratory Experience, curators had most of their GO annotation experience
with their MOD’s organism, so this variable was not used for analysis. Several curators
had many years of literature curation other than GO, however (exact counts not
available).
Years of GO Annotation Experience
At the time of the study, the 10 curators’ experience with GO annotation ranged from
a low of 6 months to a high of 8 years, with a mean of 4.1 years and standard deviation of
two years.
4. Discussion
4.1. Contributions
This section summarizes the findings and contributions of the two studies.
GO annotation is qualitatively different from indexing in process and intent.
While the GO curation process resembles topical document indexing in some ways
(and, in fact, one role curators often have is to index articles to provide access points to
specialized topics, such as research methods, that are not captured by standard indexing),
the specific process of GO annotation creation, and the subsequent use of annotations by
scientists, is quite different. Rather than summarizing what a document is generally
‘about’, GO annotation focuses on the specific claims authors make, and associates them
with specific gene products through the formal GO annotation artifact. End users use GO
annotations not to find literature, as users of bibliographic databases do, but to understand
what is known about a particular gene product. These differences have implications for
not only the study of annotation variation, but also what roles information and library
science can reasonably hold in the areas of biomedical curation and database
administration. Curators involved in hiring and training novice curators reported in
interviews that they believe it to be far easier for subject matter experts (e.g., Ph.D-
trained biological scientists) to learn curation and its associated tools (such as ontologies
and web-based databases) than it would be for information experts to learn the subject
matter necessary to become efficient and effective curators.
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GO annotation can be taught but not replicated.
The apprentice model of curator training seems to be the most effective based on
curator interviews. By observing experienced curators, curating the same articles,
discussing their differing annotations, and then rationalizing the individual annotations
into a consensus annotation, novice curators develop the skills necessary to practice GO
annotation, including how to read articles differently for curation from the way they are
read by students or investigators: which sections are most useful for annotation, which
language to focus on, and which to avoid. This approach may not result in perfectly
consistent annotation, but it provides a semi-formalized method for teaching the
rudiments of curation and transferring tacit knowledge acquired by experienced curators.
The annual GO Annotation Camp venue has been extremely important in developing this
model and in building both a community of curators and the concept of curation as a
career path in science.
Perfect consistency is unlikely given annotation complexity.
If we consider the spectrum of possible outcomes – the potential that there are
multiple genes characterized in a paper; that multiple experiment types may be present,
yielding different evidence codes and relating to different GO aspects; that differences in
workflows, reading behaviors, and experience can affect interpretation; the sheer number
of GO terms available from which curators can choose – it may begin to seem unlikely
that two or more curators could ever independently create annotations that were exactly
the same. We should keep this complexity in mind when reviewing the results above.
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A focus on perfect consistency obscures diverse sources of variation.
As shown in 3.2.2, exact match consistency at the paper level was rare: less that 20%
in the SMS 4x paper set, 34% in the 2x set (due to zero annotations), and only 50% of
MMS papers had one or more pairs of exact matches. Gross numbers on consistency,
however, are not useful for summarizing the results, because they aggregate across papers
and obscure facet-level variation. Consistency statistics do not provide information about
whether the differences between compared annotations are either meaningful or negative.
One example is the facet analysis of the annotation instances for MMS paper MP2, where
the ten consensus annotations were inconsistent, but the Completeness measure showed
that none of the compared annotations had false negative instances, only false positives.
One of the goals of developing granular facets of annotation quality was to transcend the
limitations of simple consistency measurements.
Several types of variation in GO annotations were observed in the studies. Individual
evidence sources had wide ranges of annotation instances. Individual curators made
differing amounts of instances across papers, and chose widely different terms, genes,
and evidence codes within them. Variation was observed by organism expertise, by group
assignment, and between individual and consensus annotations. Years of GO curation
experience was found to not be a predictor of annotation instance quantities. The curators
themselves had widely different educational, training, and curatorial backgrounds.
Interestingly, large numbers of annotation instances seems to counter the idea that
curators are conservative about annotating only those claims about which they are very
confident. Table 6 showed that while the SMS organism experts’ instances for the two
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papers included in both studies ranged from 1-8, the MMS curators’ instances ranged
from 0-35.
Perfect consistency is not necessarily optimal.
Perfect consistency among annotators may not be desirable even if it were possible.
Slight variation in term selection, for example, may provide broader or deeper coverage
of an evidence source, in the same way that multiple indexers of a document may be
technically inconsistent in index term selection, but in practice provide different levels of
conceptual specificity that lead to multiple useful access points.
Slight differences may also be acceptable to end users and administrators if the
annotations are not inaccurate or misleading. Two cases from the Specificity facet
calculation in section 3.3.4 are instructive: The three terms in the second instance of MP2
were adjacent, while in SP3, some terms were 11 nodes apart. The former may be an
acceptable level of variation, while the latter may not. The setting of thresholds of
acceptable variation should, of course, be left to those who create and use the annotations
as they deem them suitable. One approach could be the use of GO ‘Slims’ to smooth
variation and provide rubrics for assessing consistency. GO Slims are versions of the GO
vocabularies that contain less granular subsets of the entire trees. If a tree is collapsed
into smaller numbers of more generalized categories, instances that have term
mismatches at the full GO level may be consistent if they fall within the same larger bins
of GO Slims. Dolan et al.’s (2005) work employed this method, but, as they note, the
variation in how GO Slim bins are constructed can have significant impacts on the
calculations of annotation consistency, and the category definitions or variation
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thresholds for comparison need to be applied uniformly by different evaluators to enable
consistent assessments of quality.
There are other reasons why perfect consistency is elusive. While a finite number of
GO-annotatable claims exist within a particular evidence source, the concept of a
‘consensus’ annotation is still only a surrogate for truth, in that even if all annotators of
an article agree, they may still be incorrect in terms of one or more of the quality facets.
Agreement is no guarantee of accuracy.
The common evaluation practice of summing and averaging judges’ scores assumes
that they are experts and are qualified to make judgments; even qualified judges vary in
the stringency/leniency of their ratings (see Shrout & Fleiss, 1979). Pooling may be
useful in certain contexts, but here, since we are more interested in the underlying process
of annotation and the individual differences of curators’ annotations, pooling or
averaging might obscure the information in which we are interested.
One related issue is the relatively large proportion of cases in the SMS that lacked
any annotations by one or more curators. The absence of annotation is not necessarily a
negative situation. Curators described three possible reasons why they might not make an
annotation where it had been expected:
1. There is no annotation present in the paper, in the opinion of that curator.
2. An annotation exists in the paper, but was overlooked by the curator.
3. An annotation exists in the paper, and is recognized by the curator, but is not
made because of MOD policy or curator judgment (e.g., it doesn't add anything
new that isn’t already present in the database (and the MOD’s policy is not to
110
curate every paper); the annotation should be made from a different or earlier
paper; etc.).
These are very different reasons, but in the absence of contextual information
obtained from observations or other methods, we will be unable to make any claims
about why a particular annotation was not made by one curator, but was made by another.
Curators seem conservative about making annotations – during interviews several said
that they would prefer to not make an annotation at all than to risk making an inaccurate
or incorrect one due to uncertainty, given the potential negative impacts on research. The
first case seems to have occurred with the SMS 2x coverage article set, where 11 of the
32 papers had zero annotations from both curators, and in the 4x set with papers SP8 and
SP9, where the individuals’ zero instances were carried over to the consensus annotation.
Several curators implicitly addressed the second case in interviews; when asked about
differences discovered when discussing their individual annotations in the consensus
pairings, they mentioned that the other curator would frequently have identified and
annotation that the first curator had missed. The third case is expected to be a small
portion of the missing annotations, given the study instructions and the presence of notes
from curators in the spreadsheets that explain why they would not make the annotation in
practice.
Pairwise matching and comparison of instances is difficult and atypical.
The difficulties associated with matching annotation instances across curators for
strict pairwise comparison limits our ability to use formal measures to cases where a large
proportion of the curators’ annotation instances intersect. Other approaches, such as
fuzzy matching or heuristic algorithms may be more suitable. One example could be the
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use of database approaches to compute the intersection of instance sets and to calculate
the Completeness and Specificity metrics to derive relative scores based upon a
combination of those three facets.
We can see examples of the drawbacks of the pairwise matching approach in the
facet analysis (section 3.3.4). In the MP2 Consistency calculation, only sixteen of the
original 54 instances were useful for pairwise comparisons. In the Reliability facet
computation for RP1, on the second reading the curator decided that the evidence was not
strong enough to warrant IMP annotations in addition to the IDA annotations, which
resulted in inconsistent original and subsequent annotations. In this case, if we rely upon
the binary measurement of ‘consistent/inconsistent’ as the method of evaluating
performance, the curator is penalized for improving over time.
The annotation quality facets require revision to be more useful in practice.
Section 3.3.4 evaluated the study data against the proposed GO quality facets; here
we address the performance of the facets themselves. How useful do they appear to be?
What modifications need to be made?
The concept of decomposing ‘consistency’ into facets such as Specificity and
Completeness that are more granular in order to understand different types of variation
has face validity. The use of dichotomous attribute values and cumulative binary facet
scores of 1 or 0 are not as informative as they could be. A different approach to capturing
the granularity of the attributes in a summary measure is needed. The Specificity measure
is useful only for determining relative distance. It cannot be used for normative
evaluation, because, while the stated goal of GO is to annotate to the most specific
appropriate term, we cannot assume that ‘more specific’ equates to ‘better’. In the MMS
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MP2 example calculated above, for example, the MOD representatives may have expert
knowledge (or other reasons) that caused them to select the broader term ‘response to
stress’ rather than the more granular terms chosen by the other participants. Also, since
both the depth and the number of nodes per branch can vary by annotation pairs, a
normalization method is needed in order to be able to state which of two instances is
conceptually closer or more distant when branch depth varies. Different weightings of
some facets and attributes may be important for instances where a paper has large or
small numbers of annotations; where there are significant discrepancies in curators’ GO
term assignments; and in general to capture relative importance of certain attributes of the
GO annotation compared to others, which may be context-dependent.
However, more than the shortcomings of the facets, the inability to more easily
perform pairwise matching of instances greatly inhibited our ability to evaluate the data
using the faceted measures. Effective methods for deriving the intersections of two or
more sets of annotation instances would make the use of the measures practical.
Finally, while these measures are designed to evaluate human-created GO
annotations, they could also potentially be useful as performance standards for the
evaluation of automated systems (such as in a BioCreAtIvE (Hirschman et al., 2005)
challenge setting), or for assessing variation between human-curated and automated
annotations.
Electronic workflows may inhibit explanations of variation.
The electronic-only workflow model observed in the SMS seems to optimize curator
time by eliminating intermediate tasks and artifacts, but further obscures the intellectual
linkage between the evidence source and the final GO annotation since it resides only in
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the curator’s head. Significant investments of time were required in the Reliability pilot
study to observe curators using the concurrent verbal report method in order to try to
apprehend some of the internalized reading- and annotation behaviors and associated
decision-making. The Future Work section below describes methods for end-to-end
evidence linkage that are being developed that could address this issue.
A useful corpus of high-coverage GO annotations was created.
The prospective nature of the two studies produced a valuable set of nearly 4,000
new GO annotation instances covering five organisms. This data set may be useful for
further analysis of variation (as described below in Future Work), for use in training
novice curators, as well as for use as training data or reference (‘gold standard’) data for
automated systems for GO annotation and claim extraction. It has also provided the
additional benefit of adding to the existing pool of GO annotations. This set of
annotations will be made available at a future date for use by other investigators.
4.2. Limitations
These studies have certain limitations, described below, which inhibit generalization
of their results.
Participant sample size and composition.
While thirty-one curators participated in the studies (and that number represents a
large percentage of the population of GO curators that exist), that is only a sample from a
small number of model organism databases, and results might have varied significantly if
a different group of curators from different organisms had participated.
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Limited facet-level analysis was performed.
Due to the complexity of instance matching described above, only a very small
sample of annotations were analyzed using the quality facet metrics in section 3.3.4. We
attempted to choose representative annotations, but the small sample size means
generalizations about the remainder of the annotations cannot be made, and not enough
calculations were made to provide meaningful aggregate statistics at the facet level.
Worktask considerations.
While curators in both studies were instructed in general to perform their annotation
tasks as they normally would, differences in quantities of personal annotations (in the
paper documents) and GO annotations by organism novices and experts in the MMS
might in part be the result of experts annotating differently from their normal approach in
order to ‘set a good example’, or be more thorough to help novices during the discussion
portion of the GO meeting understand from where in the documents GO annotations were
drawn. Additionally, while the studies were designed to be as naturalistic as possible,
certain aspects were different enough from the curators’ normal workflow and practices
to have affected outcomes. Perhaps the most significant of these occurred in the SMS,
where curators were instructed to work alone, and not seek input or advice from other
curators when making their annotations. In the individual interviews and focus group that
were subsequently conducted, this restriction was the most often repeated negative
attribute of the study: most local curators said that their normal work behavior was to
discuss annotations and the underlying papers quite frequently with their colleagues, and
the inability to do so in this case made the work more difficult and more time-consuming,
when they had to search for information online or in reference materials that they may
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otherwise have been able to turn around and ask a colleague. While the intent of this
restriction was to avoid curators converging on the same outcome and obscuring
variation, it also forced a situation where the task was somewhat unnatural. However,
half of the participating SMS curators work off-site full time, and thus do not have the
ability to obtain assistance as easily as those curators who work together. In the
individual interviews, the off-site curators reported that they were more likely to return to
the pool of uncurated papers an article that contained unfamiliar information than they
would be to contact the other curators to seek assistance. Remote curators also tended to
have more curation- and work experience as well, though, and may typically have fewer
questions about the papers. A related factor is that different MODs have different
annotation workflows. In some cases, curators are expected to do several kinds of
curation, including GO annotation, while other MODs are more specialized, with some
curators focused on GO annotation, and others performing other curation tasks.
5. Conclusions and Future Work
5.1. Conclusions
This project provided the first in-depth investigation of biocurators’ Gene Ontology
annotation behaviors, both in terms of fine-grained multilevel analysis of annotation
instances, as well as contextual factors that may influence curator annotation behavior.
Variation in curator annotations was expected prior to conducting this study, but the
origins, magnitude, and types of variation were unknown. From a basic science
perspective, this project was interested in beginning to understand the origins of
differences in human information interaction behavior in the context of Gene Ontology
annotation. Given a standard task, with the same evidence sources and controlled
vocabularies, why and how do people differ in such aspects as their term selection,
identification of genes, reading behavior, and interpretation of experiments? What is the
relative difficulty of locating an annotatable gene product, identifying the experiment (for
the Evidence Code), and selecting an appropriate GO term? While it may appear that
gene products may be easily identified within a paper, to which of them it may be
appropriate to make a GO annotation is less clear. While the experiment may be
described in detail in the Methods section of a paper, it may not be obvious which
Evidence Code should be applied. More work on the cognitive processes underlying
these activities of identification and relation is needed, as described below.
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In addition to understanding basic human information interaction behavior, the
project was interested in: a) outcomes that might assist in the training of novice scientific
curators by studying the practices of expert curators; b) testing measures of annotation
quality that might be useful to MOD administrators and funding agencies; and c) using
the knowledge obtained from the studies to augment the performance of human
annotators as well as improving automated approaches to GO annotation. The interviews
with experienced curators reinforced the apprentice model of curatorial training, and also
provided workflow information that could assist in the development of better training
models. The annotation quality facet analysis allowed for a more granular assessment of
annotation variation, and could be more useful when refined if methods to address
mismatched instances are also developed. Finally, the set of novel annotation instances
should be useful for conducting both human- and automated performance improvement
activities. The Future Work section below discusses additional projects to help advance
these three research objectives.
An example of how endemic variation is in the annotation process is illustrated by
curators’ differing values in perhaps the most straightforward element of the GO
annotation: the aspect, which has only three possible values. Table 24 illustrates eighteen
observed variants for this element.
Table 24. Variation in curators’ GO aspect values
molecular_function
biological_process
cellular_component
Function
Process
Component
function
process
component
MF
BP
CC
FUNCTION
PROCESS
COMPONENT
F
P
C
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And, as the responses to the question about curators’ areas of expertise show (Table
15), variation in what terms are used to describe biological concepts extends even to the
names of specialties within the domain of biomedical research. While at one level this
may indicate the need for ontologies and controlled vocabularies, this work has shown
that even when those tools are present, variation in use will persist. Some may eventually
be compensated for by automated means, but some will likely remain extremely difficult
to evaluate.
5.2. Future work
This section addresses future work to answer additional research questions raised by
the results of this project.
Do group dynamics help explain the variation between individual and consensus
annotations?
As noted in section 2.7, curators in the SMS were observed while they participated in
paired discussions to rationalize differences in their individual annotations to create
consensus annotations. While these data were not used in this study, they may help us
further understand the origins of individual differences, as well as insights to group
dynamics, such as when curators of the same and different levels of expertise rationalize
variations in individual annotations.
Do systematic features of the literature lead to variation in annotations?
One unexplored source of variation is the document corpus itself: Do differences in
the underlying papers explain part of all of the variation in annotations? Attributes such
as document length and complexity, or large or small scale experiments, could be
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evaluated in relation to instance counts, term specificity, or curator attributes such as
organism expertise or years of GO annotation experience. Some data was collected
during the individual interviews in both studies on curators’ perceived differences in the
articles used for annotation, and their behavioral responses.
Does vocabulary size explain variation?
This project did not investigate specific term differences on a large scale outside of
the example Specificity calculations. A more comprehensive comparison of the
intersection of term sets, particularly from the MMS, could be informative, particularly in
conjunction with the experience and expertise contextual data. Also of interest is where
divergent terms come from that do not overlap. As with other types of manual
classification tasks, we might expect that variation in term assignment would increase as
the number of available terms increases, in both breadth and depth. One test of this
hypothesis could be the use of the minimal GO ontologies called ‘GO Slims’ (described
in section 4.1) compared with the full GO ontologies, applied to the same evidence
sources.
Do curators’ indexing outcomes mirror their annotation variation?
During the SMS study, as noted in section 2.1.1, the curators performed a ‘full
curation’ of the papers, so additional data exists that can be used for further analysis, such
as evaluation of the consistency of the high-level indexing performed on papers. Since
these terms are drawn from a very small controlled vocabulary, it would be interesting to
compare consistency of that task with that of the GO annotation component, where
curators must choose from a much larger set of terms. Also, rather than capturing the
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claims of the paper in a formal structure, this type of curation is more similar to a typical
article indexing task, where the goal is to identify the ‘main topics’ of a paper, or what
the paper is ‘about’. It may be possible to compare the SMS curators’ term selections
with the MeSH terms assigned by MEDLINE indexers, as the pilot study in MacMullen
(2006a) attempted to do.
Can the information in these studies assist in training novice curators?
Bertrand and Cellier (1995) identified three general indexing strategies based upon
indexers’ expertise. Can effective strategies for the creation of GO annotations be
identified from the contextual data collected in this study from expert curators? These
could be useful for training novice curators in best practices of curation.
How do end users use annotations and perceive GO annotation quality?
The studies reported here focused on GO annotation from the curator perspective,
but, as with that area, little investigation has been done of scientists’ use of GO
annotations in their everyday work tasks. Work on scientists’ information behaviors,
trust, quality perceptions, and roles in creation and revision of GO annotations are
needed. What is learned from studies of these kinds could inform not only the further
development of measures of GO annotation quality, but may help us to understand
curator variation.
At what level of granularity can GO annotations be linked to underlying evidence
sources?
The cognitive gap that currently exists between GO annotations and the evidence
sources from which they are drawn is another area where work is needed. This could be
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addressed through possible collaborations with the GOA (Gene Ontology Annotation)
group at the European Bioinformatics Institute (EBI), the WormBase MOD, and others
who are developing annotation and curation applications that tie the final formal GO
annotations directly to the underlying components of the primary source that the curator
believes establishes the claims the authors are making (e.g., Couto, et al., 2007).
Applications of this kind could be useful at a practical level for training new curators, as
well as helping to understand from where curators derive their annotations, and perhaps
why they differ.
Research priorities.
This work has shown that a large number of contextual factors exist that may
influence the amounts and types of variation in GO annotations. This section has
described some approaches to addressing research questions that remain. Two non-
contextual areas which should be studied next are a deeper analysis of the term variation
observed in the MMS, and studies of GO end-users’ information needs and quality
perceptions. These studies could be performed concurrently, with GO users assessing the
relative importance of selected terms to areas of interest to end users.
APPENDICES
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A1. Protocol: Individual interviews
This section provides the semi-structured interview protocols for the individual
curator interviews.
A1.1. Single-MOD study
Personal education and experience; work roles
- Describe your educational background [prompts: undergrad major, graduate
specialization(s), other training and certification]
- Describe your laboratory experience (if any) [prompts: duration, specialization,
organism / disease focus]
- Describe how you came to be involved in biological database curation [prompts: (if
applicable) what made you decide to stop working in a lab environment?]
- What did you have to learn early on as a curator to help you better do your work?
[prompts: biology/organism knowledge, computer skills, ontology knowledge]
- How much publication experience do you have as a lab scientist? [probe: (if
little/significant:) Do you think this makes it more/less difficult for you to make
annotations?]
- Do you have lab experience with more than one organism? [probe: How do you think
this affects the way you make GO annotations?]
- Do you have curation/annotation experience with more than one organism? [probe:
What are some differences you’ve experienced curating multiple organisms? [prompt:
different workflows, different types of organisms’ research foci, etc.]
- Describe any specific training you may have had in curation and related topics (e.g,,
training in IT, ontologies). [probe: number of GO meetings attended, for example]
- How would you describe your roles as a curator, both to the database, and within
science overall? [prompt: compared with lab work, if applicable; what goals are
curators trying to achieve through their work and the development of the database?]
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Annotation processes and tasks
- Describe the steps you take when making a GO annotation from a scientific article.
[draw diagram to confirm]
- Elaborate on the sub-tasks involved in each step; what knowledge, skills, and external
tools do you use?
- How much time, on average, does it take to create GO annotations from a typical
experimental paper?
- What are some things that you encounter during this process that slow it down or
speed it up? [prompt: article type, experiment type, presence/absence of knowledge to
understand the paper]
- When examining the source article for assertions from which to annotate, describe
what sections of the article you look at, and in what order.
- What specific kinds of information are you looking for when doing this? [prompt:
keywords (such as…), methods, tables, figures]
- What are some facets that indicate to you what your annotation may be? [prompt:
article type (e.g., experimental vs. review), methodology; do they notice a difference
between ‘genetics’ papers vs ‘biochemistry’ papers, as one curator does?]
- What do you use as reference material to support your memory and knowledge when
building the components of an annotation? [prompt: e.g., when identifying the
Evidence Code, is the GO definition list consulted? Laboratory manuals to understand
methods?]
- Are there specific types of data you are looking for in each article when you do a full
curation? What are they? [supervisor listed them (informally) as “GO, phenotypes,
literature topics, new gene names and other general data for a gene.”]
- Who do you normally talk with when you have about questions about annotations
during curation? [probe: supervisor vs peer. Draw a network diagram of who asks and
is asked based on what criteria.]
- Can you give examples of situations where that normal process didn’t work, or you
had to take a different approach? [prompt: what features of the documents or the
assertions inhibited the normal process?]
- What do you think caused that situation? [prompt: type of article, type of experiment,
protocol/method, gene, etc. in the article?]
- What was unusual about the exercise compared with your normal work process?
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A1.2. Multi-MOD study
(Note: Questions equivalent to those in the single-MOD study about personal education
and experience are addressed in the brief written questionnaire attached to the GO
annotation template, and thus were not asked during the interviews.)
The goals of this interview are to learn about your personal approach to GO annotation in
detail, and to learn how you may have approached this study differently from your
normal curation and annotation activities.
Typical annotation process
- Describe your normal or typical personal GO annotation process. [prompts: You
might think of a recent experience you’ve had, or a specific paper that you remember]
- Describe the specific steps you take when reading a paper to make GO annotations.
[prompts: Which section do you read first? Next? Do you read the entire paper, or
only specific sections? Are there sections you always/never read? In what order do
you read the paper?]
- In addition to the paper itself, what other tools or resources do you typically have
nearby when annotating? [prompts: MOD-specific curator interface; GO ontology
browser; other external reference materials, such as text- or reference books]
- Do you read the article on the screen, or print it out?
- Do you make marks or notes on the article? [prompts: what / how / why]
- Do you take intermediate notes on a separate paper or in a file?
MMS study specifics
- What was different about this study from the way you normally do GO annotation?
[prompts: organism diversity; consensus step]
- Have you performed a consensus annotation process at your own database? What was
that experience like for you during this study?
- Did you read the papers from organisms you are (less-,un-)familiar with differently
than (your own, the ones you’re familiar with?) What did you do differently?
- Were there differences in the structure or format of the unfamiliar papers that
influenced your annotation? [prompts: paper structure; order of sections; length]
- Were there differences in the underlying experiments or organisms in the unfamiliar
papers that influenced your annotation? [prompts: experiment types, terminology,
fundamental biological differences (e.g., no leaf morphogenesis in mammals)]
- Do you have any other comments or questions about this study that we haven’t
discussed?
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A2. Protocol: Self-administered curator questionnaire (MMS)
Note: These questions were also used to extract the equivalent data from the individual
SMS interviews.
1. In what disciplines are your degrees? (list all) (e.g., BA in biology, BS in chemistry,
Ph.D in genetics)
2. What would you say is your main area, or areas, of expertise? (e.g., transcription,
DNA repair, development, meiosis)
3. What organisms do you have lab experience with? (pre- and post-doc levels)
4. What organisms do you have GO curation experience with?
Subsequent follow-up question (via email): How many months or years of GO annotation
experience did you have at the time of the study?
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A3. Protocol: SMS focus group
This section provides the protocol used in the SMS focus group discussions. This is a
guide only; the discussion was driven primarily by the curators’ responses to each others’
statements about curation and annotations.
The practice of annotation
- Given a general model of an annotation process [show diagram], talk about how your
individual approaches vary in actual practice. [prompt: different order, iterations, etc.]
- What skills and experience do you think are important for a curator to have to be
successful? [prompt: bioscience degree, lab experience, computer experience, specific
organism experience]
- What does ‘quality’ mean in the context of GO annotations? How would you define a
‘high-quality’ GO annotation? How much variation in each field is acceptable, and
are some weighted more heavily than others?
The annotation exercises
- Describe the discussions you had when performing the annotation consensus exercise;
what did they consist of? [prompt: arguments from experience, reference to the
original article, reference to other sources]
- What were some typical differences between the annotations? [probe: Why do you
think they occurred? Do you ever have these types of discussions with other curators
in the normal course of your work, prior to finalizing an annotation? Under what
conditions does this occur?]
The future of annotation
- What changes do you see in the next few years in biology or informatics that may
change the way GO annotation is done?
- Ignoring current technology as much as you can, what would help you as a curator
make better annotations? [prompt: where ‘better’ means ‘more’, ‘faster’, ‘cheaper’,
etc. Probe: Include not only technological changes, but changes in the publication
process; impact of open access journals, different instantiations of articles, etc.]
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A4. Protocol: SMS observations
This section provides the protocols used for the observation of individual curator
annotations and consensus annotations. In both cases, the audio recorder was left on even
during times when no one was speaking, to enable the calculation of time spent per sub-
task and total elapsed time. The researcher recorded field notes and observations about
workflows and other events to enhance the recording.
Reliability observations
The curators were instructed 1) to briefly describe their actions and thoughts, but not
to make detailed explanations of them; and 2) to try avoid thinking about any memories
they may have of the paper, or what they did the first time. [In all four cases, the papers
did not look familiar to the curators, and only in certain instances did they remember
aspects of them.] Questions from the researcher were typically held until the end, except
for brief clarifications or note for the recording about what was taking place.
Consensus observations
The curators were asked to arrive at a consensus by whatever means they felt
comfortable. Questions from the researcher were held until the end.
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A5. Protocol: Artifact collection and analysis
This section provides the protocol used to collect the individual and consensus group
annotations, as well as any manually annotated articles.
SMS study
- Curators who do both individual and consensus annotations remotely should send
copies of their annotation spreadsheets to the study coordinator in advance of the
meeting.
- Curators who will do individual annotations remotely and consensus annotations at
Stanford should bring their spreadsheets to the meeting.
- Curators who do both individual and consensus annotations on site should give their
spreadsheets and documents to the local study coordinator.
MMS study
- GO annotation spreadsheets should be emailed prior to the meeting to the local study
coordinator to be de-identified and aggregated before being sent to the study PI.
- Participants bringing or sending copies of their manually-annotated articles to the
local study coordinator should mark each one with their curator ID, not their name.
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A6. Article corpus for Single-MOD study
This appendix lists the articles annotated in the main SMS study, followed by those for
the Reliability arm.
P1. Ford AS, Guan Q, Neeno-Eckwall E, Culbertson MR. Ebs1p, a negative regulator of
gene expression controlled by the Upf proteins in the yeast Saccharomyces
cerevisiae. Eukaryot Cell. 2006 Feb;5(2):301-12. PMID: 16467471
P2. Miao M, Ryan KJ, Wente SR. The integral membrane protein Pom34p functionally
links nucleoporin subcomplexes. Genetics. 2006 Mar;172(3):1441-57. Epub 2005
Dec 15. PMID: 16361228
P3. Trautwein M, Schindler C, Gauss R, Dengjel J, Hartmann E, Spang A. Arf1p, Chs5p
and the ChAPs are required for export of specialized cargo from the Golgi. EMBO
J. 2006 Mar 8;25(5):943-54. Epub 2006 Feb 23. PMID: 16498409
P4. Swanson KA, Hicke L, Radhakrishnan I. Structural basis for monoubiquitin
recognition by the Ede1 UBA domain. J Mol Biol. 2006 May 5;358(3):713-24.
Epub 2006 Mar 9. PMID: 16563434
P5. Monroe DS Jr, Leitzel AK, Klein HL, Matson SW. Biochemical and genetic
characterization of Hmi1p, a yeast DNA helicase involved in the maintenance of
mitochondrial DNA. Yeast. 2005 Dec;22(16):1269-86. PMID: 16358299
P6. Mesecke N, Terziyska N, Kozany C, Baumann F, Neupert W, Hell K, Herrmann JM.
A disulfide relay system in the intermembrane space of mitochondria that mediates
protein import. Cell. 2005 Jul 1;121(7):1059-69. PMID: 15989955
P7. Saerens SM, Verstrepen KJ, Van Laere SD, Voet AR, Van Dijck P, Delvaux FR,
Thevelein JM. The Saccharomyces cerevisiae EHT1 and EEB1 genes encode
novel enzymes with medium-chain fatty acid ethyl ester synthesis and hydrolysis
capacity. J Biol Chem. 2006 Feb 17;281(7):4446-56. Epub 2005 Dec 15. PMID:
16361250
P8. Hoffmann ER, Borts RH. Trans events associated with crossovers are revealed in the
absence of mismatch repair genes in Saccharomyces cerevisiae. Genetics. 2005
Mar;169(3):1305-10. Epub 2005 Jan 16. PMID: 15654113
P9. Helmstaedt K, Strittmatter A, Lipscomb WN, Braus GH. Evolution of 3-deoxy-D-
arabino-heptulosonate-7-phosphate synthase-encoding genes in the yeast
Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9784-
9. Epub 2005 Jun 29. PMID: 15987779
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P10. McNabb DS, Pinto I. Assembly of the Hap2p/Hap3p/Hap4p/Hap5p-DNA
complex in Saccharomyces cerevisiae. Eukaryot Cell. 2005 Nov;4(11):1829-39.
PMID: 16278450
P11. Noma A, Kirino Y, Ikeuchi Y, Suzuki T. Biosynthesis of wybutosine, a hyper-
modified nucleoside in eukaryotic phenylalanine tRNA. EMBO J. 2006 May
17;25(10):2142-54. Epub 2006 Apr 27. PMID: 16642040
P12. Warringer J, Blomberg A. Involvement of yeast YOL151W/GRE2 in ergosterol
metabolism. Yeast. 2006 Apr 15;23(5):389-98. PMID: 16598690
P13. Ishchenko AA, Yang X, Ramotar D, Saparbaev M. The 3'->5' exonuclease of
Apn1 provides an alternative pathway to repair 7,8-dihydro-8-oxodeoxyguanosine
in Saccharomyces cerevisiae. Mol Cell Biol. 2005 Aug;25(15):6380-90. PMID:
16024777
P14. Wang Z, Jones GM, Prelich G. Genetic analysis connects SLX5 and SLX8 to the
SUMO pathway in Saccharomyces cerevisiae. Genetics. 2006 Mar;172(3):1499-
509. Epub 2005 Dec 30. PMID: 16387868
P15. Huang LS, Doherty HK, Herskowitz I. The Smk1p MAP kinase negatively
regulates Gsc2p, a 1,3-beta-glucan synthase, during spore wall morphogenesis in
Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2005 Aug
30;102(35):12431-6. Epub 2005 Aug 22. PMID: 16116083
P16. Qiu J, Yoon JH, Shen B. Search for apoptotic nucleases in yeast: role of Tat-D
nuclease in apoptotic DNA degradation. J Biol Chem. 2005 Apr
15;280(15):15370-9. Epub 2005 Jan 18. PMID: 15657035
P17. Murakami Y, Siripanyaphinyo U, Hong Y, Tashima Y, Maeda Y, Kinoshita T.
The initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-Y, a
seventh component. Mol Biol Cell. 2005 Nov;16(11):5236-46. Epub 2005 Sep 14.
PMID: 16162815
P18. Chuang SM, Madura K. Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4
binds the proteasome in the presence of translationally damaged proteins.
Genetics. 2005 Dec;171(4):1477-84. Epub 2005 Aug 22. PMID: 16118187
P19. Duttagupta R, Tian B, Wilusz CJ, Khounh DT, Soteropoulos P, Ouyang M,
Dougherty JP, Peltz SW. Global analysis of Pub1p targets reveals a coordinate
control of gene expression through modulation of binding and stability. Mol Cell
Biol. 2005 Jul;25(13):5499-513. PMID: 15964806
P20. Bebenek K, Garcia-Diaz M, Patishall SR, Kunkel TA. Biochemical properties of
Saccharomyces cerevisiae DNA polymerase IV. J Biol Chem. 2005 May
20;280(20):20051-8. Epub 2005 Mar 17. PMID: 15778218
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P21. Hoffmann ER, Borts RH. Trans events associated with crossovers are revealed in
the absence of mismatch repair genes in Saccharomyces cerevisiae. Genetics. 2005
Mar;169(3):1305-10. Epub 2005 Jan 16. PMID: 15654113
P22. von Janowsky B, Major T, Knapp K, Voos W. The disaggregation activity of the
mitochondrial ClpB homolog Hsp78 maintains Hsp70 function during heat stress.
J Mol Biol. 2006 Mar 31;357(3):793-807. Epub 2006 Jan 19. PMID: 16460754
P23. Ambrona J, Vinagre A, Ramirez M. Rapid asymmetrical evolution of
Saccharomyces cerevisiae wine yeasts. Yeast. 2005 Dec;22(16):1299-306. PMID:
16358308
P24. Rhodin J, Astromskas E, Cohn M. Characterization of the DNA binding features
of Saccharomyces castellii Cdc13p. J Mol Biol. 2006 Jan 20;355(3):335-46. Epub
2005 Nov 14. PMID: 16318854
P25. Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T. The m-
AAA protease defective in hereditary spastic paraplegia controls ribosome
assembly in mitochondria. Cell. 2005 Oct 21;123(2):277-89. PMID: 16239145
P26. Caesar R, Warringer J, Blomberg A. Physiological importance and identification
of novel targets for the N-terminal acetyltransferase NatB. Eukaryot Cell. 2006
Feb;5(2):368-78. PMID: 16467477
P27. Shaheen HH, Hopper AK. Retrograde movement of tRNAs from the cytoplasm
to the nucleus in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2005 Aug
9;102(32):11290-5. Epub 2005 Jul 22. PMID: 16040803
P28. Henry JM, Camahort R, Rice DA, Florens L, Swanson SK, Washburn MP, Gerton
JL. Mnd1/Hop2 facilitates Dmc1-dependent interhomolog crossover formation in
meiosis of budding yeast. Mol Cell Biol. 2006 Apr;26(8):2913-23. PMID:
16581767
P29. Teo H, Gill DJ, Sun J, Perisic O, Veprintsev DB, Vallis Y, Emr SD, Williams RL.
ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in
linking to ESCRT-I and membranes. Cell. 2006 Apr 7;125(1):99-111. PMID:
16615893
P30. Rand JD, Grant CM. The thioredoxin system protects ribosomes against stress-
induced aggregation. Mol Biol Cell. 2006 Jan;17(1):387-401. Epub 2005 Oct 26.
PMID: 16251355
P31. VerPlank L, Li R. Cell cycle-regulated trafficking of Chs2 controls actomyosin
ring stability during cytokinesis. Mol Biol Cell. 2005 May;16(5):2529-43. Epub
2005 Mar 16. PMID: 15772160
133
P32. Fernandez-Murray JP, McMaster CR. Glycerophosphocholine catabolism as a
new route for choline formation for phosphatidylcholine synthesis by the Kennedy
pathway. J Biol Chem. 2005 Nov 18;280(46):38290-6. Epub 2005 Sep 19. PMID:
16172116
P33. Mesecke N, Terziyska N, Kozany C, Baumann F, Neupert W, Hell K, Herrmann
JM. A disulfide relay system in the intermembrane space of mitochondria that
mediates protein import. Cell. 2005 Jul 1;121(7):1059-69. PMID: 15989955
P34. Sterling CH, Sweasy JB. DNA polymerase 4 of Saccharomyces cerevisiae is
important for accurate repair of methyl-methanesulfonate-induced DNA damage.
Genetics. 2006 Jan;172(1):89-98. Epub 2005 Oct 11. PMID: 16219787
P35. Poulsen P, Lo Leggio L, Kielland-Brandt MC. Mapping of an internal protease
cleavage site in the Ssy5p component of the amino acid sensor of Saccharomyces
cerevisiae and functional characterization of the resulting pro- and protease
domains by gain-of-function genetics. Eukaryot Cell. 2006 Mar;5(3):601-8.
PMID: 16524914
P36. Tsai HK, Lu HH, Li WH. Statistical methods for identifying yeast cell cycle
transcription factors. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13532-7.
Epub 2005 Sep 12. PMID: 16157877
P37. Kwan JJ, Warner N, Maini J, Chan Tung KW, Zakaria H, Pawson T, Donaldson
LW. Saccharomyces cerevisiae Ste50 binds the MAPKKK Ste11 through a head-
to-tail SAM domain interaction. J Mol Biol. 2006 Feb 10;356(1):142-54. Epub
2005 Nov 28. PMID: 16337230
P38. Resnick AC, Snowman AM, Kang BN, Hurt KJ, Snyder SH, Saiardi A. Inositol
polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory
activity. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12783-8. Epub 2005 Aug
25. PMID: 16123124
P39. Castrejon F, Gomez A, Sanz M, Duran A, Roncero C. The RIM101 pathway
contributes to yeast cell wall assembly and its function becomes essential in the
absence of mitogen-activated protein kinase Slt2p. Eukaryot Cell. 2006
Mar;5(3):507-17. PMID: 16524906
P40. Leger-Silvestre I, Caffrey JM, Dawaliby R, Alvarez-Arias DA, Gas N, Bertolone
SJ, Gleizes PE, Ellis SR. Specific Role for Yeast Homologs of the Diamond
Blackfan Anemia-associated Rps19 Protein in Ribosome Synthesis. J Biol Chem.
2005 Nov 18;280(46):38177-85. Epub 2005 Sep 12. PMID: 16159874
P41. Su X, Dowhan W. Regulation of cardiolipin synthase levels in Saccharomyces
cerevisiae. Yeast. 2006 Mar;23(4):279-91. PMID: 16544270
134
P42. Kostelansky MS, Sun J, Lee S, Kim J, Ghirlando R, Hierro A, Emr SD, Hurley JH.
Structural and functional organization of the ESCRT-I trafficking complex. Cell.
2006 Apr 7;125(1):113-26. PMID: 16615894
P43. Pinsky BA, Kotwaliwale CV, Tatsutani SY, Breed CA, Biggins S. Glc7/protein
phosphatase 1 regulatory subunits can oppose the Ipl1/aurora protein kinase by
redistributing Glc7. Mol Cell Biol. 2006 Apr;26(7):2648-60. PMID: 16537909
P44. Belanger KD, Gupta A, MacDonald KM, Ott CM, Hodge CA, Cole CM, Davis LI.
Nuclear pore complex function in Saccharomyces cerevisiae is influenced by
glycosylation of the transmembrane nucleoporin Pom152p. Genetics. 2005
Nov;171(3):935-47. Epub 2005 Aug 22. PMID: 16118201
P45. Lu A, Hirsch JP. Cyclic AMP-independent regulation of protein kinase A
substrate phosphorylation by Kelch repeat proteins. Eukaryot Cell. 2005
Nov;4(11):1794-800. PMID: 16278446
P46. Sambade M, Alba M, Smardon AM, West RW, Kane PM. A genomic screen for
yeast vacuolar membrane ATPase mutants. Genetics. 2005 Aug;170(4):1539-51.
Epub 2005 Jun 3. PMID: 15937126
P47. Young MJ, Theriault SS, Li M, Court DA. The carboxyl-terminal extension on
fungal mitochondrial DNA polymerases: identification of a critical region of the
enzyme from Saccharomyces cerevisiae. Yeast. 2006 Jan 30;23(2):101-16. PMID:
16491467
P48. Sano T, Kihara A, Kurotsu F, Iwaki S, Igarashi Y. Regulation of the sphingoid
long-chain base kinase Lcb4p by ergosterol and heme: studies in
phytosphingosine-resistant mutants. J Biol Chem. 2005 Nov 4;280(44):36674-82.
Epub 2005 Sep 1. PMID: 16141212
SMS Reliability study papers:
Curator RC1 
 
RP1 (6 month interval): 
 
Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P,
Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins.
Nature. 2006 Feb 16;439(7078):811-6. PMID: 16362057
135
RP2 (12 month interval): 
 
Shaner L, Trott A, Goeckeler JL, Brodsky JL, Morano KA. The function of the yeast
molecular chaperone Sse1 is mechanistically distinct from the closely related hsp70
family. J Biol Chem. 2004 May 21;279(21):21992-2001. PMID: 15028727
Curator RC2 
 
RP3 (6 month interval):
Saito K, Fujimura-Kamada K, Furuta N, Kato U, Umeda M, Tanaka K. Cdc50p, a
protein required for polarized growth, associates with the Drs2p P-type ATPase
implicated in phospholipid translocation in Saccharomyces cerevisiae. Mol Biol Cell.
2004 Jul;15(7):3418-32. PMID: 15090616
RP4 (12 month interval): 
 
Paumet F, Rahimian V, Rothman JE. The specificity of SNARE-dependent fusion is
encoded in the SNARE motif. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3376-80.
PMID: 14981247
136
A7. Article corpus for Multi-MOD study
This appendix lists the articles annotated in the MMS study by paper number.
P1. Noma A, Kirino Y, Ikeuchi Y, Suzuki T. Biosynthesis of wybutosine, a hyper-
modified nucleoside in eukaryotic phenylalanine tRNA. EMBO J. 2006 May
17;25(10):2142-54. Epub 2006 Apr 27. PMID: 16642040
P2. Warringer J, Blomberg A. Involvement of yeast YOL151W/GRE2 in ergosterol
metabolism. Yeast. 2006 Apr 15;23(5):389-98. PMID: 16598690
P3. Malone CJ, Misner L, Le Bot N, Tsai MC, Campbell JM, Ahringer J, White JG. The
C. elegans hook protein, ZYG-12, mediates the essential attachment between the
centrosome and nucleus. Cell. 2003 Dec 26;115(7):825-36. PMID: 14697201
P4. Wu YC, Tsai MC, Cheng LC, Chou CJ, Weng NY. C. elegans CED-12 acts in the
conserved crkII/DOCK180/Rac pathway to control cell migration and cell corpse
engulfment. Dev Cell. 2001 Oct;1(4):491-502. PMID: 11703940
P5. Fahlgren N, Montgomery TA, Howell MD, Allen E, Dvorak SK, Alexander AL,
Carrington JC. Regulation of AUXIN RESPONSE FACTOR3 by TAS3 ta-
siRNA affects developmental timing and patterning in Arabidopsis. Curr Biol.
2006 May 9;16(9):939-44. PMID: 16682356
P6. Auldridge ME, Block A, Vogel JT, Dabney-Smith C, Mila I, Bouzayen M,
Magallanes-Lundback M, DellaPenna D, McCarty DR, Klee HJ. Characterization
of three members of the Arabidopsis carotenoid cleavage dioxygenase family
demonstrates the divergent roles of this multifunctional enzyme family. Plant J.
2006 Mar;45(6):982-93. PMID: 16507088
P7. Beigneux AP, Vergnes L, Qiao X, Quatela S, Davis R, Watkins SM, Coleman RA,
Walzem RL, Philips M, Reue K, Young SG. Agpat6--a novel lipid biosynthetic
gene required for triacylglycerol production in mammary epithelium. J Lipid Res.
2006 Apr;47(4):734-44. Epub 2006 Jan 31. PMID: 16449762
P8. Kim YS, Nakanishi G, Lewandoski M, Jetten AM. GLIS3, a novel member of the
GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation
functions. Nucleic Acids Res. 2003 Oct 1;31(19):5513-25. PMID: 14500813
P9. Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, Herr JC, Okumura K,
Hasegawa A, Koyama K, Suri A. Characterization of a novel human sperm-
associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal
kinase-interacting protein. Biochem J. 2005 Jul 1;389(Pt 1):73-82. PMID:
15693750
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P10. Abdul KM, Terada K, Yano M, Ryan MT, Streimann I, Hoogenraad NJ, Mori M.
Functional analysis of human metaxin in mitochondrial protein import in cultured
cells and its relationship with the Tom complex. Biochem Biophys Res Commun.
2000 Oct 5;276(3):1028-34. PMID: 11027586
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A8. UNC IRB application and approval
These studies were reviewed and approved by the University of North Carolina’s
Institutional Review Board on 2006-04-04, and renewed on 2007-03-22, with an
expiration date of 2008-03-20. The study number is 06-0044. Portions of the IRB
documents that follow are redacted to preserve the anonymity and privacy of study
participants.
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OFFICE OF HUMAN RESEARCH ETHICS
Institutional Review Board
APPLICATION FOR IRB APPROVAL OF HUMAN SUBJECTS RESEARCH
Version 7-Mar-2006
Part A.1. Contact Information, Agreements, and Signatures
Title of Study: Strategies for information integration using annotation evidence Date: 2006-03-27
Name and degrees of Principal Investigator: W. John MacMullen, B.S., M.S.I.S.
Department: School of Information & Library Science Mailing address/CB #: 3360
UNC-CH PID: xxxxxxxxx Pager:
Phone #: 919-xxx-xxxx Fax #: Email Address:
For trainee-led projects: __ undergraduate _x_ graduate __ postdoc __ resident __ other
Name of faculty advisor: Gary Marchionini
Department: School of Information & Library Science Mailing address/CB #: 3360
Phone #: 919-xxx-xxxx Fax #: Email Address:
Name, phone number, email address of project manager or coordinator, if any: none
List all other project personnel including co-investigators, and anyone else who has contact with subjects
or identifiable data from subjects: none
Name of funding source or sponsor:
__ not funded _x_ Federal __ State __ industry __ foundation __ UNC-CH
__ other (specify): Sponsor or award number: NIH/NLM 1 F37 LM009194-01
Include following items with your submission, where applicable.
• Check the relevant items below and include one copy of all checked items 1-11 in the order listed.
• Also include two additional collated sets of copies (sorted in the order listed) for items 1-7.
Check Item Total No. of Copies
x 1. This application. One copy must have original PI signatures. 3
x
2. Consent and assent forms, fact or information sheets; include phone and
verbal consent scripts. 3
 3. HIPAA authorization addendum to consent form. 3
 4. All recruitment materials including scripts, flyers and advertising, letters,
emails. 3
x
5. Questionnaires, focus group guides, scripts used to guide phone or in-person
interviews, etc. 3
x
6. Protocol, grant application or proposal supporting this submission; (e.g.,
extramural grant application to NIH or foundation, industry protocol, student
proposal).
3
x
7. Documentation of reviews from any other committees (e.g., GCRC, Oncology
Protocol Review Committee, or local review committees in Academic Affairs). 3
 8. Addendum for Multi-Site Studies where UNC-CH is the Lead CoordinatingCenter. 1
 9. Data use agreements (may be required for use of existing data from thirdparties). 1
x
10. Documentation of required training in human research ethics for all study
personnel. 1
 11. Investigator Brochure if a drug study. 1
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Principal Investigator: I will personally conduct or supervise this research study. I will
ensure that this study is performed in compliance with all applicable laws, regulations
and University policies regarding human subjects research. I will obtain IRB approval
before making any changes or additions to the project. I will notify the IRB of any other
changes in the information provided in this application. I will provide progress reports to
the IRB at least annually, or as requested. I will report promptly to the IRB all
unanticipated problems or serious adverse events involving risk to human subjects. I will
follow the IRB approved consent process for all subjects. I will ensure that all
collaborators, students and employees assisting in this research study are informed about
these obligations. All information given in this form is accurate and complete.
Signature of Principal Investigator Date
Faculty Advisor if PI is a Student or Trainee Investigator: I accept ultimate
responsibility for ensuring that this study complies with all the obligations listed above
for the PI.
Signature of Faculty Advisor Date
Department or Division Chair, Center Director (or counterpart) of PI: (or Vice-
Chair or Chair’s designee if Chair is investigator or otherwise unable to review): I certify
that this research is appropriate for this Principal Investigator, that the investigators are
qualified to conduct the research, and that there are adequate resources (including
financial, support and facilities) available. If my unit has a local review committee for
pre-IRB review, this requirement has been satisfied. I support this application, and
hereby submit it for further review.
Signature of Department Chair or designee Date
Print Name of Department Chair or designee Department
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Part A.2. Summary Checklist
Are the following involved? Yes No
A.2.1. Existing data, research records, patient records, and/or human biological
specimens? _x_ __
A.2.2. Surveys, questionnaires, interviews, or focus groups with subjects? _x_ __
A.2.3. Videotaping, audiotaping, filming of subjects (newly collected or existing)? _x_ __
A.2.4. Do you plan to enroll subjects from these vulnerable or select populations:
a. UNC-CH students or UNC-CH employees? ....................................................
b. Non-English-speaking? ...................................................................................
c. Decisionally impaired? ....................................................................................
d. Patients? ...........................................................................................................
e. Prisoners, others involuntarily detained or incarcerated, or parolees? .............
f. Pregnant women? .............................................................................................
g. Minors (less than 18 years)? If yes, give age range: to years ................
__
__
__
__
__
__
__
_x_
_x_
_x_
_x_
_x_
_x_
_x_
A.2.5. a. Is this a multi-site study (sites outside UNC-CH engaged in the research)?
b. Is UNC-CH the sponsor or lead coordinating center?
If yes, include the Addendum for Multi-site Studies where UNC-CH is the
Lead Coordinating Center.
If yes, will any of these sites be outside the United States?
If yes, provide contact information for the foreign IRB.
__
__
__
_x_
__
__
A.2.6. Will there be a data and safety monitoring committee (DSMB or DSMC)? __ _x_
A.2.7. a. Are you collecting sensitive information such as sexual behavior, HIV
status, recreational drug use, illegal behaviors, child/physical abuse,
immigration status, etc?
b. Do you plan to obtain a federal Certificate of Confidentiality for this study?
__
__
_x_
_x_
A.2.8. a. Investigational drugs? (provide IND # )
b. Approved drugs for “non-FDA-approved” conditions?
All studies testing substances in humans must provide a letter of acknowledge-
ment from the UNC Health Care Investigational Drug Service (IDS).
__
__
_x_
_x_
A.2.9. Placebo(s)? __ _x_
A.2.10. Investigational devices, instruments, machines, software? (provide IDE #) __ _x_
A.2.11. Fetal tissue? __ _x_
A.2.12. Genetic studies on subjects’ specimens? __ _x_
A.2.13. Storage of subjects’ specimens for future research?
If yes, see instructions for Consent for Stored Samples. __ _x_
A.2.14. Diagnostic or therapeutic ionizing radiation, or radioactive isotopes, which
subjects would not receive otherwise?
If yes, approval by the UNC-CH Radiation Safety Committee is required.
__ _x_
A.2.15. Recombinant DNA or gene transfer to human subjects?
If yes, approval by the UNC-CH Institutional Biosafety Committee is required. __ _x_
A.2.16. Does this study involve UNC-CH cancer patients?
If yes, submit this application directly to the Oncology Protocol Review
Committee.
__ _x_
A.2.17. Will subjects be studied in the General Clinical Research Center (GCRC)?
If yes, obtain the GCRC Addendum from the GCRC and submit complete
application (IRB application and Addendum) to the GCRC.
__ _x_
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Part A.3. Conflict of Interest Questions and Certification
The following questions apply to all investigators and study staff engaged in the design, conduct, or
reporting results of this project and/or their immediate family members. For these purposes, "family"
includes the individual’s spouse and dependent children. “Spouse” includes a person with whom one lives
together in the same residence and with whom one shares responsibility for each other’s welfare and shares
financial obligations.
A.3.1. Currently or during the term of this research study, does any member of the
research team or his/her family member have or expect to have:
(a) A personal financial interest in or personal financial relationship (including gifts
of cash or in-kind) with the sponsor of this study?
(b) A personal financial interest in or personal financial relationship (including gifts
of cash or in-kind) with an entity that owns or has the right to commercialize a
product, process or technology studied in this project?
(c) A board membership of any kind or an executive position (paid or unpaid) with
the sponsor of this study or with an entity that owns or has the right to
commercialize a product, process or technology studied in this project?
__ yes
__ yes
__ yes
_x_ no
_x_ no
_x_ no
A.3.2. Has the University or has a University-related foundation received a cash or in-
kind gift from the Sponsor of this study for the use or benefit of any member of the
research team? __ yes _x_ no
A.3.3. Has the University or has a University-related foundation received a cash or in-
kind gift for the use or benefit of any member of the research team from an entity that
owns or has the right to commercialize a product, process or technology studied in this
project? __ yes _x_ no
If the answer to ANY of the questions above is yes, the affected research team member(s) must complete
and submit to the Office of the University Counsel the form accessible at http://coi.unc.edu. List name(s)
of all research team members for whom any answer to the questions above is yes:
Certification by Principal Investigator: By submitting this IRB application, I (the PI)
certify that the information provided above is true and accurate regarding my own
circumstances, that I have inquired of every UNC-Chapel Hill employee or trainee who will
be engaged in the design, conduct or reporting of results of this project as to the questions
set out above, and that I have instructed any such person who has answered “yes” to any of
these questions to complete and submit for approval a Conflict of Interest Evaluation Form.
I understand that as Principal Investigator I am obligated to ensure that any potential
conflicts of interest that exist in relation to my study are reported as required by University
policy.
Signature of Principal Investigator Date
Faculty Advisor if PI is a Student or Trainee Investigator: I accept ultimate responsibility
for ensuring that the PI complies with the University’s conflict of interest policies and
procedures.
Signature of Faculty Advisor Date
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Part A.4. Questions Common to All Studies
For all questions, if the study involves only secondary data analysis, focus on your proposed design,
methods and procedures, and not those of the original study that produced the data you plan to use.
A.4.1. Brief Summary. Provide a brief non-technical description of the study, which will be used for
internal and external communications regarding this research. Include purpose, methods, and participants.
Typical summaries are 50-100 words.
This study investigates how expert human curators extract knowledge from scientific articles and create
intellectual linkages (‘annotations’) between that knowledge and specific gene products in databases of
model organism information, with the goal of developing assistive strategies and tools for information
integration. The annotation work processes of approximately 15 curators will be studied through
observation, interviews, structured tasks, artifact analysis, and group discussions.
A.4.2. Purpose and Rationale. Provide a summary of the background information, state the research
question(s), and tell why the study is needed. If a complete rationale and literature review are in an
accompanying grant application or other type of proposal, only provide a brief summary here. If there is no
proposal, provide a more extensive rationale and literature review, including references.
The creation and use of annotations in biological databases is a growing part of biomedical research, due in
part to large-scale genome sequencing. At the same time, scientific knowledge in the form of published
journal articles continues to grow faster than individuals’ abilities to synthesize them, leading to
information overload and knowledge fragmentation by specialty. While the linkage of published
scientific knowledge with primary data in databases could potentially provide significant integration
and defragmentation of scientific knowledge, annotation as a work practice is an understudied area of
research. This study will investigate the nature of annotation work processes and artifacts in the
context of Gene Ontology annotations in model organism databases, including measures of quality,
such as consistency, reliabilty, accuracy, and completeness. [Complete rationale and literature review
are in the accompanying grant proposal.]
A.4.3. Subjects. You should describe the subject population even if your study does not involve direct
interaction (e.g., existing records). Specify number, gender, ethnicity, race, and age. Specify whether
subjects are healthy volunteers or patients. If patients, specify any relevant disease or condition and
indicate how potential subjects will be identified.
The subjects are adult curators of biological databases, typically holding Ph.D degrees in biomedical
sciences. The subject population is approximately 15 healthy volunteers of various genders, ethnicities,
races, and ages.
A.4.4. Inclusion/exclusion criteria. List required characteristics of potential subjects, and those that
preclude enrollment or involvement of subjects or their data. Justify exclusion of any group, especially by
criteria based on gender, ethnicity, race, or age. If pregnant women are excluded, or if women who become
pregnant are withdrawn, specific justification must be provided.
All curators from relevant biological databases are eligible to participate regardless of gender, ethnicity, or
race. Children are excluded from this research since none are employed as curators.
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A.4.5. Full description of the study design, methods and procedures. Describe the research study.
Discuss the study design; study procedures; sequential description of what subjects will be asked to do;
assignment of subjects to various arms of the study if applicable; doses; frequency and route of
administration of medication and other medical treatment if applicable; how data are to be collected
(questionnaire, interview, focus group or specific procedure such as physical examination, venipuncture,
etc.). Include information on who will collect data, who will conduct procedures or measurements.
Indicate the number and duration of contacts with each subject; outcome measurements; and follow-up
procedures.
The study addresses three areas related to annotation in one type of biological database (those focused on a
particular model organism), covered by the following aims:
Aim 1. Analysis of annotation processes and artifacts. This aim studies the artifacts of model organism
databases (MODs) in the form of Gene Ontology annotations and the evidence sources (e.g., published
scientific articles) from which they are derived, through the use of quantitative and qualitative
methods. Specific samples of publicly-available annotations from multiple MODs will be acquired,
quantified by measures (such as publication year and language, journal title), and categorized by facets
(such as index term overlap). The human and mechanical processes by which annotations in MODs are
created and maintained will be studied through individual interviews and observations with each
participating subject, and by conducting one or more focus groups with the population of human
curators described in A.4.3. (example interview and focus group questions attached). Subjects will be
asked to ‘think aloud’ as they perform tasks, in order to understand tacit knowledge and non-obvious
work facets. Artifacts relating to the annotation process, such as marked-up source articles, personal
notes, and computer screens, will be collected with the subjects’ permission for additional contextual
analysis to provide a fuller picture of the process.
Aim 2. Assessment of annotation quality metrics. Subsequent to the annotation process analysis in Aim 1,
the curators will be asked to perform their normal work processes on a predefined set of scientific
articles for the purpose of evaluating the validity of a set of annotation quality metrics. The set of
articles will be divided in equal parts among two or more equal groups of curators (quantities depend
upon enrollment). Each individual will annotate a subset of his/her group’s documents, with a
predefined amount of overlap in shared documents. For example, assume 6 total curators who are
randomly assigned to two groups of 3, and a total of 6 unique articles. With a group of 3 curators and a
subset of 3 of the 6 total articles, each curator will annotate 2 articles, one of which a second curator in
the group will also annotate. Each article will thus be annotated by 2 curators per group. The pairs of
curators with shared articles will subsequently rationalize (if different) their individual annotations,
leading to a single ‘gold standard’ annotation for that document. Following this step, each group will
be assigned the 3 papers from the other group, and will repeat the task without knowledge of the other
groups’ annotations. This design provides for 4x coverage of each article, and an ability to compare
individual annotations against gold standards devised by independent groups, without an external
standard process. The two rounds of annotation can be visualized in the following example (the actual
experiment will have randomized group and article assignments and may vary in size):
Round 1 Curators Round 2 Curators
Group 1 Group 2 Group 1 Group 2
Papers C1 C2 C3 C4 C5 C6 Papers C1 C2 C3 C4 C5 C6
P1 x x P1 x x
Set 1 P2 x x P2 x x
P3 x x P3 x x
P4 x x P4 x x
Set 2 P5 x x P5 x x
P6 x x P6 x x
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The data from these experiments will be analyzed using the quality metrics defined in the attachment
“Facets and measures of annotation quality in model organism databases”.
Aim 3. Development of one or more strategies for information integration from the evidence in Aims 1 and
2. The information collected and analyzed in Aims 1 and 2 (particularly the differences in annotation
processes, and in annotations of the same articles made by different curators), will be synthesized
using the ‘grounded theory’ technique and other theory-building approaches, as described in the
accompanying research proposal, to attempt to develop one or more strategies for information
integration that could be tested in future studies. This work does not involve human subjects.
The work described in these aims (content analysis, interviews, observations, quality experiments, data
analysis, and theory development) will be performed by the PI under the supervision of the faculty
advisor. The contact with subjects described in aims 1 and 2 will be performed in the same time period
in the subjects’ normal work setting. The quantitative- and content analyses in Aim 1, and the theory
development in Aim 3, will be performed by the PI at different times.
A.4.6. Benefits to subjects and/or society. Describe any potential for direct benefit to individual subjects,
as well as the benefit to society based on scientific knowledge to be gained; these should be clearly
distinguished. Consider the nature, magnitude, and likelihood of any direct benefit to subjects. If there is
no direct benefit to the individual subject, say so here and in the consent form (if there is a consent form).
Do not list monetary payment or other compensation as a benefit.
The anticipated societal benefits include a greater understanding of an important but little-studied area, as
well as the development of one or more strategies for information integration that could reduce
information overload and knowledge fragmentation. Research subjects are not expected to derive
immediate and specific benefits from the study, but may experience a broader understanding of the
nature of the annotation process that could improve their subsequent individual annotation
performance.
A.4.7. Full description of risks and measures to minimize risks. Include risk of psychosocial harm
(e.g., emotional distress, embarrassment, breach of confidentiality), economic harm (e.g., loss of
employment or insurability, loss of professional standing or reputation, loss of standing within the
community) and legal jeopardy (e.g., disclosure of illegal activity or negligence), as well as known side
effects of study medication, if applicable, and risk of pain and physical injury. Describe what will be done
to minimize these risks. Describe procedures for follow-up, when necessary, such as when subjects are
found to be in need of medical or psychological referral. If there is no direct interaction with subjects, and
risk is limited to breach of confidentiality (e.g., for existing data), state this.
No risks to participants are anticipated given the nature of the information they are providing. Interviews
and observations will take place in private. Individual performance on the experimental annotation
tasks will not be reported by curator name, only by a code as described below.
A.4.8. Data analysis. Tell how the qualitative and/or quantitative data will be analyzed. Explain how the
sample size is sufficient to achieve the study aims. This might include a formal power calculation or
explanation of why a small sample is sufficient (e.g., qualitative research, pilot studies).
The small number of participants in Aims 1 and 2 is not a concern to validity because the nature of the
research is focused on the elicitation of process details and the trial of quality measures, not a large-scale
assessment of annotation quality in a particular MOD. The experimental data from Aim 2 will be analyzed
with standard inter-coder reliability measures such as Cohen’s kappa and its variants.
146
A.4.9. Will you collect or receive any of the following identifiers? Does not apply to consent forms.
__ No _x_ Yes If yes, check all that apply:
a. _x_ Names
b. __ Telephone numbers
c. __ Any elements of dates (other than
year) for dates directly related to an
individual, including birth date, admission
date, discharge date, date of death. For
ages over 89: all elements of dates
(including year) indicative of such age,
except that such ages and elements may be
aggregated into a single category of age 90
and older
d. __ Any geographic subdivisions smaller
than a State, including street address, city,
county, precinct, zip code and their
equivalent geocodes, except for the initial
three digits of a zip code
e. __ Fax numbers
f. _x_ Electronic mail addresses
g. __ Social security numbers
h. __ Medical record numbers
i. __ Health plan beneficiary numbers
j. __ Account numbers
k. __ Certificate/license numbers
l. __ Vehicle identifiers and serial numbers
(VIN), including license plate numbers
m. __ Device identifiers and serial numbers
(e.g., implanted medical device)
n. _x_ Web universal resource locators (URLs)
o. __ Internet protocol (IP) address numbers
p. __ Biometric identifiers, including finger
and voice prints
q. __ Full face photographic images and any
comparable images
r. __ Any other unique identifying number,
characteristic or code, other than dummy
identifiers that are not derived from actual
identifiers and for which the re-
identification key is maintained by the
health care provider and not disclosed to the
researcher
A.4.10. Confidentiality of the data. Describe procedures for maintaining confidentiality of the data you
will collect or will receive. Describe how you will protect the data from access by those not authorized.
How will data be transmitted among research personnel? Where relevant, discuss the potential for
deductive disclosure (i.e., directly identifying subjects from a combination of indirect IDs).
For analysis purposes, personal identities are not relevant as data will be aggregated. Each subject will be
assigned a unique identifier when transcribing and coding the data. The consent forms and the file linking
the identifier with the subject’s name will be stored securely as described in A.4.12 and A.4.13 below.
A.4.11. Data sharing. With whom will identifiable (contains any of the 18 identifiers listed in question 9
above) data be shared outside the immediate research team? For each, explain confidentiality measures.
Include data use agreements, if any.
_x_ No one
__ Coordinating Center:
__ Statisticians:
__ Consultants:
__ Other researchers:
__ Registries:
__ Sponsors:
__ External labs for additional testing:
__ Journals:
__ Publicly available dataset:
__ Other:
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A.4.12. Data security for storage and transmission. Please check all that apply.
For electronic data:
__ Secure network _x_ Password access __ Encryption
_x_ Other (describe): Audio recordings will not identify participant names.
_x_ Portable storage (e.g., laptop computer, flash drive)
Describe how data will be protected for any portable device: The electronic name/identifier
linkage data will be stored in a password-protected file on portable storage media (floppy disk or flash
drive) in a locked cabinet for the duration of the study, and then destroyed. Data stored on investigator’s
laptop and backup disks will be the coded, de-identified data only.
For hardcopy data (including human biological specimens, CDs, tapes, etc.):
_x_ Data de-identified by research team (stripped of the 18 identifiers listed in question 7 above)
__ Locked suite or office
_x_ Locked cabinet
_x_ Data coded by research team with a master list secured and kept separately
_x_ Other (describe): Consent forms will be stored in the same locked cabinet as linkage file.
A.4.13. Post-study disposition of identifiable data or human biological materials. Describe your plans
for disposition of data or human biological specimens that are identifiable in any way (directly or via
indirect codes) once the study has ended. Describe your plan to destroy identifiers, if you will do so.
The name/identifier linkage file described in A.4.12 will be destroyed after the completion of the study by
erasure of the electronic media.
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Part A.5. The Consent Process and Consent Documentation (including Waivers)
The standard consent process is for all subjects to sign a document containing all the elements of informed
consent, as specified in the federal regulations. Some or all of the elements of consent, including
signatures, may be altered or waived under certain circumstances.
• If you will obtain consent in any manner, complete section A.5.1.
• If you are obtaining consent, but requesting a waiver of the requirement for a signed consent
document, complete section A.5.2.
• If you are requesting a waiver of any or all of the elements of consent, complete section A.5.3.
You may need to complete more than one section. For example, if you are conducting a phone survey with
verbal consent, complete sections A.5.1, A.5.2, and possibly A.5.3.
A.5.1. Describe the process of obtaining informed consent from subjects. If children will be enrolled
as subjects, describe the provisions for obtaining parental permission and assent of the child. If
decisionally impaired adults are to be enrolled, describe the provision for obtaining surrogate consent from
a legally authorized representative (LAR). If non-English speaking people will be enrolled, explain how
consent in the native language will be obtained. Address both written translation of the consent and the
availability of oral interpretation. After you have completed this part A.5.1, if you are not requesting a
waiver of any type, you are done with Part A.5.; proceed to Part B.
Consent will be obtained in writing, in person, using the attached consent form. All potential participants
are adult English speakers.
A.5.2. Justification for a waiver of written (i.e., signed) consent. The default is for subjects to sign a
written document that contains all the elements of informed consent. Under limited circumstances, the
requirement for a signed consent form may be waived by the IRB if either of the following is true:
a. The only record linking the subject and the research would be the consent
document and the principal risk would be potential harm resulting from a breach of
confidentiality (e.g., study involves sensitive data that could be damaging if
disclosed).
Explain.
b. The research presents no more than minimal risk of harm to subjects and involves
no procedures for which written consent is normally required outside of the research
context (e.g., phone survey).
Explain.
If you checked “yes” to either, will consent be oral? Will you give out a fact sheet?
Use an online consent form, or include information as part of the survey itself, etc?
__ yes __ no
__ yes __ no
 If you have justified a waiver of written (signed) consent (A.5.2), you should complete A.5.3 only if
your consent process will not include all the other elements of consent.
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A.5.3. Justification for a full or partial waiver of consent. The default is for subjects to give informed
consent. A waiver might be requested for research involving only existing data or human biological
specimens (see also Part C). More rarely, it might be requested when the research design requires
withholding some study details at the outset (e.g., behavioral research involving deception). In limited
circumstances, parental permission may be waived. This section should also be completed for a waiver of
HIPAA authorization if research involves Protected Health Information (PHI) subject to HIPAA regulation,
such as patient records.
__ Requesting waiver of some elements (specify; see SOP 28 on the IRB web site):
__ Requesting waiver of consent entirely
If you check either of the boxes above, answer items a-f.. To justify a full waiver of the requirement
for informed consent, you must be able to answer “yes” (or “not applicable” for question c) to items a-
f. Insert brief explanations that support your answers.
a. Will the research involve no greater than minimal risk to subjects or to their
privacy?
Explain.
__ yes __ no
b. Is it true that the waiver will not adversely affect the rights and welfare of
subjects? (Consider the right of privacy and possible risk of breach of confidentiality
in light of the information you wish to gather.)
Explain.
__ yes __ no
c. When applicable to your study, do you have plans to provide subjects with
pertinent information after their participation is over? (e.g., Will you provide details
withheld during consent, or tell subjects if you found information with direct clinical
relevance? This may be an uncommon scenario.)
Explain.
__ yes __ not
applicable
d. Would the research be impracticable without the waiver? (If you checked “yes,”
explain how the requirement to obtain consent would make the research
impracticable, e.g., are most of the subjects lost to follow-up or deceased?).
Explain.
__ yes __ no
e. Is the risk to privacy reasonable in relation to benefits to be gained or the
importance of the knowledge to be gained?
Explain.
__ yes __ no
If you are accessing patient records for this research, you must also be able to answer “yes” to item f
to justify a waiver of HIPAA authorization from the subjects.
f. Would the research be impracticable if you could not record (or use) Protected
Health Information (PHI)? (If you checked “yes,” explain how not recording or
using PHI would make the research impracticable).
Explain.
__ yes __ no
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Part B. Questions for Studies that Involve Direct Interaction with Human Subjects
 If this does not apply to your study, do not submit this section.
B.1. Methods of recruiting. Describe how and where subjects will be identified and recruited. Indicate
who will do the recruiting, and tell how subjects will be contacted. Describe efforts to ensure equal access
to participation among women and minorities. Describe how you will protect the privacy of potential
subjects during recruitment. For prospective subjects whose status (e.g., as patient or client), condition, or
contact information is not publicly available (e.g., from a phone book or public web site), the initial contact
should be made with legitimate knowledge of the subjects’ circumstances. Ideally, the individual with such
knowledge should seek prospective subjects’ permission to release names to the PI for recruitment.
Alternatively, the knowledgeable individual could provide information about the study, including contact
information for the investigator, so that interested prospective subjects can contact the investigator.
Provide the IRB with a copy of any document or script that will be used to obtain the patients’ permission
for release of names or to introduce the study. Check with your IRB for further guidance.
The first group of subjects (N=~15) was identified through conversations with the PI of a particular model
organism database who is interested in measures of annotation quality. The PI and curatorial staff have
committed to participate at a high level. Additional participants from other MODs may be identified
and recruited with their help if the first round of the study is useful and informative. No specific
additional groups, PIs, or curators have been identified as of the date of this application.
B.2. Protected Health Information (PHI). If you need to access Protected Health Information (PHI) to
identify potential subjects who will then be contacted, you will need a limited waiver of HIPAA
authorization. If this applies to your study, please provide the following information.
a. Will the information collected be limited only to that necessary to contact the subjects to ask if they are
interested in participating in the study?
b. How will confidentiality/privacy be protected prior to ascertaining desire to participate?
c. When and how will you destroy the contact information if an individual declines participation?
B.3. Duration of entire study and duration of an individual subject’s participation, including follow-
up evaluation if applicable. Include the number of required contacts and approximate duration of each
contact.
The portions of the study involving human subjects (Aims 1 and 2) are estimated to over a one-week
timeframe in June 2006, with the duration of individual subjects’ cumulative participation (including
interview, observation, annotation activities, and focus group) estimated at 6-8 hours, distributed over the
1-week period. Minimal follow-up on an individual basis may be required to clarify subjects’ answers or
descriptions if unclear during data transcription.
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B.4. Where will the subjects be studied? Describe locations where subjects will be studied, both on and
off the UNC-CH campus.
Subjects will be studied in their own work settings (typically academic research environments). There are
currently no plans to recruit or study subjects on the UNC-CH campus.
B.5. Privacy. Describe procedures that will ensure privacy of the subjects in this study. Examples include
the setting for interviews, phone conversations, or physical examinations; communication methods or
mailed materials (e.g., mailings should not indicate disease status or focus of study on the envelope).
Interviews and observations will occur in private spaces reserved in subjects’ workplace. Since the subjects
in the defined group already know each other and work together within the same organization, no
attempt will be made to restrict them from discussing the content of the focus group, or their individual
experiences, with each other outside of the study. Data resulting from interactions with subjects will be
protected as described above in A.4.12 and A.4.13. The consent form notes that the while individual
participant names will not be disclosed, the database name may be acknowledged in publications.
B.6. Inducements for participation. Describe all inducements to participate, monetary or non-monetary.
If monetary, specify the amount and schedule for payments and how this will be prorated if the subject
withdraws (or is withdrawn) from the study prior to completing it. For compensation in foreign currency,
provide a US$ equivalent. Provide evidence that the amount is not coercive (e.g., describe purchasing
power for foreign countries). Include food or refreshments that may be provided.
No monetary compensation is being offered to induce participation in the study. As described in B.1. and
B.5., the subjects are part of a single research organization that is interested in the topic of the
proposed research for their own benefit.
B.7. Costs to be borne by subjects. Include child care, travel, parking, clinic fees, diagnostic and
laboratory studies, drugs, devices, all professional fees, etc. If there are no costs to subjects other than their
time to participate, indicate this.
No costs other than time are expected to be borne by subjects.
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Part C. Questions for Studies using Data, Records or Human Biological Specimens
without Direct Contact with Subjects
 If this does not apply to your study, do not submit this section.
C.1. What records, data or human biological specimens will you be using? (check all that apply):
_x_ Data already collected for another research study
__ Data already collected for administrative purposes (e.g., Medicare data, hospital discharge data)
__ Medical records (custodian may also require form, e.g., HD-974 if UNC-Health Care System)
__ Electronic information from clinical database (custodian may also require form)
__ Patient specimens (tissues, blood, serum, surgical discards, etc.)
_x_ Other (specify): Publicly-available documents (e.g., public database entries).
C.2. For each of the boxes checked in 1, how were the original data, records, or human biological
specimens collected? Describe the process of data collection including consent, if applicable.
The data are existing annotations from publicly-available databases that may be used in comparison with
the data collected from subjects. The public annotation data does not have individual names associated
with it.
C.3. For each of the boxes checked in 1, where do these data, records or human biological specimens
currently reside?
Principal Investigator’s laptop and backups.
C.4. For each of the boxes checked in 1, from whom do you have permission to use the data, records or
human biological specimens? Include data use agreements, if required by the custodian of data that are not
publicly available.
All data are publicly available from Internet-accessible databases, most federally-funded.
C.5. If the research involves human biological specimens, has the purpose for which they were collected
been met before removal of any excess? For example, has the pathologist in charge or the clinical
laboratory director certified that the original clinical purpose has been satisfied? Explain if necessary.
__ yes __ no __ not applicable (explain)
C.6. Do all of these data records or specimens exist at the time of this application? If not, explain how
prospective data collection will occur.
__ yes _x_ no If no, explain: The data exists today, but is subject to continual revision and updating
due to the nature of the information resources.
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A9. Participant consent forms
For the single-MOD study, the original consent form as approved by the UNC
IRB was used (attached following this page). For the multi-MOD study, the same
form was used, but some of the activities listed under the section ‘What will happen if
you take part in the study?’ were not performed by the participants, so those portions
were marked out. Specifically, for the expert participants, formal observations and
concurrent verbal reports were not conducted, and no focus groups were conducted.
There were also three GO Camp attendees who submitted their annotations; their
forms requested consent for only the item ‘Asking you to perform typical work tasks
with specific documents’; all others were marked out, as well as the statement asking
for consent to make audio recordings, under the section ‘How will your privacy be
protected?’
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University of North Carolina-Chapel Hill
Consent to Participate in a Research Study
Adult Participants
Social Behavioral Form
________________________________________________________________________
IRB Study # 06-0044
Consent Form Version Date: 9-Mar-2005
Title of Study: Strategies for information integration using annotation evidence
Principal Investigator: W. John MacMullen
UNC-Chapel Hill Department: School of Information and Library Science
UNC-Chapel Hill Phone number: 919-962-8366
Email Address:
Faculty Advisor: Gary J. Marchionini
Funding Source: Microsoft Research; National Library of Medicine
Study Contact telephone number: 919-xxx-xxxx
_________________________________________________________________
What are some general things you should know about research studies?
You are being asked to take part in a research study. To join the study is voluntary. You may
refuse to join, or you may withdraw your consent to be in the study, for any reason, without
penalty.
Research studies are designed to obtain new knowledge. This new information may help people
in the future. You may not receive any direct benefit from being in the research study. There also
may be risks to being in research studies.
Details about this study are discussed below. It is important that you understand this information
so that you can make an informed choice about being in this research study.
You will be given a copy of this consent form. You should ask the researchers named above, or
staff members who may assist them, any questions you have about this study at any time.
What is the purpose of this study?
The purpose of this research study is to learn about annotations in biological databases. We are
interested in how annotations are made, how they are used, and their features. We are also
studying the validity of specific measures of annotation quality, such as consistency, reliability,
accuracy, and completeness.
You are being asked to be in the study because as a biological database curator, your expertise is
valuable in helping us understand the creation and maintenance of annotations in databases.
How many people will take part in this study?
If you decide to participate, you will be one of approximately 15 people in the study.
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How long will your part in this study last?
Your participation in this study will take approximately 6-8 hours, but may be distributed over
multiple days at your convenience.
What will happen if you take part in the study?
We are using multiple research methods to understand annotation practices in biological
databases. Specifically, we will be:
- Asking you how you do your work. We will ask you to describe in detail what your normal
work tasks consist of, and how you complete them, including what knowledge and skills are
required. This discussion will be audio recorded to ensure accurate transcription.
- Observing you as you do your work. By observing how you complete actual work tasks in a
natural setting, we may learn more about the annotation process than by discussion alone.
- Asking you to 'think aloud' while doing your work. This means that at certain times during the
observation, we will ask you to describe what you are thinking and doing as you perform a
particular work task. This process will include audio recordings of your spoken thoughts to
ensure we have described them accurately.
- Viewing artifacts related to your work. Looking at artifacts such as documents, notes, and
computer screens you create and use in you work will help us understand what you do.
- Asking you to perform typical work tasks with specific documents. For the purposes of
evaluating different measures of annotation quality, we will ask you to perform your normal
annotation-related tasks using predefined documents to allow for comparisons with other
participants. You will be assigned articles at random to annotate. Afterward, you will also
collaborate with other curators who have made annotations to the same documents, in order
to arrive at a consensus annotation. Your annotations will also be compared to other curators’
consensus annotations to see if there are differences.
- Asking you to participate in a group discussion (‘focus group’). The group will be asked to
discuss general questions about annotation in biological databases, and the quality measures
being studied. No questions will be directed to you individually, but instead will be posed to
the group. You may choose to respond or not respond at any point during the discussion. The
focus group discussion will be audio recorded to ensure accurate transcription. Participants
will not be identified by their real names in transcripts.
What are the possible benefits from being in this study?
Research is designed to benefit society by gaining new knowledge. You may also expect to
benefit by participating in this study by learning more about annotation practices from the
research findings and the other curators. This may help you in your future work.
What are the possible risks or discomforts involved from being in this study?
There are no anticipated risks to you as a participant of this study. There may be uncommon or
previously unknown risks. You should report any problems to the researcher.
How will your privacy be protected?
You will not be identified by name in any report or publication about this study, but the name of
the database may be acknowledged in publications. Although every effort will be made to keep
research records private, there may be times when federal or state law requires the disclosure of
such records, including personal information. This is very unlikely, but if disclosure is ever
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required, UNC-Chapel Hill will take steps allowable by law to protect the privacy of personal
information. In some cases, your information in this research study could be reviewed by
representatives of the University, research sponsors, or government agencies for purposes such as
quality control or safety.
Your participation will be audio recorded in certain cases as described above. Recordings are
used to create transcripts to ensure accurate descriptions of your participation. Your real name
will not be used in transcripts. The recordings and the files that link your real name to the
anonymous identifier used in the transcripts will be stored securely. Only the researcher and
faculty advisor will have access to these materials. The original recordings and the file linking
your name to the anonymous identifier will be destroyed after the conclusion of the study.
Will you receive anything for being in this study?
You will not receive anything for taking part in this study.
Will it cost you anything to be in this study?
There will be no costs for being in the study other than your participation time.
What if you have questions about this study?
You have the right to ask, and have answered, any questions you have about this research. If you
have questions or concerns, you should contact the researcher listed on the first page of this form.
What if you have questions about your rights as a research participant?
All research on human volunteers is reviewed by a committee that works to protect your rights
and welfare. If you have questions or concerns about your rights as a research subject you may
contact, anonymously if you wish, the Institutional Review Board at 919-966-3113 or by email to
IRB_subjects@unc.edu.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Participant’s Agreement:
I have read the information provided above. I have asked all the questions I have at this time. I
voluntarily agree to participate in this research study.
_________________________________________ _________________
Signature of Research Participant Date
_________________________________________
Printed Name of Research Participant
_________________________________________ _________________
Signature of Person Obtaining Consent Date
_________________________________________
Printed Name of Person Obtaining Consent
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A10. Original consensus annotations for MMS P2 quality facet
calculations
Original annotations.
Gene Aspect GOID GO Term EC With/from Qualifier
C1C3
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 6950 response to stress IMP
C2C10
GRE2 P 6950 response to stress IMP
GRE2 P 6696
ergosterol
biosynthesis IGI
SGD:S000001049|
SGD:S000005224|
SGD:S000004815|
SGD:S000004540|
SGD:S000004442
GRE2 P 16044
membrane
organization and
biogenesis IMP
C4C7
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 46467
membrane lipid
biosynthesis IMP
GRE2 P 9651
response to salt
stress IMP
GRE2 P 9651
response to cation
stress IMP
C5C9
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 9651
response to salt
stress IMP
GRE2 P 51592
response to calcium
ion IMP
C6C8
GRE2 P 9651
response to salt
stress IMP
GRE2 P 43157
response to cation
stress IMP
GRE2 P 6970
ergosterol
metabolism IMP
GRE2 P 6970
response to osmotic
stress IMP
ENO1 P 43157
response to cation
stress IEP
TDH1 P 43157
response to cation
stress IEP
HXK1 P 43157
response to cation
stress IEP
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Gene Aspect GOID GO Term EC With/from Qualifier
RNR4 P 43157
response to cation
stress IEP
BGL2 P 43157
response to cation
stress IEP
ERG10 P 43157
response to cation
stress IEP
ERG6 P 43157
response to cation
stress IEP
MVD1 P 43157
response to cation
stress IEP
GRE2 F 16491
oxidoreductase
activity ISS
NCBI:
AK121335
GRE2 F 47044
3-alpha(or 20-beta)-
hydroxysteroid
dehydrogenase
activity ISS
EMBL:
M38180
GRE2 F 0252
C-3 sterol
dehydrogenase (C-4 
sterol decarboxylase)
activity ISS
SGD:
S00002969
C11C15
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 6970
response to osmotic
stress IMP
GRE2 F 16491
oxidoreductase
activity ISS
C13C22
GRE2 P 8204
ergosterol
metabolism IMP
GRE2 P 43157
response to cation
stress IMP
GRE2 P 9651
response to salt
stress IMP
GRE2 P 6950 response to stress IMP
GRE2 P 46677 response to antibiotic IMP
GRE2 F 16491
oxidoreductase
activity ISS
SGD:
S000002969
ERG10 P 6696
ergosterol
biosynthesis IGI
SGD:
S000005511
ERG6 P 6696
ergosterol
biosynthesis IGI
SGD:
S000005511
ERG19 P 6696
ergosterol
biosynthesis IGI
SGD:
S000005511
C18C21
GRE2 P 6950 response to stress IMP
GRE2 P 9651
response to salt
stress IMP
GRE2 P 43157
response to cation
stress IMP
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Gene Aspect GOID GO Term EC With/from Qualifier
GRE2 P 8204
ergosterol
metabolism IDA
GRE2 P 16125 sterol metabolism IDA
GRE2 P 16044
membrane
organization and
biogenesis IMP
GRE2 P 19725 cell homeostasis IMP
GRE2 P 42391
regulation of
membrane potential IMP
GRE2 P 6696
ergosterol
biosynthesis IMP
Ydr541cp P 16125 sterol metabolism ISS Q12068
Ygl139wp P 16125 sterol metabolism ISS Q12068
Ygl157wp P 16125 sterol metabolism ISS Q12068
C12C14C19C20
GRE2 P 48193
Golgi vesicle
transport IMP
GRE2 P 6950 response to stress IMP
GRE2 P 8204
ergosterol
metabolism IMP
Evaluation set.
Gene Aspect GOID GO Term EC With/from Qualifier
C1C3
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 6950 response to stress IMP
C2C10
GRE2 P 6950 response to stress IMP
GRE2 P 6696
ergosterol
biosynthesis IGI
SGD:S000001049|
SGD:S000005224|
SGD:S000004815|
SGD:S000004540|
SGD:S000004442
C4C7
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 9651
response to salt
stress IMP
C5C9
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 9651
response to salt
stress IMP
C6C8
GRE2 P 9651 response to salt IMP
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Gene Aspect GOID GO Term EC With/from Qualifier
stress
GRE2 P 6970
ergosterol
metabolism IMP
C11C15
GRE2 P 6696
ergosterol
biosynthesis IMP
GRE2 P 6970
response to osmotic
stress IMP
C13C22
GRE2 P 8204
ergosterol
metabolism IMP
GRE2 P 6950 response to stress IMP
C18C21
GRE2 P 6950 response to stress IMP
GRE2 P 8204
ergosterol
metabolism IDA
C12C14C19C20
GRE2 P 6950 response to stress IMP
GRE2 P 8204
ergosterol
metabolism IMP
Matched instances.
i Pair Gene A GOID GO Term EC W/F Q
C1C3 GRE2 P 6696 ergosterol biosynthesis IMP
1 C2C10 GRE2 P 6696 ergosterol biosynthesis IGI [various]
2 C4C7 GRE2 P 6696 ergosterol biosynthesis IMP
3 C5C9 GRE2 P 6696 ergosterol biosynthesis IMP
4 C6C8 GRE2 P 6970 ergosterol metabolism IMP
5 C11C15 GRE2 P 6696 ergosterol biosynthesis IMP
6 C13C22 GRE2 P 8204 ergosterol metabolism IMP
7 C18C21 GRE2 P 8204 ergosterol metabolism IDA
8 C12C14C19C20 GRE2 P 8204 ergosterol metabolism IMP
C1C3 GRE2 P 6950 response to stress IMP
9 C2C10 GRE2 P 6950 response to stress IMP
10 C4C7 GRE2 P 9651 response to salt stress IMP
11 C5C9 GRE2 P 9651 response to salt stress IMP
12 C6C8 GRE2 P 9651 response to salt stress IMP
13 C11C15 GRE2 P 6970
response to osmotic
stress IMP
14 C13C22 GRE2 P 6950 response to stress IMP
15 C18C21 GRE2 P 6950 response to stress IMP
16 C12C14C19C20 GRE2 P 6950 response to stress IMP
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